TW201434974A - Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device - Google Patents

Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device Download PDF

Info

Publication number
TW201434974A
TW201434974A TW103109220A TW103109220A TW201434974A TW 201434974 A TW201434974 A TW 201434974A TW 103109220 A TW103109220 A TW 103109220A TW 103109220 A TW103109220 A TW 103109220A TW 201434974 A TW201434974 A TW 201434974A
Authority
TW
Taiwan
Prior art keywords
formula
group
liquid crystal
ring
ether
Prior art date
Application number
TW103109220A
Other languages
Chinese (zh)
Other versions
TWI638856B (en
Inventor
Yuko Katano
Norio Tamura
Yujiro Oguchi
Takahiro Yamauchi
Rika Hisada
Original Assignee
Jnc Corp
Jnc Petrochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jnc Corp, Jnc Petrochemical Corp filed Critical Jnc Corp
Publication of TW201434974A publication Critical patent/TW201434974A/en
Application granted granted Critical
Publication of TWI638856B publication Critical patent/TWI638856B/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Liquid Crystal (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nonlinear Science (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)

Abstract

A liquid crystal alignment agent is provided, which is a solution obtained by containing a polyamic acid or derivatives thereof, obtained by reacting a tetracarboxylic dianhydride with a diamine, and a solvent, wherein the solvent contains at least one compound represented by the following formula (A). The liquid crystal alignment agent, in which change of viscosity at room temperature does not easily happened, does not generate cissing when coating the alignment agent or whitening of a formed alignment film. In addition, the alignment stability of a liquid crystal molecule in the liquid crystal alignment film formed by using the liquid crystal alignment agent is good. Furthermore, a liquid crystal display device having the liquid crystal alignment film has excellent image sticking property. In the formula, R1 and R2 are each independently an alkyl group having 1 to 3 carbons.

Description

液晶配向劑、液晶配向膜及液晶顯示元件 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

本發明涉及一種用於形成液晶顯示元件的液晶配向膜的液晶配向劑及液晶顯示元件。更詳細而言,本發明涉及一種不易引起室溫下的黏度變化、且不會產生塗布配向劑時的凹陷(cissing)或經製膜的配向膜的白化的液晶配向劑,及具備由該液晶配向劑所獲得的液晶配向膜的液晶顯示元件。 The present invention relates to a liquid crystal alignment agent and a liquid crystal display element for forming a liquid crystal alignment film of a liquid crystal display element. More specifically, the present invention relates to a liquid crystal alignment agent which is less likely to cause a change in viscosity at room temperature and which does not cause cissing when applying an alignment agent or whitening of an alignment film formed by a film, and is provided with the liquid crystal. A liquid crystal display element of a liquid crystal alignment film obtained by an alignment agent.

液晶顯示元件是在設置有透明電極或金屬電極的基板表面形成包含聚醯胺酸、聚醯亞胺等的液晶配向膜來作為液晶顯示元件用基板,將2片液晶顯示元件用基板對向配置並在其間隙內形成液晶層而製成夾層構造的單元。通常,對形成在電極上的聚醯亞胺膜的表面進行所謂的“摩擦處理”來製作所述液晶配向膜。另外,也利用不進行摩擦的垂直配向膜、照射偏光紫外線(Ultraviolet,UV)的光配向膜等。 In the liquid crystal display device, a liquid crystal alignment film containing a polyacrylic acid, a polyimide, or the like is formed on the surface of a substrate on which a transparent electrode or a metal electrode is provided, as a substrate for a liquid crystal display element, and two liquid crystal display element substrates are aligned. A liquid crystal layer is formed in the gap to form a unit of a sandwich structure. Usually, the surface of the polyimide film formed on the electrode is subjected to a so-called "friction treatment" to produce the liquid crystal alignment film. Further, a vertical alignment film that does not rub, a light alignment film that emits polarized ultraviolet rays (UV), and the like are also used.

通常,配向膜的形成採用印刷法或噴墨法,但伴隨最近 的液晶顯示元件的高品質化,形成配向膜時的印刷不均已對顯示特性帶來影響,確保良好的製膜性變得更重要(參照專利文獻1等)。 Usually, the alignment film is formed by a printing method or an inkjet method, but with the recent The high quality of the liquid crystal display device and the unevenness in printing when the alignment film is formed have an influence on the display characteristics, and it is more important to ensure good film formation properties (see Patent Document 1, etc.).

在配向膜製膜時所看到的製膜不良的原因之一可列舉室溫下的配向劑的黏度下降。由於液晶配向劑的印刷在室溫下進行,因此由黏度下降所引起的膜厚不均等正成為問題。另外,塗布配向劑時產生凹陷而容易產生針孔等的現象、或者配向劑吸濕而導致配向劑本身或配向膜發生白化的現象也成為問題。進而,已知所述液晶配向膜的膜厚不均、針孔、白化現象與液晶面板的配向性、殘像特性的不佳有關(參照專利文獻2及專利文獻3等)。 One of the causes of the film formation failure observed in the formation of the alignment film is a decrease in the viscosity of the alignment agent at room temperature. Since the printing of the liquid crystal alignment agent is performed at room temperature, uneven film thickness due to a decrease in viscosity is becoming a problem. Further, when a coating agent is applied, a phenomenon of pinholes or the like is likely to occur, or a phenomenon in which the alignment agent absorbs moisture and the alignment agent itself or the alignment film is whitened is also problematic. Further, it is known that the film thickness unevenness, the pinhole, and the whitening phenomenon of the liquid crystal alignment film are related to the misalignment of the liquid crystal panel and the afterimage characteristics (see Patent Document 2 and Patent Document 3).

[現有技術文獻] [Prior Art Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本專利特開2009-37222 [Patent Document 1] Japanese Patent Laid-Open No. 2009-37222

[專利文獻2]日本專利特開平10-274772 [Patent Document 2] Japanese Patent Laid-Open No. 10-274772

[專利文獻3]國際公開第2009/148100 [Patent Document 3] International Publication No. 2009/148100

本發明的目的在於提供一種液晶配向劑,其不易引起室溫下的黏度變化、且不會產生塗布配向劑時的凹陷或經製膜的配向膜的白化。另外,本發明的目的在於提供一種液晶顯示元件,其具有由該配向劑所獲得的液晶配向膜、殘像特性優異、且配向穩定性良好。 An object of the present invention is to provide a liquid crystal alignment agent which is less likely to cause a change in viscosity at room temperature and which does not cause whitening of a depression or a film-forming alignment film when an alignment agent is applied. Further, an object of the present invention is to provide a liquid crystal display element which has a liquid crystal alignment film obtained from the alignment agent and which is excellent in afterimage characteristics and has good alignment stability.

本發明包含以下的構成。 The present invention includes the following constitutions.

[1]一種液晶配向劑,其是含有使四羧酸二酐與二胺進行反應而獲得的聚醯胺酸或其衍生物、及溶劑而成的溶液,且所述溶劑含有由下述式(A)所表示的化合物的至少1個: 式中,R1及R2分別獨立地為碳數1~3的烷基。 [1] A liquid crystal alignment agent containing a polyglycine or a derivative thereof obtained by reacting tetracarboxylic dianhydride with a diamine, and a solvent, and the solvent contains the following formula At least one of the compounds represented by (A): In the formula, R 1 and R 2 are each independently an alkyl group having 1 to 3 carbon atoms.

[2]根據所述[1]所述的液晶配向劑,其中:所述由式(A)所表示的化合物為選自由下述式(A-1)~式(A-6)所表示的化合物的群組中的至少一個。 [2] The liquid crystal alignment agent according to the above [1], wherein the compound represented by the formula (A) is selected from the group consisting of the following formulas (A-1) to (A-6). At least one of the groups of compounds.

[3]根據所述[2]所述的液晶配向劑,其中:所述由式(A)所表示的化合物為選自由式(A-1)、式(A-4)及式(A-6)所表示的化合物的群組中的至少一個。 [3] The liquid crystal alignment agent according to [2], wherein the compound represented by the formula (A) is selected from the group consisting of the formula (A-1), the formula (A-4), and the formula (A-). 6) at least one of the group of compounds represented.

[4]根據所述[1]至[3]中任一項所述的液晶配向劑,其中:所述溶劑含有選自不良溶劑的群組中的至少一個,所述不良 溶劑包含:乙二醇碳酸酯、1,2-丙二醇碳酸酯、1,3-丙二醇碳酸酯、2-甲基-1,3-丙二醇碳酸酯、乙二醇單丁醚(丁基溶纖劑)、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單苯醚、乙二醇苯醚乙酸酯、乙二醇甲基苯醚、乙二醇乙基苯醚、乙二醇二乙醚、二乙二醇單甲醚、二乙二醇二甲醚、二乙二醇甲基乙基醚、二乙二醇甲基苯醚、二乙二醇單乙醚、二乙二醇單乙醚乙酸酯、二乙二醇二乙醚、二乙二醇單丁醚、二乙二醇二丁醚、二乙二醇單丁醚乙酸酯、二乙二醇單丙醚、二乙二醇單-2-乙基己醚、三乙二醇單甲醚、三乙二醇單十二烷基醚、三乙二醇二甲醚、三乙二醇二乙醚、四乙二醇二甲醚、丙二醇二乙酸酯、丙二醇單甲醚、丙二醇甲基苯醚、丙二醇單乙醚、丙二醇單乙醚乙酸酯、丙二醇單丁醚乙酸酯、丙二醇單苯醚、丙二醇單丙醚、二丙二醇二甲醚、二丙二醇單丙醚、三丙二醇二甲醚、三丙二醇二乙醚、乙酸正丙酯、乙酸丁酯、乙酸戊酯、乙酸正己酯、乙酸環己酯、乙酸2-甲基環己酯、丙酸正丁酯、2-羥基-異丁酸甲酯、2-甲基戊酮-2,4-二醇、第三丁醇、三乙基甲醇、第三戊醇、1-甲基環己醇、2,5-二甲基己烷-2,5-二醇、正丁醇、雙(3-甲基丁基)醚、二正戊醚(二戊醚)、4-庚酮、5-壬酮、2,6-二甲基-4-庚酮、乙酸4-甲基-2-戊酯、乳酸丁酯、乳酸異戊酯、乳酸正丁酯、二丙二醇甲醚、4-羥基-4-甲基-2-戊酮(二丙酮醇)、甲基-3-甲氧基丙酸酯、乙基-3-乙氧基丙酸酯、苄醇、苯乙醇、1-丁氧基-2-丙醇、2-(2-甲氧基丙氧基)丙醇、乙酸2-羥基乙酯、2,4-戊二酮、乙基-3-乙氧基丙酸酯、糠醇、四氫糠醇、3-甲基-3-甲氧基丁醇、1,3-二氧戊環、丙酸異戊酯、異丁酸異戊酯、二異戊醚、丁醯苯、及二異丁基酮。 [4] The liquid crystal alignment agent according to any one of [1] to [3] wherein the solvent contains at least one selected from the group of poor solvents, the defect The solvent comprises: ethylene glycol carbonate, 1,2-propylene glycol carbonate, 1,3-propanediol carbonate, 2-methyl-1,3-propanediol carbonate, ethylene glycol monobutyl ether (butyl cellosolve), Ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monophenyl ether, ethylene glycol phenyl ether acetate, ethylene glycol methyl Phenyl ether, ethylene glycol ethyl phenyl ether, ethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol methyl benzene Ether, diethylene glycol monoethyl ether, diethylene glycol monoethyl ether acetate, diethylene glycol diethyl ether, diethylene glycol monobutyl ether, diethylene glycol dibutyl ether, diethylene glycol monobutyl ether Acid ester, diethylene glycol monopropyl ether, diethylene glycol mono-2-ethylhexyl ether, triethylene glycol monomethyl ether, triethylene glycol monododecyl ether, triethylene glycol dimethyl ether , triethylene glycol diethyl ether, tetraethylene glycol dimethyl ether, propylene glycol diacetate, propylene glycol monomethyl ether, propylene glycol methyl phenyl ether, propylene glycol monoethyl ether, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate Ester, propylene glycol monophenyl ether, propylene glycol Propyl ether, dipropylene glycol dimethyl ether, dipropylene glycol monopropyl ether, tripropylene glycol dimethyl ether, tripropylene glycol diethyl ether, n-propyl acetate, butyl acetate, amyl acetate, n-hexyl acetate, cyclohexyl acetate, acetic acid 2 -methylcyclohexyl ester, n-butyl propionate, methyl 2-hydroxy-isobutyrate, 2-methylpentanone-2,4-diol, tert-butanol, triethylmethanol, third pentane Alcohol, 1-methylcyclohexanol, 2,5-dimethylhexane-2,5-diol, n-butanol, bis(3-methylbutyl)ether, di-n-pentyl ether (dipentyl ether) ), 4-heptanone, 5-fluorenone, 2,6-dimethyl-4-heptanone, 4-methyl-2-pentyl acetate, butyl lactate, isoamyl lactate, n-butyl lactate, Dipropylene glycol methyl ether, 4-hydroxy-4-methyl-2-pentanone (diacetone alcohol), methyl-3-methoxypropionate, ethyl-3-ethoxypropionate, benzyl alcohol , phenylethyl alcohol, 1-butoxy-2-propanol, 2-(2-methoxypropoxy)propanol, 2-hydroxyethyl acetate, 2,4-pentanedione, ethyl-3- Ethoxypropionate, decyl alcohol, tetrahydrofurfuryl alcohol, 3-methyl-3-methoxybutanol, 1,3-dioxolane, isoamyl propionate, isoamyl isobutyrate, diiso) Pentyl ether, butyl benzene, and diisobutyl ketone.

[5]根據所述[1]至[4]中任一項所述的液晶配向劑,其中:所述溶劑含有選自包含N-烷基-2-吡咯烷酮類、N-環己基-2-吡咯烷酮、內酯類及1,3-二烷基-2-咪唑烷酮類的良溶劑的群組中的至少一個。 [5] The liquid crystal alignment agent according to any one of [1] to [4] wherein the solvent contains a group selected from the group consisting of N-alkyl-2-pyrrolidone, N-cyclohexyl-2- At least one of the group of good solvents of pyrrolidone, lactone, and 1,3-dialkyl-2-imidazolidinone.

[6]根據所述[5]所述的液晶配向劑,其中:所述良溶劑為選自N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、N-環己基-2-吡咯烷酮、γ-丁內酯、及1,3-二甲基-2-咪唑烷酮中的至少一個。 [6] The liquid crystal alignment agent according to [5], wherein the good solvent is selected from the group consisting of N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, and N-cyclohexyl-2- At least one of pyrrolidone, γ-butyrolactone, and 1,3-dimethyl-2-imidazolidinone.

[7]根據所述[1]至[6]中任一項所述的液晶配向劑,其中:與二胺進行反應的四羧酸二酐為選自由下述式(AN-I)~式(AN-VII)及式(PAN-1)~式(PAN-8)所表示的四羧酸二酐的群組中的至少一個: 式(AN-I)、式(AN-IV)及式(AN-V)中,X獨立為單鍵或-CH2-;式(AN-II)中,G為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(AN-II)~式(AN-IV)中,Y獨立為選自下述的三價的基的群組中的1個,結合鍵與任意的碳連結,所述基的至少1個氫可由甲基、乙基或苯基取代; 式(AN-III)~式(AN-V)中,環A為碳數3~10的單環式烴的 基或碳數6~30的縮合多環式烴的基,所述基的至少1個氫可由甲基、乙基或苯基取代,連接在環上的結合鍵與構成環的任意的碳連結,2根結合鍵可與同一個碳連結;式(AN-VI)中,X10為碳數2~6的伸烷基,Me表示甲基,Ph表示苯基;式(AN-VII)中,G10獨立為-O-、-COO-或-OCO-,而且,r獨立為0或1。 [7] The liquid crystal alignment agent according to any one of [1] to [6] wherein the tetracarboxylic dianhydride which is reacted with the diamine is selected from the group consisting of the following formula (AN-I) (AN-VII) and at least one of the group of tetracarboxylic dianhydride represented by the formula (PAN-1) to (PAN-8): In the formula (AN-I), the formula (AN-IV) and the formula (AN-V), X is independently a single bond or -CH 2 -; in the formula (AN-II), G is a single bond, and the carbon number is 1~ 20 alkyl, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; (AN-II)~ In AN-IV), Y is independently one selected from the group consisting of trivalent groups, and a bond is bonded to any carbon, and at least one hydrogen of the group may be methyl, ethyl or benzene. Base substitution In the formula (AN-III) to the formula (AN-V), the ring A is a monocyclic hydrocarbon group having 3 to 10 carbon atoms or a condensed polycyclic hydrocarbon group having 6 to 30 carbon atoms, and at least the group One hydrogen may be substituted by a methyl group, an ethyl group or a phenyl group, and the bond bond attached to the ring may be bonded to any carbon constituting the ring, and two bond bonds may be bonded to the same carbon; in the formula (AN-VI), X 10 is an alkylene group having 2 to 6 carbon atoms, Me represents a methyl group, and Ph represents a phenyl group; in the formula (AN-VII), G 10 is independently -O-, -COO- or -OCO-, and r is independent. Is 0 or 1.

[8]根據所述[7]所述的液晶配向劑,其中:與二胺進行反應的四羧酸二酐為選自由下述式(AN-1-1)、式(AN-1-13)、式(AN-2-1)、式(AN-2-2)、式(AN-3-1)、式(AN-3-2)、式(AN-4-1)、式(AN-4-5)、式(AN-4-6)、式(AN-4-17)、式(AN-4-21)、式(AN-4-26)、式(AN-4-30)、式(AN-9-1)、式(AN-13-1)、式(AN-16-1)及式(PAN-1)所組成的群組中的至少一個: [8] The liquid crystal alignment agent according to [7], wherein the tetracarboxylic dianhydride which is reacted with the diamine is selected from the group consisting of the following formula (AN-1-1), and the formula (AN-1-13) ), Formula (AN-2-1), Formula (AN-2-2), Formula (AN-3-1), Formula (AN-3-2), Formula (AN-4-1), Formula (AN) -4-5), formula (AN-4-6), formula (AN-4-17), formula (AN-4-21), formula (AN-4-26), formula (AN-4-30) At least one of the group consisting of: (AN-9-1), (AN-13-1), (AN-16-1), and (PAN-1):

式(AN-4-17)中,m為1~12的整數;式(AN-13-1)中,Ph表示苯基。 In the formula (AN-4-17), m is an integer of 1 to 12; in the formula (AN-13-1), Ph represents a phenyl group.

[9]根據所述[1]至[8]中任一項所述的液晶配向劑,其中:與四羧酸二酐進行反應的二胺為選自由下述式(DI-1)~式(DI-16)、式(DIH-1)~式(DIH-3)、式(DI-31)~式(DI-35)及式(PDI-1)~式(PDI-12)所組成的群組中的至少一個: 式(DI-1)中,G20為-CH2-,至少1個-CH2-可被-NH-、-O-取代,m為1~12的整數,伸烷基的至少1個氫可被-OH取代;式(DI-3)及式(DI-5)~式(DI-7)中,G21獨立為單鍵、-NH-、-NCH3-、-O-、-S-、-S-S-、-SO2-、-CO-、-COO-、-CONH-、-CONCH3-、-C(CH3)2-、-C(CF3)2-、-(CH2)m'-、-O-(CH2)m'-O-、-N(CH3)-(CH2)k-N(CH3)-、-(O-C2H4)m'-O-、-O-CH2-C(CF3)2-CH2-O-、-O-CO-(CH2)m'-CO-O-、-CO-O-(CH2)m'-O-CO-、-(CH2)m'-NH-(CH2)m'-、-CO-(CH2)k-NH-(CH2)k-、-(NH-(CH2)m')k-NH-、-CO-C3H6-(NH-C3H6)n-CO-或-S-(CH2)m'-S-,m'獨立為1~12的整數,k為1~5的整數,n為1或2;式(DI-4)中,s獨立為0~2的整數;式(DI-2)~式(DI-7)中的環己烷環及苯環的至少1個氫可由-F、 -Cl、碳數1~3的伸烷基、-OCH3、-OH、-CF3、-CO2H、-CONH2、-NHC6H5、苯基或苄基取代,此外,在式(DI-4)中,環己烷環及苯環的至少1個氫可由下述式(DI-4-a)~式(DI-4-e)取代;鍵結位置未固定在構成環的碳原子上的基表示在所述環上的鍵結位置任意,-NH2在環己烷環或苯環上的鍵結位置為除G21或G22的鍵結位置以外的任意的位置; 式(DI-4-a)及(DI-4-b)中,R20獨立為氫或-CH3 式(DI-11)中,r為0或1;式(DI-8)~式(DI-11)中,鍵結在環上的-NH2的鍵結位置為任意的位置; 式(DI-12)中,R21及R22獨立為碳數1~3的烷基或苯基,G23獨立為碳數1~6的伸烷基、伸苯基或經烷基取代的伸苯基,w為1~10的整數;式(DI-13)中,R23獨立為碳數1~5的烷基、碳數1~5的烷氧基或-Cl,p獨立為0~3的整數,q為0~4的整數;式(DI-14)中,環B為單環的雜環式芳香族基,R24為氫、-F、-Cl、-B、碳數1~6的烷基、烷氧基、乙烯基、炔基,q獨立為0~4的整數;式(DI-15)中,環C為雜環式芳香族基或雜環式脂肪族基;式(DI-16)中,G24為單鍵、碳數2~6的伸烷基或1,4-伸苯基,r為0或1;鍵結位置未固定在構成環的碳原子上的基表示在所述環上的鍵結 位置任意;式(DI-13)~式(DI-16)中,鍵結在環上的-NH2的鍵結位置為任意的位置; 式(DIH-1)中,G25為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(DIH-2)中,環D為環己烷環、苯環或萘環,所述基的至少1個氫可由甲基、乙基或苯基取代;式(DIH-3)中,環E分別獨立地為環己烷環、或苯環,所述基的至少1個氫可由甲基、乙基或苯基取代,Y為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(DIH-2)及式(DIH-3)中,鍵結在環上的-CONHNH2的鍵結位置為任意的位置; 式(DI-31)中,G26為單鍵、-O-、-COO-、-OCO-、-CO-、-CONH-、-CH2O-、-OCH2-、-CF2O-、-OCF2-或-(CH2)m'-,m'為1~12的整數,R25為碳數3~30的烷基、苯基、具有類固醇骨架的基、或由下述 的式(DI-31-a)所表示的基,所述烷基中,至少1個氫可由-F取代,而且至少1個-CH2-可由-O-、-CH=CH-或-C≡C-取代,所述苯基的氫可由-F、-CH3、-OCH3、-OCH2F、-OCHF2、-OCF3、碳數3~30的烷基、或碳數3~30的烷氧基取代,鍵結在苯環上的-NH2的鍵結位置表示在所述環中為任意的位置, 式(DI-31-a)中,G27、G28及G29為鍵結基,它們獨立為單鍵、或碳數1~12的伸烷基,所述伸烷基的1個以上的-CH2-可由-O-、-COO-、-OCO-、-CONH-、-CH=CH-取代,環B21、環B22、環B23及環B24獨立為1,4-伸苯基、1,4-伸環己基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、萘-1,5-二基、萘-2,7-二基或蒽-9,10-二基,環B21、環B22、環B23及環B24中,至少1個氫可由-F或-CH3取代,s、t及u獨立為0~2的整數,它們的合計為1~5,當s、t或u為2時,各個括號內的2個鍵結基可以相同,也可以不同,而且,2個環可以相同,也可以不同,R26為-F、-OH、碳數1~30的烷基、碳數1~30的氟取代烷基、碳數1~30的烷氧基、-CN、-OCH2F、-OCHF2或-OCF3,所述碳數1~30的烷基的至少1個-CH2-可由以下述式(DI-31-b)所表示的二價的基取代, 式(DI-31-b)中,R27及R28獨立為碳數1~3的烷基,v為1~6的整數; 式(DI-32)及式(DI-33)中,G30獨立為單鍵、-CO-或-CH2-,R29獨立為氫或-CH3,R30為氫、碳數1~20的烷基、或碳數2~20的烯基;式(DI-33)中的苯環的1個氫可由碳數1~20的烷基或苯基取代,鍵結位置未固定在構成環的任一個碳原子上的基表示在所述環上的鍵結位置任意;式(DI-32)及式(DI-33)中,鍵結在苯環上的-NH2表示在所述環上的鍵結位置任意; 式(DI-34)及式(DI-35)中,G31獨立為-O-或碳數1~6的伸烷基,G32為單鍵或碳數1~3的伸烷基,R31為氫或碳數1~20的烷基,所述烷基的至少1個-CH2-可由-O-、-CH=CH-或-C≡C-取代,R32為碳數6~22的烷基,R33為氫或碳數1~22的烷基,環B25為1,4-伸苯基或1,4-伸環己基,r為0或1;而且,鍵結在苯環上的-NH2表示在所述環上的鍵結位置任意; The liquid crystal alignment agent according to any one of the above [1], wherein the diamine reacted with the tetracarboxylic dianhydride is selected from the group consisting of the following formula (DI-1). (DI-16), formula (DIH-1)~ (DIH-3), formula (DI-31)~ (DI-35) and formula (PDI-1)~ (PDI-12) At least one of the groups: In the formula (DI-1), G 20 is -CH 2 -, at least one -CH 2 - may be substituted by -NH- or -O-, m is an integer of from 1 to 12, and at least one hydrogen of the alkyl group is extended. Can be substituted by -OH; in formula (DI-3) and formula (DI-5)~ (DI-7), G 21 is independently a single bond, -NH-, -NCH 3 -, -O-, -S -, -SS-, -SO 2 -, -CO-, -COO-, -CONH-, -CONCH 3 -, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 m' -, -O-(CH 2 ) m' -O-, -N(CH 3 )-(CH 2 ) k -N(CH 3 )-, -(OC 2 H 4 ) m' -O- , -O-CH 2 -C(CF 3 ) 2 -CH 2 -O-, -O-CO-(CH 2 ) m' -CO-O-, -CO-O-(CH 2 ) m' -O -CO-, -(CH 2 ) m' -NH-(CH 2 ) m' -, -CO-(CH 2 ) k -NH-(CH 2 ) k -, -(NH-(CH 2 ) m' k -NH-, -CO-C 3 H 6 -(NH-C 3 H 6 ) n -CO- or -S-(CH 2 ) m' -S-, m' is independently an integer from 1 to 12, k is an integer of 1 to 5, n is 1 or 2; in the formula (DI-4), s is independently an integer of 0 to 2; a cyclohexane ring in the formula (DI-2) to (DI-7) And at least one hydrogen of the benzene ring may be -F, -Cl, an alkylene group having 1 to 3 carbon atoms, -OCH 3 , -OH, -CF 3 , -CO 2 H, -CONH 2 , -NHC 6 H 5 , phenyl or benzyl substitution, in addition, in the formula (DI-4), at least one hydrogen of the cyclohexane ring and the benzene ring may be represented by the following formula (D) I-4-a)~(DI-4-e) substitution; the bond position is not fixed at the carbon atom constituting the ring, and the bond position on the ring is arbitrary, and -NH 2 is in cyclohexane. The bonding position on the ring or the benzene ring is any position other than the bonding position of G 21 or G 22 ; In the formulae (DI-4-a) and (DI-4-b), R 20 is independently hydrogen or -CH 3 ; In the formula (DI-11), r is 0 or 1; in the formula (DI-8) to the formula (DI-11), the bonding position of -NH 2 bonded to the ring is an arbitrary position; In the formula (DI-12), R 21 and R 22 are independently an alkyl group having 1 to 3 carbon atoms or a phenyl group, and G 23 is independently an alkylene group having a carbon number of 1 to 6, a phenyl group or an alkyl group. Phenyl is extended, w is an integer of 1 to 10; in the formula (DI-13), R 23 is independently an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or -Cl, and p is independently 0. An integer of ~3, q is an integer from 0 to 4; in the formula (DI-14), ring B is a monocyclic heterocyclic aromatic group, and R 24 is hydrogen, -F, -Cl, -B, carbon number 1 to 6 alkyl, alkoxy, vinyl, alkynyl, q is independently an integer of 0 to 4; in the formula (DI-15), ring C is a heterocyclic aromatic group or a heterocyclic aliphatic group In the formula (DI-16), G 24 is a single bond, an alkylene group having 2 to 6 carbon atoms or a 1,4-phenylene group, and r is 0 or 1; the bonding position is not fixed to the carbon atom constituting the ring; The upper base indicates that the bonding position on the ring is arbitrary; in the formula (DI-13) to the formula (DI-16), the bonding position of the -NH 2 bonded to the ring is an arbitrary position; In the formula (DIH-1), G 25 is a single bond, an alkylene group having 1 to 20 carbon atoms, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; in the formula (DIH-2), ring D is a cyclohexane ring, a benzene ring or a naphthalene ring, and at least one hydrogen of the group may be substituted by a methyl group, an ethyl group or a phenyl group; In the formula (DIH-3), the ring E is independently a cyclohexane ring or a benzene ring, and at least one hydrogen of the group may be substituted by a methyl group, an ethyl group or a phenyl group, and Y is a single bond, a carbon number of 1 ~20 alkylene, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; formula (DIH-2) and formula In (DIH-3), the bonding position of -CONHNH 2 bonded to the ring is an arbitrary position; In the formula (DI-31), G 26 is a single bond, -O-, -COO-, -OCO-, -CO-, -CONH-, -CH 2 O-, -OCH 2 -, -CF 2 O- , -OCF 2 - or -(CH 2 ) m' -, m' is an integer of 1 to 12, and R 25 is an alkyl group having 3 to 30 carbon atoms, a phenyl group, a group having a steroid skeleton, or the following a group represented by the formula (DI-31-a) wherein at least one hydrogen of the alkyl group may be substituted by -F, and at least one -CH 2 - may be -O-, -CH=CH- or -C≡ C-substituted, the hydrogen of the phenyl group may be -F, -CH 3 , -OCH 3 , -OCH 2 F, -OCHF 2, -OCF 3, an alkyl group having 3 to 30 carbon atoms, or a carbon number of 3 to 30 The alkoxy group is substituted, and the bonding position of -NH 2 bonded to the benzene ring means an arbitrary position in the ring. In the formula (DI-31-a), G 27 , G 28 and G 29 are a bonding group, which are independently a single bond or an alkylene group having 1 to 12 carbon atoms, and one or more alkylene groups. -CH 2 - may be substituted by -O-, -COO-, -OCO-, -CONH-, -CH=CH-, and ring B 21 , ring B 22 , ring B 23 and ring B 24 are independently 1,4-stretched Phenyl, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, naphthalene-1,5- In the diyl, naphthalene-2,7-diyl or inden-9,10-diyl, ring B 21 , ring B 22 , ring B 23 and ring B 24 , at least one hydrogen may be substituted by -F or -CH 3 , s, t, and u are independent integers of 0 to 2, and their total is 1 to 5. When s, t, or u is 2, the two bonding groups in each parenthesis may be the same or different, and The two rings may be the same or different, and R 26 is -F, -OH, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, or CN, -OCH 2 F, -OCHF 2 or -OCF 3 , at least one -CH 2 - of the alkyl group having 1 to 30 carbon atoms may be divalent represented by the following formula (DI-31-b) Substitution, In the formula (DI-31-b), R 27 and R 28 are independently an alkyl group having 1 to 3 carbon atoms, and v is an integer of 1 to 6; In formula (DI-32) and formula (DI-33), G 30 is independently a single bond, -CO- or -CH 2 -, R 29 is independently hydrogen or -CH 3 , R 30 is hydrogen, and carbon number is 1~ An alkyl group of 20 or an alkenyl group having 2 to 20 carbon atoms; one hydrogen of the benzene ring in the formula (DI-33) may be substituted by an alkyl group having 1 to 20 carbon atoms or a phenyl group, and the bonding position is not fixed. The group on any one of the carbon atoms represents any bonding position on the ring; in the formula (DI-32) and the formula (DI-33), -NH 2 bonded to the benzene ring is represented in The bonding position on the ring is arbitrary; In the formula (DI-34) and the formula (DI-35), G 31 is independently -O- or an alkylene group having 1 to 6 carbon atoms, and G 32 is a single bond or an alkylene group having 1 to 3 carbon atoms, R 31 is hydrogen or an alkyl group having 1 to 20 carbon atoms, and at least one -CH 2 - of the alkyl group may be substituted by -O-, -CH=CH- or -C≡C-, and R 32 is a carbon number of 6~ An alkyl group of 22, R 33 is hydrogen or an alkyl group having 1 to 22 carbon atoms, and ring B 25 is a 1,4-phenylene group or a 1,4-cyclohexylene group, and r is 0 or 1; -NH 2 on the benzene ring means that the bonding position on the ring is arbitrary;

式(PDI-7)中,R51獨立為-CH3、-OCH3、-CF3或-COOCH3,b獨立為0~2的整數;式(PDI-12)中,R43為碳數1~10的烷基或烷氧基,至少1個氫可被氟取代。 In the formula (PDI-7), R 51 is independently -CH 3 , -OCH 3 , -CF 3 or -COOCH 3 , b is independently an integer of 0 to 2; in the formula (PDI-12), R 43 is a carbon number From 1 to 10 alkyl groups or alkoxy groups, at least one hydrogen may be substituted by fluorine.

[10]根據所述[9]所述的液晶配向劑,其中:與四羧酸二酐進行反應的二胺為選自由下述式(DI-1-3)、式(DI-2-1)、式(DI-4-1)、式(DI-4-5)、式(DI-5-1)、式(DI-5-5)、式(DI-5-9)、式(DI-5-30)、式(DI-5-37)、式(DI-7-3)、式(DI-8-2)、式(DI-12-1)、式(DI-13-1)、式(DI-14-8)、式(DIH-2-1)、式(DI-31-2)、式(DI-31-5)、式(DI-31-47)、式(DI-34-2)、式(DI-34-4)、式(DI-34-7)、式(PDI-6-1)、及式(PDI-7-1)所組成的群組中的至少一個: [10] The liquid crystal alignment agent according to [9], wherein the diamine reacted with the tetracarboxylic dianhydride is selected from the group consisting of the following formula (DI-1-3), and the formula (DI-2-1) ), formula (DI-4-1), formula (DI-4-5), formula (DI-5-1), formula (DI-5-5), formula (DI-5-9), formula (DI -5-30), formula (DI-5-37), formula (DI-7-3), formula (DI-8-2), formula (DI-12-1), formula (DI-13-1) , formula (DI-14-8), formula (DIH-2-1), formula (DI-31-2), formula (DI-31-5), formula (DI-31-47), formula (DI- At least one of a group consisting of 34-2), a formula (DI-34-4), a formula (DI-34-7), a formula (PDI-6-1), and a formula (PDI-7-1) :

式(DI-5-1)、式(DI-5-37)及式(DI-7-3)中,m為1~12的整數;式(DI-5-30)中,k為1~5的整數;式(DI-7-3)中,n為1或2;式(DI-31-2)中,R34為碳數1~30的烷基或碳數1~30的烷氧基;式(DI-31-5)中,R35為碳數1~30的烷基或碳數1~30的烷氧基;式(DI-34-2)中,R40為氫或碳數1~20的烷基;式(DI-34-4)及式(DI-34-7)中,R41為氫或碳數1~12的烷基。 In the formula (DI-5-1), the formula (DI-5-37), and the formula (DI-7-3), m is an integer from 1 to 12; in the formula (DI-5-30), k is 1~ An integer of 5; in the formula (DI-7-3), n is 1 or 2; in the formula (DI-31-2), R 34 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms. In the formula (DI-31-5), R 35 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms; in the formula (DI-34-2), R 40 is hydrogen or carbon. In the formula (DI-34-4) and the formula (DI-34-7), R 41 is hydrogen or an alkyl group having 1 to 12 carbon atoms.

[11]根據所述[1]至[10]中任一項所述的液晶配向劑,其中:更包括選自包含烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、噁嗪化合物、噁唑啉化合物、及環 氧化合物的化合物的群組中的至少一個。 [11] The liquid crystal alignment agent according to any one of [1] to [10] wherein, further comprising a radically polymerizable unsaturated double bond selected from the group consisting of an alkenyl-substituted nadicilide compound Compound, oxazine compound, oxazoline compound, and ring At least one of the group of compounds of the oxygen compound.

[12]根據所述[11]所述的液晶配向劑,其中:所述烯基取代納迪克醯亞胺化合物為選自包含雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、N,N'-間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、及N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)的化合物的群組中的至少一個。 [12] The liquid crystal alignment agent according to [11], wherein the alkenyl-substituted nadicilide compound is selected from the group consisting of bis{4-(allylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxy quinone imine)phenyl}methane, N,N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3- Group of compounds of dicarboxy quinone imine) and N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine) At least one of them.

[13]根據所述[11]所述的液晶配向劑,其中:所述具有自由基聚合性不飽和雙鍵的化合物為選自包含N,N'-伸乙基雙丙烯醯胺、N,N'-(1,2-二羥基伸乙基)雙丙烯醯胺、伸乙基雙丙烯酸酯、及4,4'-亞甲基雙(N,N-二羥基伸乙基丙烯酸酯苯胺)的化合物的群組中的至少一個。 [13] The liquid crystal alignment agent according to [11], wherein the compound having a radical polymerizable unsaturated double bond is selected from the group consisting of N, N'-extended ethyl bis acrylamide, N, N'-(1,2-dihydroxyethylidene)bisacrylamide, ethylidene diacrylate, and 4,4'-methylenebis(N,N-dihydroxyethyl acrylate) At least one of the groups of compounds.

[14]根據所述[11]所述的液晶配向劑,其中:所述環氧化合物為選自包含N,N,N',N'-四縮水甘油基-間二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷、2-[4-(2,3-環氧基丙氧基)苯基]-2-[4-[1,1-雙[4-([2,3-環氧基丙氧基]苯基)]乙基]苯基]丙烷、3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯、N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、及2-(3,4-環氧基環己基)乙基三甲氧基矽烷的化合物的群組中的至少一個。 [14] The liquid crystal alignment agent according to [11], wherein the epoxy compound is selected from the group consisting of N, N, N', N'-tetraglycidyl-m-xylylenediamine, 1, 3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane, 2 -[4-(2,3-epoxypropoxy)phenyl]-2-[4-[1,1-bis[4-([2,3-epoxypropoxy]phenyl) Ethyl]phenyl]propane, 3,4-epoxycyclohexenylmethyl-3',4'-epoxycyclohexenecarboxylate, N-phenylmaleimide-A At least one of the group consisting of a glycidyl acrylate copolymer and a compound of 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane.

[15]一種液晶配向膜,其由根據所述[1]至[14]中任一項所述的液晶配向劑形成。 [15] A liquid crystal alignment film formed of the liquid crystal alignment agent according to any one of [1] to [14].

[16]一種液晶顯示元件,其包括根據所述[15]所述的液晶配向膜。 [16] A liquid crystal display element comprising the liquid crystal alignment film according to [15].

本發明可提供一種液晶配向劑,其不易引起室溫下的黏度變化、且不會產生塗布配向劑時的凹陷或經製膜的配向膜的白化。另外,具備由該液晶配向劑所獲得的液晶配向膜的液晶顯示元件可提供一種殘像特性優異、且配向穩定性良好的液晶顯示元件。 The present invention can provide a liquid crystal alignment agent which is less likely to cause a change in viscosity at room temperature and which does not cause whitening of a depression or a film-forming alignment film when an alignment agent is applied. In addition, the liquid crystal display element including the liquid crystal alignment film obtained from the liquid crystal alignment agent can provide a liquid crystal display element having excellent afterimage characteristics and excellent alignment stability.

本發明的液晶配向劑含有作為四羧酸二酐與二胺的反應產物的聚醯胺酸或其衍生物。作為所述四羧酸二酐,例如可列舉:感光性四羧酸二酐、脂肪族四羧酸二酐、脂環式四羧酸二酐、芳香族四羧酸二酐等。作為所述二胺,例如可列舉:感光性二胺、非側鏈型二胺、側鏈型二胺、醯肼等。所述聚醯胺酸或其衍生物是指當製成含有溶劑的後述的液晶配向劑時溶解於溶劑中的成分,且是指當將該液晶配向劑製成後述的液晶配向膜時,可形成以聚醯亞胺為主成分的液晶配向膜的成分。作為此種聚醯胺酸的衍生物,例如可列舉可溶性聚醯亞胺、聚醯胺酸酯、聚醯肼酸、聚醯胺酸醯胺、及聚醯肼酸-醯胺酸等,更具體而言,可列舉:1)聚醯胺酸的所有胺基與羧基進行脫水閉環反應而成的聚醯亞胺,2)部分地進行脫水閉環反應而成的部分聚醯亞胺,3)將聚醯胺酸的羧基變換成酯而成的聚醯胺酸酯,4)將四羧酸二酐化合物中所含有的酸二酐的一部分取代成有機二羧酸並進行反應而獲得的 聚醯胺酸-聚醯胺共聚物,以及5)使該聚醯胺酸-聚醯胺共聚物的一部分或全部進行脫水閉環反應而成的聚醯胺醯亞胺等。所述聚醯胺酸聚合物及聚醯亞胺聚合物可以是1種化合物,也可以是2種以上。 The liquid crystal alignment agent of the present invention contains polyamic acid or a derivative thereof as a reaction product of a tetracarboxylic dianhydride and a diamine. Examples of the tetracarboxylic dianhydride include photosensitive tetracarboxylic dianhydride, aliphatic tetracarboxylic dianhydride, alicyclic tetracarboxylic dianhydride, and aromatic tetracarboxylic dianhydride. Examples of the diamine include a photosensitive diamine, a non-side chain type diamine, a side chain type diamine, and an anthracene. The poly-proline or a derivative thereof is a component which is dissolved in a solvent when it is prepared as a liquid crystal alignment agent to be described later, and is a liquid crystal alignment film which will be described later. A component of a liquid crystal alignment film containing polybenrene as a main component is formed. Examples of such a derivative of polyglycine include soluble polyimine, polyphthalate, polydecanoic acid, polyamidamine, and polydecanoic acid-proline, and the like. Specific examples include: 1) polyimine which is obtained by dehydration ring-closure reaction of all amine groups of polyproline and carboxyl groups, and 2) partial polyimine which is partially subjected to dehydration ring closure reaction, 3) a polyphthalamide obtained by converting a carboxyl group of a poly-proline to an ester, and 4) a part obtained by substituting a part of an acid dianhydride contained in a tetracarboxylic dianhydride compound into an organic dicarboxylic acid and reacting the same The polyaminic acid-polyamide copolymer and 5) a polyamidoximine which is obtained by subjecting a part or all of the polyamic acid-polyamide copolymer to a dehydration ring-closure reaction. The polyaminic acid polymer and the polyimine polymer may be one type of compound or two or more types.

對本發明中所使用的用語進行說明。對化學結構式進行定義時所使用的“任意的”表示不僅位置任意,而且個數也任意。在化學結構式中,以六邊形包圍文字(例如A)的基是指環結構的基(環A)。 The terms used in the present invention will be described. The "arbitrary" used in defining the chemical structural formula means that the position is arbitrary and the number is arbitrary. In the chemical structural formula, a group enclosing a character (for example, A) in a hexagonal shape means a group (ring A) of a ring structure.

對用於製造本發明的所述聚醯胺酸聚合物及聚醯亞胺聚合物的四羧酸二酐進行說明。以下,“四羧酸二酐”這一記載不僅表示單獨使用四羧酸二酐的情況,也表示以混合物的形式使用多個四羧酸二酐的情況。 The tetracarboxylic dianhydride used to produce the polyaminic acid polymer and the polyimine polymer of the present invention will be described. Hereinafter, the description of "tetracarboxylic dianhydride" means not only the case where tetracarboxylic dianhydride is used alone, but also the case where a plurality of tetracarboxylic dianhydrides are used in the form of a mixture.

若有必要,則也可以通過摩擦處理或光照射來對由本發明的液晶配向劑所形成的配向膜賦予異向性。 If necessary, an anisotropic property may be imparted to the alignment film formed of the liquid crystal alignment agent of the present invention by rubbing treatment or light irradiation.

當通過光照射來賦予異向性時,若將本發明的液晶配向劑塗覆在基板上,通過預加熱來使其乾燥後,經由偏光板而照射紫外線的直線偏光,則與偏光方向大致平行的聚合物主鏈的源自感光性二胺的感光性基會產生光異構化。由於與偏光方向大致平行的聚合物的主鏈被選擇性地光異構化或光二聚化,因此形成膜的聚合物的主鏈中,朝向相對於所照射的紫外線的偏光方向為大致直角方向的成分佔據支配地位。因此,對基板進行加熱而使聚醯胺酸進行脫水.閉環來製成聚醯亞胺膜後,使用該基板進行組裝而成的單元中所注入的液晶組合物的液晶分子使長軸在相對於所照射的紫外線的偏光方向成直角的方向上一致來進行配向。對膜 照射紫外線的直線偏光的步驟可在用於聚醯亞胺化的加熱步驟之前,也可以在進行加熱來進行聚醯亞胺化之後。 When the anisotropic property is imparted by light irradiation, the liquid crystal alignment agent of the present invention is applied onto a substrate, dried by preheating, and linearly polarized light that is irradiated with ultraviolet rays via a polarizing plate is substantially parallel to the polarizing direction. The photosensitive base derived from the photosensitive diamine of the polymer backbone generates photoisomerization. Since the main chain of the polymer substantially parallel to the polarizing direction is selectively photoisomerized or photodimerized, the direction of the polarizing direction with respect to the ultraviolet ray to be irradiated is substantially perpendicular to the main chain of the polymer forming the film. The ingredients dominate. Therefore, the substrate is heated to dehydrate the polylysine. After the polyimine film is formed in a closed loop, the liquid crystal molecules of the liquid crystal composition injected in the unit assembled using the substrate have the long axes aligned in a direction perpendicular to the polarization direction of the irradiated ultraviolet rays. Perform alignment. Film The step of irradiating the ultraviolet light in a linearly polarized light may be performed before the heating step for polyimidization or after the polyimidization by heating.

對用於製造本發明的聚醯胺酸或其衍生物的四羧酸二酐進行說明。 The tetracarboxylic dianhydride used to produce the poly-proline or its derivative of the present invention will be described.

本發明中所使用的四羧酸二酐可無限制地從公知的四羧酸二酐中選擇。此種四羧酸二酐可以是屬二羧酸酐直接鍵結在芳香環上的芳香族系(包含雜芳香環系)、及二羧酸酐未直接鍵結在芳香環上的脂肪族系(包含雜環系)、感光性四羧酸二酐的任一者的群組中的四羧酸二酐。 The tetracarboxylic dianhydride used in the present invention can be selected from known tetracarboxylic dianhydrides without limitation. The tetracarboxylic dianhydride may be an aromatic system (including a heteroaromatic ring system) in which a dicarboxylic acid anhydride is directly bonded to an aromatic ring, and an aliphatic system in which a dicarboxylic acid anhydride is not directly bonded to an aromatic ring (including Tetracarboxylic dianhydride in the group of any of the heterocyclic system and the photosensitive tetracarboxylic dianhydride.

作為此種四羧酸二酐的適宜的例子,就原料獲得的容易性、或聚合物聚合時的容易性、膜的電特性的觀點而言,可列舉由式(AN-I)~式(AN-VII)及式(PAN-1)~式(PAN-8)所表示的四羧酸二酐。 A suitable example of such a tetracarboxylic dianhydride is a formula (AN-I) to a formula (E-I) to the viewpoint of easiness of obtaining a raw material, easiness in polymerization of a polymer, and electrical properties of a film. AN-VII) and a tetracarboxylic dianhydride represented by the formula (PAN-1) to (PAN-8).

式(AN-I)、式(AN-IV)及式(AN-V)中,X獨立為單鍵或-CH2-。式(AN-II)中,G為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-。式(AN-II)~式(AN-IV)中,Y獨立為選自下述的三價的基的群組中的1個,結合鍵與任意的碳連結,該基的至少1個氫可由甲基、乙基或苯基取代。 In the formula (AN-I), the formula (AN-IV), and the formula (AN-V), X is independently a single bond or -CH 2 -. In the formula (AN-II), G is a single bond, an alkylene group having 1 to 20 carbon atoms, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or - C(CF 3 ) 2 -. In the formula (AN-II) to the formula (AN-IV), Y is independently one selected from the group consisting of trivalent groups described below, and a bond is bonded to an arbitrary carbon, and at least one hydrogen of the group is present. It may be substituted by a methyl group, an ethyl group or a phenyl group.

式(AN-III)~式(AN-V)中,環A為碳數3~10的單環式烴的基或碳數6~30的縮合多環式烴的基,該基的至少1個氫可由甲基、乙基或苯基取代,連接在環上的結合鍵與構成環的任意的碳連結,2根結合鍵可與同一個碳連結,式(AN-VI)中,X10為碳數2~6的伸烷基,Me表示甲基,Ph表示苯基。而且,式(AN-VII)中,G10獨立為-O-、-COO-或-OCO-,r獨立為0或1。 In the formula (AN-III) to the formula (AN-V), the ring A is a group of a monocyclic hydrocarbon having 3 to 10 carbon atoms or a group of a condensed polycyclic hydrocarbon having 6 to 30 carbon atoms, and at least 1 of the group The hydrogen may be substituted by a methyl group, an ethyl group or a phenyl group, and the bonding bond attached to the ring may be bonded to any carbon constituting the ring, and the two bonding bonds may be bonded to the same carbon, in the formula (AN-VI), X 10 It is an alkylene group having 2 to 6 carbon atoms, Me represents a methyl group, and Ph represents a phenyl group. Further, in the formula (AN-VII), G 10 is independently -O-, -COO- or -OCO-, and r is independently 0 or 1.

更詳細而言,可列舉由以下的式(AN-1)~式(AN-16-14)的式所表示的四羧酸二酐。 More specifically, tetracarboxylic dianhydride represented by the following formula (AN-1) to formula (AN-16-14) can be mentioned.

式(AN-1)中,G11為單鍵、碳數1~12的伸烷基、1,4-伸苯基或1,4-伸環己基。X11獨立為單鍵或-CH2-。G12獨立為下述的三價的基的任一種。 In the formula (AN-1), G 11 is a single bond, an alkylene group having 1 to 12 carbon atoms, a 1,4-phenylene group or a 1,4-cyclohexylene group. X 11 is independently a single bond or -CH 2 -. G 12 is independently any of the following trivalent groups.

當G12為>CH-時,CH的氫可被-CH3取代。當G12為>N-時,G11不為單鍵及-CH2-,X11不為單鍵。而且,R11為氫或-CH3。作為由式(AN-1)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 When G 12 is >CH-, the hydrogen of CH can be substituted by -CH 3 . When G 12 is >N-, G 11 is not a single bond and -CH 2 -, and X 11 is not a single bond. Moreover, R 11 is hydrogen or -CH 3 . Examples of the tetracarboxylic dianhydride represented by the formula (AN-1) include compounds represented by the following formulas.

式(AN-1-2)及式(AN-1-14)中,m為1~12的整數。 In the formula (AN-1-2) and the formula (AN-1-14), m is an integer of 1 to 12.

式(AN-2)中,R12獨立為氫、-CH3、-CH2CH3、或苯基。作為由式(AN-2)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-2), R 12 is independently hydrogen, -CH 3 , -CH 2 CH 3 or a phenyl group. Examples of the tetracarboxylic dianhydride represented by the formula (AN-2) include compounds represented by the following formulas.

式(AN-3)中,環A11為環己烷環或苯環。作為由式(AN-3)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-3), the ring A 11 is a cyclohexane ring or a benzene ring. Examples of the tetracarboxylic dianhydride represented by the formula (AN-3) include compounds represented by the following formulas.

式(AN-4)中,環A11為環己烷環或苯環。G13為單鍵、-(CH2)m-、-O-、-S-、-C(CH3)2-、-SO2-、-CO-、-C(CF3)2-、或由下述的式(G13-1)所表示的二價的基,m為1~12的整數。 In the formula (AN-4), the ring A 11 is a cyclohexane ring or a benzene ring. G 13 is a single bond, -(CH 2 ) m -, -O-, -S-, -C(CH 3 ) 2 -, -SO 2 -, -CO-, -C(CF 3 ) 2 -, or The divalent group represented by the following formula (G13-1), m is an integer of 1-12.

式(G13-1)中,G13a及G13b分別獨立地為單鍵、-O-或由-NHCO- 所表示的二價的基。伸苯基優選1,4-伸苯基及1,3-伸苯基。作為由式(AN-4)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (G13-1), G 13a and G 13b are each independently a single bond, -O- or a divalent group represented by -NHCO-. The phenyl group is preferably a 1,4-phenylene group and a 1,3-phenylene group. Examples of the tetracarboxylic dianhydride represented by the formula (AN-4) include compounds represented by the following formulas.

式(AN-4-17)中,m為1~12的整數。 In the formula (AN-4-17), m is an integer of 1 to 12.

式(AN-5)中,R11為氫或-CH3。鍵結位置未固定在構成苯環的碳原子上的R11表示在苯環中的鍵結位置任意。作為由式(AN-5)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-5), R 11 is hydrogen or -CH 3 . R 11 in which the bonding position is not fixed to the carbon atom constituting the benzene ring indicates that the bonding position in the benzene ring is arbitrary. Examples of the tetracarboxylic dianhydride represented by the formula (AN-5) include compounds represented by the following formulas.

式(AN-6)中,X11獨立為單鍵或-CH2-。X12為-CH2-、-CH2CH2-或-CH=CH-。n為1或2。作為由式(AN-6)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-6), X 11 is independently a single bond or -CH 2 -. X 12 is -CH 2 -, -CH 2 CH 2 - or -CH=CH-. n is 1 or 2. Examples of the tetracarboxylic dianhydride represented by the formula (AN-6) include compounds represented by the following formulas.

式(AN-7)中,X11為單鍵或-CH2-。作為由式(AN-7)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-7), X 11 is a single bond or -CH 2 -. Examples of the tetracarboxylic dianhydride represented by the formula (AN-7) include compounds represented by the following formulas.

式(AN-8)中,X11為單鍵或-CH2-。R12為氫、-CH3、-CH2CH3、或苯基,環A12為環己烷環或環己烯環。作為由式(AN-8)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-8), X 11 is a single bond or -CH 2 -. R 12 is hydrogen, -CH 3 , -CH 2 CH 3 or a phenyl group, and ring A 12 is a cyclohexane ring or a cyclohexene ring. Examples of the tetracarboxylic dianhydride represented by the formula (AN-8) include compounds represented by the following formulas.

式(AN-9)中,r分別獨立地為0或1。作為由式(AN-9)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-9), r is independently 0 or 1. Examples of the tetracarboxylic dianhydride represented by the formula (AN-9) include compounds represented by the following formulas.

式(AN-10)為下述的四羧酸二酐。 The formula (AN-10) is the following tetracarboxylic dianhydride.

式(AN-11)中,環A11獨立為環己烷環或苯環。作為由式(AN-11)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-11), the ring A 11 is independently a cyclohexane ring or a benzene ring. Examples of the tetracarboxylic dianhydride represented by the formula (AN-11) include compounds represented by the following formulas.

式(AN-12)中,環A11分別獨立地為環己烷環或苯環。作為由式(AN-12)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-12), the ring A 11 is independently a cyclohexane ring or a benzene ring. Examples of the tetracarboxylic dianhydride represented by the formula (AN-12) include compounds represented by the following formulas.

式(AN-13)中,X13為碳數2~6的伸烷基,Ph表示苯基。作為由式(AN-13)所表示的四羧酸二酐的例子,可列舉由下述的式所 表示的化合物。 In the formula (AN-13), X 13 is an alkylene group having 2 to 6 carbon atoms, and Ph represents a phenyl group. Examples of the tetracarboxylic dianhydride represented by the formula (AN-13) include compounds represented by the following formulas.

式(AN-14)中,G14獨立為-O-、-COO-或-OCO-,r獨立為0或1。作為由式(AN-14)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-14), G 14 is independently -O-, -COO- or -OCO-, and r is independently 0 or 1. Examples of the tetracarboxylic dianhydride represented by the formula (AN-14) include compounds represented by the following formulas.

式(AN-15)中,w為1~10的整數。作為由式(AN-15)所表示的四羧酸二酐的例子,可列舉由下述的式所表示的化合物。 In the formula (AN-15), w is an integer of 1 to 10. Examples of the tetracarboxylic dianhydride represented by the formula (AN-15) include compounds represented by the following formulas.

作為所述以外的四羧酸二酐,可列舉下述的化合物。 Examples of the tetracarboxylic dianhydride other than the above include the following compounds.

在本發明中,作為所述感光性四羧酸二酐,可列舉以下的式(PAN-1)~式(PAN-8)。 In the present invention, examples of the photosensitive tetracarboxylic dianhydride include the following formula (PAN-1) to formula (PAN-8).

在重視提升液晶顯示元件的配向性的情況下,所述酸二酐之中,特優選由式(AN-1-13)、式(AN-2-1)、式(AN-2-2)、式(AN-4-17)及式(PAN-1)所表示的化合物。 When it is important to improve the alignment of the liquid crystal display element, among the acid dianhydrides, the formula (AN-1-13), the formula (AN-2-1), and the formula (AN-2-2) are particularly preferable. A compound represented by the formula (AN-4-17) and the formula (PAN-1).

在重視提升液晶顯示元件的透過率的情況下,所述酸二酐之中,特優選由式(AN-1-1)、式(AN-1-13)、式(AN-2-1)、式(AN-2-2)、式(AN-3-1)、式(AN-4-1)、式(AN-4-30)、式(AN-9-1)、式(AN-13-1)、及式(AN-16-1)所表示的化合物。 When it is important to increase the transmittance of the liquid crystal display device, among the acid dianhydrides, the formula (AN-1-1), the formula (AN-1-13), and the formula (AN-2-1) are particularly preferable. , (AN-2-2), (AN-3-1), (AN-4-1), (AN-4-30), (AN-9-1), (AN- 13-1), and a compound represented by the formula (AN-16-1).

在重視提升液晶顯示元件的電特性的情況下,所述酸二 酐之中,特優選由式(AN-3-2)、式(AN-4-5)、式(AN-4-6)、式(AN-4-21)、式(AN-4-26)及式(AN-13-1)所表示的化合物。 In the case of paying attention to improving the electrical characteristics of the liquid crystal display element, the acid two Among the anhydrides, it is particularly preferred from the formula (AN-3-2), the formula (AN-4-5), the formula (AN-4-6), the formula (AN-4-21), and the formula (AN-4-26). And a compound represented by the formula (AN-13-1).

對用於製造本發明的聚醯胺酸及其衍生物的二胺及二醯肼進行說明。當製造本發明的聚醯胺酸或其衍生物時,可無限制地從公知的二胺及二醯肼中選擇。 The diamines and dioximes used to produce the poly-proline and its derivatives of the present invention will be described. When the polyglycine or its derivative of the present invention is produced, it can be selected from known diamines and dioxins without limitation.

二胺可根據其結構而分成2種。即,具有側鏈基的二胺與不具有側鏈基的二胺,所述側鏈基是當將連結2個胺基的骨架看作主鏈時,從主鏈中分支的基。該側鏈基是具有增大預傾角的效果的基。具有此種效果的側鏈基必須是碳數3以上的基,作為具體例,可列舉:碳數3以上的烷基、碳數3以上的烷氧基、碳數3以上的烷氧基烷基、及具有類固醇骨架的基。具有1個以上的環、且其末端的環具有碳數1以上的烷基、碳數1以上的烷氧基及碳數2以上的烷氧基烷基的任一者作為取代基的基也具有作為側鏈基的效果。在以下的說明中,有時將具有此種側鏈基的二胺稱為側鏈型二胺。而且,有時將不具有此種側鏈基的二胺稱為非側鏈型二胺。 Diamines can be classified into two according to their structures. That is, a diamine having a side chain group and a diamine having no side chain group, the side chain group being a group branched from the main chain when the skeleton linking the two amine groups is regarded as a main chain. The side chain group is a group having an effect of increasing the pretilt angle. The side chain group having such an effect is required to have a carbon number of 3 or more. Specific examples thereof include an alkyl group having 3 or more carbon atoms, an alkoxy group having 3 or more carbon atoms, and an alkoxyalkyl group having 3 or more carbon atoms. a base, and a group having a steroid skeleton. A group having one or more rings and having a ring having a carbon number of 1 or more, an alkoxy group having 1 or more carbon atoms, and an alkoxyalkyl group having 2 or more carbon atoms as a substituent It has an effect as a side chain group. In the following description, a diamine having such a side chain group may be referred to as a side chain type diamine. Further, a diamine having no such a side chain group is sometimes referred to as a non-side chain type diamine.

通過將非側鏈型二胺與側鏈型二胺適當地分開使用,可對應於各自所需要的預傾角。側鏈型二胺優選以無損本發明的特性的程度來併用。另外,關於側鏈型二胺及非側鏈型二胺,優選以提升對於液晶的垂直配向性、電壓保持率、殘像特性及配向性為目的進行取捨選擇來使用。 By suitably separating the non-side chain type diamine from the side chain type diamine, it is possible to correspond to the respective pretilt angles required. The side chain type diamine is preferably used in combination to the extent that the characteristics of the present invention are not impaired. Further, it is preferable to use a side chain type diamine and a non-side chain type diamine for the purpose of improving the vertical alignment property, the voltage holding ratio, the afterimage characteristics, and the alignment property of the liquid crystal.

對非側鏈型二胺進行說明。作為已知的不具有側鏈的二胺,可列舉以下的式(DI-1)~式(DI-16)的二胺。 The non-side chain type diamine is described. Examples of the known diamine having no side chain include diamines of the following formula (DI-1) to formula (DI-16).

所述式(DI-1)中,G20為-CH2-,至少1個-CH2-可被-NH-、-O-取代,m為1~12的整數,伸烷基的至少1個氫可被-OH取代。式(DI-3)及式(DI-5)~式(DI-7)中,G21獨立為單鍵、-NH-、-NCH3-、-O-、-S-、-S-S-、-SO2-、-CO-、-COO-、-CONH-、-CONCH3-、-C(CH3)2-、-C(CF3)2-、-(CH2)m'-、-O-(CH2)m'-O-、-N(CH3)-(CH2)k-N(CH3)-、-(O-C2H4)m'-O-、-O-CH2-C(CF3)2-CH2-O-、-O-CO-(CH2)m'-CO-O-、-CO-O-(CH2)m'-O-CO-、-(CH2)m'-NH-(CH2)m'-、-CO-(CH2)k-NH-(CH2)k-、-(NH-(CH2)m')k-NH-、-CO-C3H6-(NH-C3H6)n-CO-或-S-(CH2)m'-S-,m'獨立為1~12的整數,k為1~5的整數,n為1或2。式(DI-4)中,s獨立為0~2的整數。式(DI-6)及式(DI-7)中,G22獨立為單鍵、-O-、-S-、-CO-、-C(CH3)2-、-C(CF3)2-、或碳數1~10的伸烷基。式(DI-2) ~式(DI-7)中的環己烷環及苯環的至少1個氫可由-F、-Cl、碳數1~3的伸烷基、-OCH3、-OH、-CF3、-CO2H、-CONH2、-NHC6H5、苯基或苄基取代,此外,在式(DI-4)中,可由下述式(DI-4-a)~式(DI-4-e)取代。鍵結位置未固定在構成環的碳原子上的基表示在該環上的鍵結位置任意。而且,-NH2在環己烷環或苯環上的鍵結位置為除G21或G22的鍵結位置以外的任意的位置。 In the formula (DI-1), G 20 is -CH 2 -, at least one -CH 2 - may be substituted by -NH- or -O-, m is an integer of 1 to 12, and at least 1 of an alkyl group One hydrogen can be replaced by -OH. In the formula (DI-3) and the formula (DI-5) to the formula (DI-7), G 21 is independently a single bond, -NH-, -NCH 3 -, -O-, -S-, -SS-, -SO 2 -, -CO-, -COO-, -CONH-, -CONCH 3 -, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) m' -, - O-(CH 2 ) m' -O-, -N(CH 3 )-(CH 2 ) k -N(CH 3 )-, -(OC 2 H 4 ) m' -O-, -O-CH 2 -C(CF 3 ) 2 -CH 2 -O-, -O-CO-(CH 2 ) m' -CO-O-, -CO-O-(CH 2 ) m' -O-CO-, -( CH 2 ) m' -NH-(CH 2 ) m' -, -CO-(CH 2 ) k -NH-(CH 2 ) k -, -(NH-(CH 2 ) m' ) k -NH-, -CO-C 3 H 6 -(NH-C 3 H 6 ) n -CO- or -S-(CH 2 ) m' -S-, m' is independently an integer from 1 to 12, and k is from 1 to 5. Integer, n is 1 or 2. In the formula (DI-4), s is independently an integer of 0 to 2. In the formula (DI-6) and the formula (DI-7), G 22 is independently a single bond, -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 - or an alkyl group having a carbon number of 1 to 10. At least one hydrogen of the cyclohexane ring and the benzene ring in the formula (DI-2) to the formula (DI-7) may be -F, -Cl, an alkyl group having 1 to 3 carbon atoms, -OCH 3 , -OH , -CF 3 , -CO 2 H, -CONH 2 , -NHC 6 H 5 , phenyl or benzyl substitution, and further, in the formula (DI-4), the following formula (DI-4-a) can be used. Formula (DI-4-e) substituted. The group in which the bonding position is not fixed to the carbon atom constituting the ring indicates that the bonding position on the ring is arbitrary. Further, the bonding position of -NH 2 on the cyclohexane ring or the benzene ring is any position other than the bonding position of G 21 or G 22 .

式(DI-4-a)及式(DI-4-b)中,R20獨立為氫或-CH3 In the formula (DI-4-a) and the formula (DI-4-b), R 20 is independently hydrogen or -CH 3 .

式(DI-11)中,r為0或1。式(DI-8)~式(DI-11)中,鍵結在環上的-NH2的鍵結位置為任意的位置。 In the formula (DI-11), r is 0 or 1. In the formula (DI-8) to the formula (DI-11), the bonding position of -NH 2 bonded to the ring is an arbitrary position.

式(DI-12)中,R21及R22獨立為碳數1~3的烷基或苯基,G23獨立為碳數1~6的伸烷基、伸苯基或經烷基取代的伸苯基,w為1~10的整數。式(DI-13)中,R23獨立為碳數1~5的烷基、碳數1~5的烷氧基或-Cl,p獨立為0~3的整數,q為0~4的整數。式(DI-14)中,環B為單環的雜環式芳香族基,R24為氫、-F、-Cl、-B、碳數1~6的烷基、烷氧基、乙烯基、炔基,q獨立為0~4的整數。式(DI-15)中,環C為雜環式芳香族基或雜環式脂肪族基。式(DI-16)中,G24為單鍵、碳數2~6的伸烷基或1,4-伸苯基,r為0或1。而且,鍵結位置未固定在構成環的碳原子上的基表示在該環上的鍵結位置任意。式(DI-13)~式(DI-16)中,鍵結在環上的-NH2的鍵結位置為任意的位置。 In the formula (DI-12), R 21 and R 22 are independently an alkyl group having 1 to 3 carbon atoms or a phenyl group, and G 23 is independently an alkylene group having a carbon number of 1 to 6, a phenyl group or an alkyl group. Phenyl is extended, and w is an integer from 1 to 10. In the formula (DI-13), R 23 is independently an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or -Cl, p is independently an integer of 0 to 3, and q is an integer of 0 to 4. . In the formula (DI-14), the ring B is a monocyclic heterocyclic aromatic group, and R 24 is hydrogen, -F, -Cl, -B, an alkyl group having 1 to 6 carbon atoms, an alkoxy group, or a vinyl group. , alkynyl, q is independently an integer from 0 to 4. In the formula (DI-15), the ring C is a heterocyclic aromatic group or a heterocyclic aliphatic group. In the formula (DI-16), G 24 is a single bond, an alkylene group having 2 to 6 carbon atoms or a 1,4-phenylene group, and r is 0 or 1. Further, the group in which the bonding position is not fixed to the carbon atom constituting the ring indicates that the bonding position on the ring is arbitrary. In the formula (DI-13) to the formula (DI-16), the bonding position of -NH 2 bonded to the ring is an arbitrary position.

作為所述式(DI-1)~式(DI-16)的不具有側鏈的二胺, 可列舉以下的式(DI-1-1)~式(DI-16-1)的具體例。 As the diamine having no side chain of the formula (DI-1) to formula (DI-16), Specific examples of the following formula (DI-1-1) to formula (DI-16-1) can be cited.

以下表示由式(DI-1)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-1) is shown below.

式(DI-1-7)及式(DI-1-8)中,k分別獨立地為1~3的整數。 In the formula (DI-1-7) and the formula (DI-1-8), k is independently an integer of 1 to 3.

以下表示由式(DI-2)~式(DI-3)所表示的二胺的例子。 Examples of the diamine represented by the formula (DI-2) to the formula (DI-3) are shown below.

以下表示由式(DI-4)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-4) is shown below.

以下表示由式(DI-5)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-5) is shown below.

式(DI-5-1)中,m為1~12的整數。 In the formula (DI-5-1), m is an integer of 1 to 12.

式(DI-5-12)及式(DI-5-13)中,m為1~12的整數。 In the formula (DI-5-12) and the formula (DI-5-13), m is an integer of 1 to 12.

式(DI-5-16)中,v為1~6的整數。 In the formula (DI-5-16), v is an integer of 1 to 6.

式(DI-5-30)中,k為1~5的整數。 In the formula (DI-5-30), k is an integer of 1 to 5.

式(DI-5-35)~式(DI-5-37)、及式(DI-5-39)中,m為1~12的整數,式(DI-5-38)及式(DI-5-39)中,k為1~5的整數,(DI-5-40)中,n為1或2的整數。 In the formula (DI-5-35)~(DI-5-37) and (DI-5-39), m is an integer from 1 to 12, and the formula (DI-5-38) and formula (DI- In 5-39), k is an integer of 1 to 5, and in (DI-5-40), n is an integer of 1 or 2.

以下表示由式(DI-6)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-6) is shown below.

以下表示由式(DI-7)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-7) is shown below.

式(DI-7-3)及式(DI-7-4)中,m為1~12的整數,n獨立為1或2。 In the formula (DI-7-3) and the formula (DI-7-4), m is an integer of 1 to 12, and n is independently 1 or 2.

以下表示由式(DI-8)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-8) is shown below.

以下表示由式(DI-9)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-9) is shown below.

以下表示由式(DI-10)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-10) is shown below.

以下表示由式(DI-11)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-11) is shown below.

以下表示由式(DI-12)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-12) is shown below.

以下表示由式(DI-13)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-13) is shown below.

以下表示由式(DI-14)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-14) is shown below.

以下表示由式(DI-15)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-15) is shown below.

以下表示由式(DI-16)所表示的二胺的例子。 An example of the diamine represented by the formula (DI-16) is shown below.

對二醯肼進行說明。作為已知的不具有側鏈的二醯肼,可列舉以下的式(DIH-1)~式(DIH-3)的二醯肼。 Explain the second. Examples of known diterpenes having no side chain include dioxins of the following formula (DIH-1) to formula (DIH-3).

式(DIH-1)中,G25為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-。 In the formula (DIH-1), G 25 is a single bond, an alkylene group having 1 to 20 carbon atoms, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -.

式(DIH-2)中,環D為環己烷環、苯環或萘環,該基的至少1個氫可由甲基、乙基或苯基取代。 In the formula (DIH-2), the ring D is a cyclohexane ring, a benzene ring or a naphthalene ring, and at least one hydrogen of the group may be substituted with a methyl group, an ethyl group or a phenyl group.

式(DIH-3)中,環E分別獨立地為環己烷環、或苯環,該基的至少1個氫可由甲基、乙基、或苯基取代,Y為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-。 In the formula (DIH-3), the ring E is independently a cyclohexane ring or a benzene ring, and at least one hydrogen of the group may be substituted by a methyl group, an ethyl group or a phenyl group, and Y is a single bond, and the carbon number is 1 ~20 alkylene, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -.

式(DIH-2)及式(DIH-3)中,鍵結在環上的-CONHNH2的鍵結位置為任意的位置。 In the formula (DIH-2) and the formula (DIH-3), the bonding position of -CONHNH 2 bonded to the ring is an arbitrary position.

以下表示由式(DIH-1)~式(DIH-3)所表示的二醯肼的例子。 An example of a dich represented by the formula (DIH-1) to the formula (DIH-3) is shown below.

式(DIH-1-2)中,m為1~12的整數。 In the formula (DIH-1-2), m is an integer of 1 to 12.

對側鏈型二胺進行說明。作為側鏈型二胺的側鏈基,可列舉以下的基。 The side chain type diamine is described. Examples of the side chain group of the side chain type diamine include the following groups.

作為側鏈基,首先可列舉:烷基、烷氧基、烷氧基烷基、烷基羰基、烷基羰氧基、烷氧基羰基、烷基胺基羰基、烯基、烯氧基、烯基羰基、烯基羰氧基、烯氧基羰基、烯基胺基羰基、炔基、炔氧基、炔基羰基、炔基羰氧基、炔氧基羰基、炔基胺基羰基等。這些基中的烷基、烯基及炔基均是碳數3以上的基。但是,在烷氧基烷基中,只要整個基的碳數3以上即可。這些基可以是直鏈狀,也可以是支鏈狀。 The side chain group may, first, be an alkyl group, an alkoxy group, an alkoxyalkyl group, an alkylcarbonyl group, an alkylcarbonyloxy group, an alkoxycarbonyl group, an alkylaminocarbonyl group, an alkenyl group, an alkenyloxy group, or the like. Alkenylcarbonyl, alkenylcarbonyloxy, alkenoxycarbonyl, alkenylaminocarbonyl, alkynyl, alkynyloxy, alkynylcarbonyl, alkynylcarbonyloxy, alkynyloxycarbonyl, alkynylaminocarbonyl, and the like. The alkyl group, the alkenyl group and the alkynyl group in these groups are each a group having 3 or more carbon atoms. However, in the alkoxyalkyl group, the carbon number of the entire group may be 3 or more. These groups may be linear or branched.

其次,以末端的環具有碳數1以上的烷基、碳數1以上的烷氧基或碳數2以上的烷氧基烷基作為取代基為條件,可列舉:苯基、苯基烷基、苯基烷氧基、苯氧基、苯基羰基、苯基羰氧基、苯氧基羰基、苯基胺基羰基、苯基環己氧基、碳數3以上的環烷 基、環己基烷基、環己氧基、環己氧基羰基、環己基苯基、環己基苯基烷基、環己基苯氧基、雙(環己基)氧基、雙(環己基)烷基、雙(環己基)苯基、雙(環己基)苯基烷基、雙(環己基)氧基羰基、雙(環己基)苯氧基羰基、及環己基雙(苯基)氧基羰基等環結構的基。 Next, the terminal ring has an alkyl group having 1 or more carbon atoms, an alkoxy group having 1 or more carbon atoms, or an alkoxyalkyl group having 2 or more carbon atoms as a substituent, and examples thereof include a phenyl group and a phenylalkyl group. , phenylalkoxy, phenoxy, phenylcarbonyl, phenylcarbonyloxy, phenoxycarbonyl, phenylaminocarbonyl, phenylcyclohexyloxy, cycloalkane having 3 or more carbon atoms , cyclohexylalkyl, cyclohexyloxy, cyclohexyloxycarbonyl, cyclohexylphenyl, cyclohexylphenylalkyl, cyclohexylphenoxy, bis(cyclohexyl)oxy, bis(cyclohexyl)alkane , bis(cyclohexyl)phenyl, bis(cyclohexyl)phenylalkyl, bis(cyclohexyl)oxycarbonyl, bis(cyclohexyl)phenoxycarbonyl, and cyclohexylbis(phenyl)oxycarbonyl The base of the isocyclic structure.

進而,可列舉如下的環集合基,其為具有2個以上的苯環的基、具有2個以上的環己烷環的基、或包含苯環及環己烷環的2個環以上的基,且鍵結基獨立為單鍵、-O-、-COO-、-OCO-、-CONH-或碳數1~3的伸烷基,末端的環具有碳數1以上的烷基、碳數1以上的氟取代烷基、碳數1以上的烷氧基、或碳數2以上的烷氧基烷基作為取代基。具有類固醇骨架的基作為側鏈基也有效。 Further, examples of the ring group include a group having two or more benzene rings, a group having two or more cyclohexane rings, or a group having two or more rings of a benzene ring and a cyclohexane ring. And the bonding group is independently a single bond, -O-, -COO-, -OCO-, -CONH- or an alkylene group having 1 to 3 carbon atoms, and the terminal ring has an alkyl group having 1 or more carbon atoms and a carbon number A fluorine-substituted alkyl group having 1 or more, an alkoxy group having 1 or more carbon atoms, or an alkoxyalkyl group having 2 or more carbon atoms is used as a substituent. A group having a steroid skeleton is also effective as a side chain group.

作為具有側鏈的二胺,可列舉由以下的式(DI-31)~式(DI-35)所表示的化合物。 The diamine having a side chain includes a compound represented by the following formula (DI-31) to formula (DI-35).

式(DI-31)中,G26為單鍵、-O-、-COO-、-OCO-、-CO-、-CONH-、-CH2O-、-OCH2-、-CF2O-、-OCF2-或-(CH2)m'-,m'為1~12的整數。G26的優選的例子為單鍵、-O-、-COO-、-OCO-、-CH2O-、及碳數1~3的伸烷基,特優選的例子為單鍵、-O-、-COO-、-OCO-、-CH2O-、-CH2-及-CH2CH2-。R25為碳數3~30的烷基、苯基、具有類固醇骨架的基、或由下述的式(DI-31-a)所表示的基。該烷基中,至少1個氫可由-F取代,而且至少1個-CH2-可由-O-、 -CH=CH-或-C≡C-取代。該苯基的氫可由-F、-CH3、-OCH3、-OCH2F、-OCHF2、-OCF3、碳數3~30的烷基或碳數3~30的烷氧基取代,該環己基的氫可由碳數3~30的烷基或碳數3~30的烷氧基取代。鍵結在苯環上的-NH2的鍵結位置表示在該環中為任意的位置,該鍵結位置優選間位或對位。即,當將基“R25-G26-”的鍵結位置設為1位時,2個鍵結位置優選3位與5位、或2位與5位。 In the formula (DI-31), G 26 is a single bond, -O-, -COO-, -OCO-, -CO-, -CONH-, -CH 2 O-, -OCH 2 -, -CF 2 O- , -OCF 2 - or -(CH 2 ) m' -, m' is an integer from 1 to 12. Preferable examples of G 26 are a single bond, -O-, -COO-, -OCO-, -CH 2 O-, and an alkylene group having 1 to 3 carbon atoms, and a particularly preferred example is a single bond, -O- , -COO-, -OCO-, -CH 2 O-, -CH 2 -, and -CH 2 CH 2 -. R 25 is an alkyl group having 3 to 30 carbon atoms, a phenyl group, a group having a steroid skeleton, or a group represented by the following formula (DI-31-a). In the alkyl group, at least one hydrogen may be substituted by -F, and at least one -CH 2 - may be substituted by -O-, -CH=CH- or -C≡C-. The hydrogen of the phenyl group may be substituted by -F, -CH 3 , -OCH 3 , -OCH 2 F, -OCHF 2, -OCF 3 , an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms. The hydrogen of the cyclohexyl group may be substituted by an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms. The bonding position of -NH 2 bonded to the benzene ring indicates an arbitrary position in the ring, and the bonding position is preferably a meta or para position. That is, when the bonding position of the radical "R 25 -G 26 -" is set to 1 position, the two bonding positions are preferably 3 bits and 5 bits, or 2 bits and 5 bits.

式(DI-31-a)中,G27、G28及G29為鍵結基,它們獨立為單鍵、或碳數1~12的伸烷基,該伸烷基的1個以上的-CH2-可由-O-、-COO-、-OCO-、-CONH-、-CH=CH-取代。環B21、環B22、環B23及環B24獨立為1,4-伸苯基、1,4-伸環己基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、萘-1,5-二基、萘-2,7-二基或蒽-9,10-二基,環B21、環B22、環B23及環B24中,至少1個氫可由-F或-CH3取代,s、t及u獨立為0~2的整數,它們的合計為1~5,當s、t或u為2時,各個括號內的2個鍵結基可以相同,也可以不同,而且,2個環可以相同,也可以不同。R26為-F、-OH、碳數1~30的烷基、碳數1~30的氟取代烷基、碳數1~30的烷氧基、-CN、-OCH2F、-OCHF2或-OCF3,該碳數1~30的烷基的至少1個-CH2-可由下述式(DI-31-b)所表示的二價的基取代。 In the formula (DI-31-a), G 27 , G 28 and G 29 are a bonding group, which are independently a single bond or an alkylene group having 1 to 12 carbon atoms, and one or more of the alkyl groups are - CH 2 - may be substituted by -O-, -COO-, -OCO-, -CONH-, -CH=CH-. Ring B 21 , ring B 22 , ring B 23 and ring B 24 are independently 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, pyrimidine- 2,5-diyl, pyridine-2,5-diyl, naphthalene-1,5-diyl, naphthalene-2,7-diyl or fluoren-9,10-diyl, ring B 21 , ring B 22 In the ring B 23 and the ring B 24 , at least one hydrogen may be substituted by -F or -CH 3 , and s, t and u are independently an integer of 0 to 2, and their total is 1 to 5, when s, t or u When it is 2, the two bonding groups in each parenthesis may be the same or different, and the two rings may be the same or different. R 26 is -F, -OH, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, -CN, -OCH 2 F, -OCHF 2 Or -OCF 3 , at least one -CH 2 - of the alkyl group having 1 to 30 carbon atoms may be substituted with a divalent group represented by the following formula (DI-31-b).

式(DI-31-b)中,R27及R28獨立為碳數1~3的烷基,v為1~6 的整數。R26的優選的例子為碳數1~30的烷基及碳數1~30的烷氧基。 In the formula (DI-31-b), R 27 and R 28 are independently an alkyl group having 1 to 3 carbon atoms, and v is an integer of 1 to 6. Preferable examples of R 26 are an alkyl group having 1 to 30 carbon atoms and an alkoxy group having 1 to 30 carbon atoms.

式(DI-32)及式(DI-33)中,G30獨立為單鍵、-CO-或-CH2-,R29獨立為氫或-CH3,R30為氫、碳數1~20的烷基、或碳數2~20的烯基。式(DI-33)中的苯環的至少1個氫可由碳數1~20的烷基或苯基取代。而且,鍵結位置未固定在構成環的任一個碳原子上的基表示在該環中的鍵結位置任意。優選式(DI-32)中的2個基“-伸苯基-G30-O-”的一個鍵結在類固醇核的3位,另一個鍵結在類固醇核的6位。式(DI-33)中的2個基“-伸苯基-G30-O-”在苯環上的鍵結位置優選相對於類固醇核的鍵結位置分別為間位或對位。式(DI-32)及式(DI-33)中,鍵結在苯環上的-NH2表示在該環中的鍵結位置任意。 In formula (DI-32) and formula (DI-33), G 30 is independently a single bond, -CO- or -CH 2 -, R 29 is independently hydrogen or -CH 3 , R 30 is hydrogen, and carbon number is 1~ An alkyl group of 20 or an alkenyl group having 2 to 20 carbon atoms. At least one hydrogen of the benzene ring in the formula (DI-33) may be substituted with an alkyl group having 1 to 20 carbon atoms or a phenyl group. Further, the group in which the bonding position is not fixed to any one of the carbon atoms constituting the ring means that the bonding position in the ring is arbitrary. Preferably, one of the two groups "-phenyl-G 30 -O-" in the formula (DI-32) is bonded to the 3-position of the steroid nucleus and the other is bonded to the 6-position of the steroid nucleus. The bonding position of the two groups "-phenyl-G 30 -O-" in the formula (DI-33) on the benzene ring is preferably meta or para to the bonding position of the steroid nucleus, respectively. In the formula (DI-32) and the formula (DI-33), -NH 2 bonded to the benzene ring means that the bonding position in the ring is arbitrary.

式(DI-34)及式(DI-35)中,G31獨立為-O-或碳數1~6的伸烷基,G32為單鍵或碳數1~3的伸烷基。R31為氫或碳數1~20的烷基,該烷基的至少1個-CH2-可由-O-、-CH=CH-或-C≡C-取代。R32為碳數6~22的烷基,R33為氫或碳數1~22的烷基。環B25為1,4-伸苯基或1,4-伸環己基,r為0或1。而且,鍵結在苯環上的-NH2表示在該環上的鍵結位置任意,但優選獨立且相對於G31的鍵結位置為間位或對位。 In the formula (DI-34) and the formula (DI-35), G 31 is independently -O- or an alkylene group having 1 to 6 carbon atoms, and G 32 is a single bond or an alkylene group having 1 to 3 carbon atoms. R 31 is hydrogen or an alkyl group having 1 to 20 carbon atoms, and at least one -CH 2 - of the alkyl group may be substituted by -O-, -CH=CH- or -C≡C-. R 32 is an alkyl group having 6 to 22 carbon atoms, and R 33 is hydrogen or an alkyl group having 1 to 22 carbon atoms. Ring B 25 is 1,4-phenylene or 1,4-cyclohexylene, and r is 0 or 1. Moreover, -NH 2 bonded to the benzene ring means that the bonding position on the ring is arbitrary, but is preferably independent and the bonding position with respect to G 31 is meta or para.

以下例示側鏈型二胺的具體例。作為所述式(DI-31)~式(DI-35)的具有側鏈的二胺,可列舉由下述的式(DI-31-1)~式(DI-35-3)所表示的化合物。 Specific examples of the side chain type diamine are exemplified below. The diamine having a side chain of the formula (DI-31) to the formula (DI-35) is represented by the following formula (DI-31-1) to formula (DI-35-3). Compound.

以下表示由式(DI-31)所表示的化合物的例子。 An example of the compound represented by the formula (DI-31) is shown below.

式(DI-31-1)~(DI-31-11)中,R34為碳數1~30的烷基或碳數1~30的烷氧基,優選碳數5~25的烷基或碳數5~25的烷氧基。R35為碳數1~30的烷基或碳數1~30的烷氧基,優選碳數3~25的烷基或碳數3~25的烷氧基。 In the formula (DI-31-1) to (DI-31-11), R 34 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, preferably an alkyl group having 5 to 25 carbon atoms or Alkoxy group having 5 to 25 carbon atoms. R 35 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, and preferably an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms.

式(DI-31-12)~式(DI-31-17)中,R36為碳數4~30的烷基,優選碳數6~25的烷基。R37為碳數6~30的烷基,優選碳數8~25的烷基。 In the formula (DI-31-12) to the formula (DI-31-17), R 36 is an alkyl group having 4 to 30 carbon atoms, and preferably an alkyl group having 6 to 25 carbon atoms. R 37 is an alkyl group having 6 to 30 carbon atoms, and preferably an alkyl group having 8 to 25 carbon atoms.

式(DI-31-18)~式(DI-31-43)中,R38為碳數1~20的烷基或碳數1~20的烷氧基,優選碳數3~20的烷基或碳數3~20的烷氧基。R39為氫、-F、碳數1~30的烷基、碳數1~30的烷氧基、-CN、-OCH2F、-OCHF2或-OCF3,優選碳數3~25的烷基、或碳數3~25的烷氧基。而且,G33為碳數1~20的伸烷基。 In the formula (DI-31-18) to the formula (DI-31-43), R 38 is an alkyl group having 1 to 20 carbon atoms or an alkoxy group having 1 to 20 carbon atoms, preferably an alkyl group having 3 to 20 carbon atoms. Or an alkoxy group having a carbon number of 3 to 20. R 39 is hydrogen, -F, an alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, -CN, -OCH 2 F, -OCHF 2 or -OCF 3 , preferably having a carbon number of 3 to 25. An alkyl group or an alkoxy group having a carbon number of 3 to 25. Further, G 33 is an alkylene group having 1 to 20 carbon atoms.

以下表示由式(DI-32)所表示的化合物的例子。 An example of the compound represented by the formula (DI-32) is shown below.

以下表示由式(DI-33)所表示的化合物的例子。 An example of the compound represented by the formula (DI-33) is shown below.

以下表示由式(DI-34)所表示的化合物的例子。 An example of the compound represented by the formula (DI-34) is shown below.

式(DI-34-1)~式(DI-34-12)中,R40為氫或碳數1~20的烷基,優選氫或碳數1~10的烷基,而且,R41為氫或碳數1~12的烷基。 In the formula (DI-34-1) to the formula (DI-34-12), R 40 is hydrogen or an alkyl group having 1 to 20 carbon atoms, preferably hydrogen or an alkyl group having 1 to 10 carbon atoms, and R 41 is Hydrogen or an alkyl group having 1 to 12 carbon atoms.

以下表示由式(DI-35)所表示的化合物的例子。 An example of the compound represented by the formula (DI-35) is shown below.

式(DI-35-1)~式(DI-35-3)中,R37為碳數6~30的烷基,R41為氫或碳數1~12的烷基。 In the formula (DI-35-1) to the formula (DI-35-3), R 37 is an alkyl group having 6 to 30 carbon atoms, and R 41 is hydrogen or an alkyl group having 1 to 12 carbon atoms.

作為本發明中的二胺,也可以使用由式(DI-1-1)~式(DI-35-3)所表示的二胺以外的二胺。作為此種二胺,例如可列舉由下述式(DI-36-1)~式(DI-36-8)所表示的化合物。 As the diamine in the present invention, a diamine other than the diamine represented by the formula (DI-1-1) to the formula (DI-35-3) can also be used. Examples of such a diamine include compounds represented by the following formula (DI-36-1) to formula (DI-36-8).

式(DI-36-1)~式(DI-36-8)中,R42分別獨立地表示碳數3~30的烷基。 In the formula (DI-36-1) to the formula (DI-36-8), R 42 each independently represents an alkyl group having 3 to 30 carbon atoms.

對所述感光性二胺進行說明。在本發明中,可無限制地從公知的感光性二胺中選擇。例如,作為此種感光性二胺化合物,可列舉以下的式(PDI-1)~式(PDI-12)。 The photosensitive diamine will be described. In the present invention, it can be selected from known photosensitive diamines without limitation. For example, examples of such a photosensitive diamine compound include the following formula (PDI-1) to formula (PDI-12).

式(PDI-7)中,R51獨立為-CH3、-OCH3、-CF3或-COOCH3,b為0~2的整數。式(PDI-12)中,R43為碳數1~10的烷基或烷氧基,至少1個氫可被氟取代。 In the formula (PDI-7), R 51 is independently -CH 3 , -OCH 3 , -CF 3 or -COOCH 3 , and b is an integer of 0-2. In the formula (PDI-12), R 43 is an alkyl group or alkoxy group having 1 to 10 carbon atoms, and at least one hydrogen may be substituted by fluorine.

在各二胺中,也可以在相對於二胺的單胺的比率為40莫耳%以下的範圍內,將二胺的一部分取代成單胺。此種取代可引起生成聚醯胺酸時的聚合反應的終止,可抑制聚合反應的進一步的進行。因此,通過此種取代,可容易地控制所獲得的聚合物(聚 醯胺酸或其衍生物)的分子量,例如可無損本發明的效果而改善液晶配向劑的塗布特性。只要無損本發明的效果,則被取代成單胺的二胺可以是一種,也可以是兩種以上。作為所述單胺,例如可列舉:苯胺、4-羥基苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一胺、正十二胺、正十三胺、正十四胺、正十五胺、正十六胺、正十七胺、正十八胺、及正二十胺。 In each of the diamines, a part of the diamine may be substituted with a monoamine in a range of 40 mol% or less based on the monoamine of the diamine. Such substitution can cause termination of the polymerization reaction when polyamic acid is formed, and further progress of the polymerization reaction can be suppressed. Therefore, by such substitution, the obtained polymer can be easily controlled (polymerized The molecular weight of the proline or its derivative can improve the coating properties of the liquid crystal alignment agent, for example, without impairing the effects of the present invention. The diamine substituted with a monoamine may be one type or two or more types as long as the effects of the present invention are not impaired. Examples of the monoamine include aniline, 4-hydroxyaniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, and positive ten Monoamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine, and n-dodecylamine.

所述聚醯胺酸或其衍生物可在其單體中進而含有單異氰酸酯化合物。通過在單體中含有單異氰酸酯化合物,所獲得的聚醯胺酸或其衍生物的末端得到修飾,分子量得到調節。通過使用該末端修飾型的聚醯胺酸或其衍生物,例如可無損本發明的效果而改善液晶配向劑的塗布特性。就所述觀點而言,相對於單體中的二胺及四羧酸二酐的總量,單體中的單異氰酸酯化合物的含量優選1莫耳%~10莫耳%。作為所述單異氰酸酯化合物,例如可列舉:異氰酸苯酯、及異氰酸萘酯。 The polyaminic acid or a derivative thereof may further contain a monoisocyanate compound in its monomer. By containing a monoisocyanate compound in the monomer, the terminal of the obtained polyaminic acid or its derivative is modified, and the molecular weight is adjusted. By using the terminal-modified polyglycine or a derivative thereof, for example, the coating properties of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. From this point of view, the content of the monoisocyanate compound in the monomer is preferably from 1 mol% to 10 mol% based on the total amount of the diamine and the tetracarboxylic dianhydride in the monomer. Examples of the monoisocyanate compound include phenyl isocyanate and naphthyl isocyanate.

所述感光性二胺之中,就感光性的觀點而言,更優選下述式(PDI-6-1)或式(PDI-7-1)。 Among the photosensitive diamines, from the viewpoint of photosensitivity, the following formula (PDI-6-1) or formula (PDI-7-1) is more preferable.

所述二胺的具體例之中,在重視進一步提升液晶的配向性的情況下,二胺優選由式(DI-1-3)、式(DI-4-5)、式(DI-5-1)、式(DI-5-37)、式(DI-7-3)、式(DI-31-2)、式(DI-31-5)、式(DI-31-47)、式(DI-34-2)、式(DI-34-4)或式(DI-34-7)所表 示的二胺。 Among the specific examples of the diamine, in the case where it is important to further improve the alignment of the liquid crystal, the diamine is preferably represented by the formula (DI-1-3), the formula (DI-4-5), and the formula (DI-5-). 1), formula (DI-5-37), formula (DI-7-3), formula (DI-31-2), formula (DI-31-5), formula (DI-31-47), formula ( DI-34-2), formula (DI-34-4) or formula (DI-34-7) The diamine shown.

所述二胺的具體例之中,在重視進一步提升透過率的情況下,二胺優選由式(DI-1-3)、式(DI-2-1)、式(DI-12-1)及式(DIH-2-1)所表示的二胺。 Among the specific examples of the diamine, in the case where the transmittance is further increased, the diamine is preferably represented by the formula (DI-1-3), the formula (DI-2-1), and the formula (DI-12-1). And a diamine represented by the formula (DIH-2-1).

所述二胺的具體例之中,在重視進一步提升電特性的情況下,二胺優選由式(DI-4-1)、式(DI-4-5)、式(DI-5-1)、式(DI-5-5)、式(DI-5-9)、式(DI-5-30)、式(DI-5-37)、式(DI-8-2)、式(DI-13-1)、式(DI-14-8)或式(DIH-2-1)所表示的二胺。 Among the specific examples of the diamine, in the case where it is emphasized that the electrical properties are further improved, the diamine is preferably represented by the formula (DI-4-1), the formula (DI-4-5), and the formula (DI-5-1). , formula (DI-5-5), formula (DI-5-9), formula (DI-5-30), formula (DI-5-37), formula (DI-8-2), formula (DI- 13-1), a diamine represented by the formula (DI-14-8) or the formula (DIH-2-1).

本發明中所使用的聚醯胺酸聚合物及聚醯亞胺聚合物可通過使酸二酐與二胺成分在溶劑中進行反應而獲得。在該合成反應中,除原料的選擇以外,無需特別的條件,可直接應用通常的聚醯胺酸合成中的條件。所使用的溶劑將後述。 The polyphthalic acid polymer and the polyimine polymer used in the present invention can be obtained by reacting an acid dianhydride with a diamine component in a solvent. In the synthesis reaction, conditions other than the usual polyamine synthesis can be directly applied, except for the selection of the raw materials, without special conditions. The solvent to be used will be described later.

所述液晶配向劑可以是所謂的摻合型,也可以進一步含有聚醯胺酸或其衍生物,也可以進一步含有聚醯胺酸或其衍生物以外的其他成分。其他成分可以是1種,也可以是2種以上。 The liquid crystal alignment agent may be a so-called blend type, or may further contain polyamic acid or a derivative thereof, or may further contain other components than polyamine or a derivative thereof. The other components may be one type or two or more types.

另外,例如所述液晶配向劑可在無損本發明的效果的範圍(優選所述聚醯胺酸或其衍生物的20wt%(重量百分比)以內的量)內,進一步含有丙烯酸聚合物、丙烯酸酯聚合物、及四羧酸二酐、作為二羧酸或其衍生物與二胺的反應產物的聚醯胺醯亞胺等其他聚合物成分。 Further, for example, the liquid crystal alignment agent may further contain an acrylic polymer, an acrylate, within a range not detracting from the effects of the present invention, preferably within 20% by weight of the polyaminic acid or a derivative thereof. A polymer, a tetracarboxylic dianhydride, or other polymer component such as a polyamidoximine which is a reaction product of a dicarboxylic acid or a derivative thereof and a diamine.

所述聚醯胺酸或其衍生物可與用於聚醯亞胺的膜的形成的公知的聚醯胺酸或其衍生物同樣地製造。四羧酸二酐的總添加量優選設為與二胺的總莫耳數大致等莫耳(莫耳比為0.9~1.1左右)。 The polyaminic acid or a derivative thereof can be produced in the same manner as the known polyglycine or a derivative thereof for forming a film of polyimine. The total addition amount of the tetracarboxylic dianhydride is preferably set to be approximately equal to the total number of moles of the diamine (the molar ratio is about 0.9 to 1.1).

所述聚醯胺酸或其衍生物的分子量以聚苯乙烯換算的重量平均分子量(Mw)計,優選10,000~500,000,更優選20,000~200,000。所述聚醯胺酸或其衍生物的分子量可由利用凝膠滲透色譜法(Gel Permeation Chromatography,GPC)法的測定來求出。 The molecular weight of the polyaminic acid or its derivative is preferably 10,000 to 500,000, more preferably 20,000 to 200,000, in terms of polystyrene-equivalent weight average molecular weight (Mw). The molecular weight of the polyaminic acid or its derivative can be determined by measurement by a gel permeation chromatography (GPC) method.

所述聚醯胺酸或其衍生物可通過如下方式來確認它的存在:利用紅外線(Infrared,IR)、核磁共振(Nuclear Magnetic Resonance,NMR)對使所述聚醯胺酸或其衍生物在大量的不良溶劑中沉澱而獲得的固體成分進行分析。另外,可通過如下方式來確認所使用的單體:利用氣相色譜法(Gas Chromatography,GC)、高效液相色譜法(High Performance Liquid Chromatography,HPLC)或氣相色譜質譜法(Gas Chromatography-Mass Spectrometry,GC-MS)對使用KOH或NaOH等強鹼的水溶液將所述聚醯胺酸或其衍生物分解後,使用有機溶劑從其分解物中所萃取出的萃取物進行分析。 The polyaminic acid or a derivative thereof can be confirmed by the presence of an infrared (Infrared, IR), nuclear magnetic resonance (NMR) pair to make the poly-proline or its derivative The solid component obtained by precipitation in a large amount of poor solvent was analyzed. In addition, the monomer to be used can be confirmed by gas chromatography (GC), high performance liquid chromatography (HPLC) or gas chromatography mass spectrometry (Gas Chromatography-Mass). Spectrometry, GC-MS) Decomposes the poly-proline or a derivative thereof using an aqueous solution of a strong base such as KOH or NaOH, and then extracts the extract extracted from the decomposition product using an organic solvent.

<烯基取代納迪克醯亞胺化合物> <Alkenyl substituted nadic ylidene compound>

例如,就使液晶顯示元件的電特性長期穩定的目的而言,本發明的液晶配向劑可進一步含有烯基取代納迪克醯亞胺化合物。烯基取代納迪克醯亞胺化合物可使用1種,也可以併用2種以上。就所述目的而言,相對於聚醯胺酸或其衍生物,烯基取代納迪克醯亞胺化合物的含量優選1wt%~100wt%,更優選1wt%~70wt%,進而更優選1wt%~50wt%。 For example, for the purpose of stabilizing the electrical properties of the liquid crystal display element for a long period of time, the liquid crystal alignment agent of the present invention may further contain an alkenyl-substituted nadic quinone imine compound. The alkenyl substituted nadic ylidene imine compound may be used alone or in combination of two or more. For the purpose, the content of the alkenyl-substituted nadic ylidene compound is preferably from 1% by weight to 100% by weight, more preferably from 1% by weight to 70% by weight, still more preferably 1% by weight, relative to the polyamic acid or a derivative thereof. 50wt%.

以下對納迪克醯亞胺化合物進行具體說明。 The Nadik imine compound is specifically described below.

烯基取代納迪克醯亞胺化合物優選可溶解在溶解本發明中所使用的聚醯胺酸或其衍生物的溶劑中的化合物。此種烯基取代納迪克 醯亞胺化合物的例子可列舉由下述的式(NA)所表示的化合物。 The alkenyl-substituted nadicylimine compound is preferably a compound which is soluble in a solvent which dissolves the poly-proline or a derivative thereof used in the present invention. This alkenyl substituted Nadick Examples of the quinone imine compound include compounds represented by the following formula (NA).

式(NA)中,L1及L2獨立為氫、碳數1~12的烷基、碳數3~6的烯基、碳數5~8的環烷基、芳基或苄基,n為1或2。 In the formula (NA), L 1 and L 2 are independently hydrogen, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 3 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group or a benzyl group, n It is 1 or 2.

式(NA)中,當n=1時,W為碳數1~12的烷基、碳數2~6的烯基、碳數5~8的環烷基、碳數6~12的芳基、苄基、由-Z1-(O)r-(Z2O)k-Z3-H(此處,Z1、Z2及Z3獨立為碳數2~6的伸烷基,r為0或1,而且,k為1~30的整數)所表示的基、由-(Z4)r-B-Z5-H(此處,Z4及Z5獨立為碳數1~4的伸烷基或碳數5~8的伸環烷基,B為伸苯基,而且,r為0或1)所表示的基、由-B-T-B-H(此處,B為伸苯基,而且,T為-CH2-、-C(CH3)2-、-O-、-CO-、-S-或-SO2-)所表示的基、或這些基的1個氫~3個氫經-OH取代的基。 In the formula (NA), when n=1, W is an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, and an aryl group having 6 to 12 carbon atoms. , benzyl, from -Z 1 -(O) r -(Z 2 O) k -Z 3 -H (here, Z 1 , Z 2 and Z 3 are independently an alkylene group having 2 to 6 carbon atoms, r The base represented by 0 or 1, and k is an integer from 1 to 30, consists of -(Z 4 ) r -BZ 5 -H (here, Z 4 and Z 5 independently represent a carbon number of 1 to 4). An alkyl group or a cycloalkyl group having 5 to 8 carbon atoms, B is a phenyl group, and r is a group represented by 0 or 1), and is represented by -BTBH (wherein B is a stretching phenyl group, and T is a group represented by -CH 2 -, -C(CH 3 ) 2 -, -O-, -CO-, -S- or -SO 2 -), or 1 hydrogen to 3 hydrogens of these groups via -OH Substituted base.

此時,優選的W為碳數1~8的烷基、碳數3~4的烯基、環己基、苯基、苄基、碳數4~10的聚(亞乙氧基)乙基、苯氧基苯基、苯基甲基苯基、苯基亞異丙基苯基、及這些基的1個氫或2個氫經-OH取代的基。 In this case, preferred W is an alkyl group having 1 to 8 carbon atoms, an alkenyl group having 3 to 4 carbon atoms, a cyclohexyl group, a phenyl group, a benzyl group, or a poly(ethyleneoxy)ethyl group having 4 to 10 carbon atoms. A phenoxyphenyl group, a phenylmethylphenyl group, a phenyl isopropylidenephenyl group, and a group in which one hydrogen or two hydrogens of these groups are substituted with -OH.

式(NA)中,當n=2時,W為碳數2~20的伸烷基、碳數5~8的伸環烷基、碳數6~12的伸芳基、由-Z1-O-(Z2O)k-Z3-(此處,Z1~Z3、及k的含義如上所述)所表示的基、由-Z4-B-Z5-(此處,Z4、Z5及B的含義如上所述)所表示的基、由-B-(O-B)r-T-(B-O)r-B-(此處,B為伸苯基,T為碳數1~3的伸烷 基、-O-或-SO2-,r的含義如上所述)所表示的基、或這些基的1個氫~3個氫經-OH取代的基。 In the formula (NA), when n=2, W is an alkylene group having 2 to 20 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an extended aryl group having 6 to 12 carbon atoms, and -Z 1 - a group represented by O-(Z 2 O) k -Z 3 - (here, Z 1 -Z 3 , and k have the meanings as described above), consisting of -Z 4 -BZ 5 - (here, Z 4 , The meaning of Z 5 and B is as defined above. The group represented by -B-(OB) r -T-(BO) r -B- (here, B is a phenyl group and T is a carbon number of 1-3). The alkyl group, -O- or -SO 2 -, r has the meaning indicated above, or a group in which one hydrogen to three hydrogens of these groups are substituted by -OH.

此時,優選的W為碳數2~12的伸烷基、伸環己基、伸苯基、甲代伸苯基、苯二甲基、由-C3H6-O-(Z2-O)n-O-C3H6-(此處,Z2為碳數2~6的伸烷基,n為1或2)所表示的基、由-B-T-B-(此處,B為伸苯基,而且,T為-CH2-、-O-或-SO2-)所表示的基、由-B-O-B-C3H6-B-O-B-(此處,B為伸苯基)所表示的基、及這些基的1個氫或2個氫經-OH取代的基。 In this case, preferred W is an alkylene group having 2 to 12 carbon atoms, a cyclohexylene group, a phenyl group, a phenylene group, a benzene dimethyl group, and a -C 3 H 6 -O-(Z 2 -O) group. a group represented by n -OC 3 H 6 - (here, Z 2 is an alkylene group having 2 to 6 carbon atoms, and n is 1 or 2), and is represented by -BTB- (wherein B is a stretching phenyl group, Further, T is a group represented by -CH 2 -, -O- or -SO 2 -), a group represented by -BOBC 3 H 6 -BOB- (here, B is a stretching phenyl group), and these groups One hydrogen or two hydrogen-substituted groups.

此種烯基取代納迪克醯亞胺化合物可使用例如如日本專利第2729565號公報中所記載般,通過將烯基取代納迪克酸酐衍生物與二胺在80℃~220℃的溫度下保持0.5小時~20小時來進行合成而獲得的化合物、或市售的化合物。作為烯基取代納迪克醯亞胺化合物的具體例,可列舉以下所示的化合物。 Such an alkenyl-substituted nadicylimine compound can be maintained at a temperature of from 80 ° C to 220 ° C by using an alkenyl-substituted nadic anhydride anhydride derivative and a diamine as described in, for example, Japanese Patent No. 2729565. A compound obtained by synthesis or a commercially available compound in an hour to 20 hours. Specific examples of the alkenyl-substituted nadicylimine compound include the compounds shown below.

N-甲基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-甲基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-甲基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-甲基-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2-乙基己基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2-乙基己基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-烯丙基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-烯丙基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-烯丙基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-異丙烯基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-異丙烯基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-異丙烯基- 甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-環己基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-環己基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-環己基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-苯基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-苯基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-苄基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-苄基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-苄基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2-羥乙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2-羥乙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2-羥乙基)-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2,2-二甲基-3-羥丙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2,2-二甲基-3-羥丙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2,3-二羥丙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(2,3-二羥丙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(3-羥基-1-丙烯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(4-羥基環己基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(4-羥苯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(4-羥苯基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(4-羥苯基)-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(4-羥苯基)-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(3-羥苯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯 亞胺、N-(3-羥苯基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-(對羥基苄基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{2-(2-羥基乙氧基)乙基}-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{2-(2-羥基乙氧基)乙基}-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{2-(2-羥基乙氧基)乙基}-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{2-(2-羥基乙氧基)乙基}-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{4-(4-羥苯基亞異丙基)苯基}-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{4-(4-羥苯基亞異丙基)苯基}-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-{4-(4-羥苯基亞異丙基)苯基}-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、及它們的寡聚物、N,N'-伸乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環 [2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、1,2-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙烷、1,2-雙{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙烷、1,2-雙{3'-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙烷、雙[2'-{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙基]醚、雙[2'-{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙基]醚、1,4-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}丁烷、1,4-雙{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}丁烷、N,N'-對伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-{(1-甲基)-2,4-伸苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5- 烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸、1,6-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-3-羥基-己烷、1,12-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-3,6-二羥基-十二烷、1,3-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-5-羥基-環己烷、1,5-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}-3-羥基-戊烷、1,4-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-2-羥基-苯、1,4-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-2,5-二羥基-苯、N,N'-對(2-羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對(2-羥基)苯二甲基-雙(烯丙基甲基環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間(2-羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間 (2-羥基)苯二甲基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對(2,3-二羥基)苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-2-羥基-苯氧基}苯基]丙烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-2-羥基-苯基}甲烷、雙{3-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-4-羥基-苯基}醚、雙{3-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)-5-羥基-苯基}碸、1,1,1-三{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)}苯氧基甲基丙烷、N,N',N"-三(伸乙基甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)異三聚氰酸酯、及它們的寡聚物等。 N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, N-methyl-allylmethylbicyclo[2.2.1]hept-5- Alkene-2,3-dicarboxy quinone imine, N-methyl-methylallyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N-methyl-A Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine, N-(2-ethylhexyl)-allylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxy quinone imine, N-(2-ethylhexyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy fluorene Amine, N-allyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, N-allyl-allylmethylbicyclo[2.2.1] Hg-5-ene-2,3-dicarboxy quinone imine, N-allyl-methylallyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N -Isopropenyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarminemine, N-isopropenyl-allyl (methyl)bicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine, N-isopropenyl- Methylallyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine, N-cyclohexyl-allyl bicyclo [2.2.1] hept-5-ene-2,3 -Dicarboxy quinone imine, N-cyclohexyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N-cyclohexyl-methylallyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine, N-phenyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindole Imine, N-phenyl-allyl (methyl) bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine, N-benzyl-allyl bicyclo [2.2.1 Gh-5-ene-2,3-dicarboxy quinone imine, N-benzyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N -benzyl-methallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine, N-(2-hydroxyethyl)-allylbicyclo[2.2.1] Hg-5-ene-2,3-dicarboxy quinone imine, N-(2-hydroxyethyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimine, N-(2-hydroxyethyl)-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine, N-(2,2-di Methyl-3-hydroxypropyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarminemine, N-(2,2-dimethyl-3-hydroxypropane Allyl group Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, N-(2,3-dihydroxypropyl)-allylbicyclo[2.2.1]hept-5-ene -2,3-dicarboxy quinone imine, N-(2,3-dihydroxypropyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyanthracene Imine, N-(3-hydroxy-1-propenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N-(4-hydroxycyclohexyl) -allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine, N-(4-hydroxyphenyl)-allylbicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine, N-(4-hydroxyphenyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyl Yttrium, N-(4-hydroxyphenyl)-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmine, N-(4-hydroxyphenyl) -methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, N-(3-hydroxyphenyl)-allylbicyclo[2.2.1]g -5-ene-2,3-dicarboxyfluorene Imine, N-(3-hydroxyphenyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N-(p-hydroxybenzyl) -allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, N-{2-(2-hydroxyethoxy)ethyl}-allylbicyclo[2.2. 1]hept-5-ene-2,3-dicarboxy quinone imine, N-{2-(2-hydroxyethoxy)ethyl}-allyl (methyl)bicyclo[2.2.1]heptane- 5-ene-2,3-dicarboxy quinone imine, N-{2-(2-hydroxyethoxy)ethyl}-methylallylbicyclo[2.2.1]hept-5-ene-2, 3-dicarboxy quinone imine, N-{2-(2-hydroxyethoxy)ethyl}-methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyl Yttrium, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyanthracene Imine, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3- Dicarboxy quinone imine, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-methylallylbicyclo[2.2.1]hept-5-ene-2,3 -Dicarboxy quinone imine, N-{4-(4-hydroxyphenyl isopropylidene)phenyl}-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy fluorene Amine, N-{4-(4-hydroxyphenylisopropylidene)phenyl }-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine, N-{4-(4-hydroxyphenyl isopropylidene)phenyl} -Methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine, and oligomers thereof, N,N'-extended ethyl-bis(allyl bicyclol [2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-extended ethyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene- 2,3-dicarboxy quinone imine), N,N'-extended ethyl-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmine), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-hexamethylene-bis(ene) Propylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-hexamethylene-bis(allylmethylbicyclo[2.2.1]heptane- 5-ene-2,3-dicarboxy quinone imine), N,N'-dodecamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyfluorene Imine), N, N'-docamethylene-bis(allylmethyl bicyclic [2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2, 3-dicarboxy quinone imine), N,N'-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine), 1, 2-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)propoxy}ethane, 1,2-double {3'-( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)propoxy}ethane, 1,2-bis{3'-(methylallylbicyclo) [2.2.1]hept-5-ene-2,3-dicarboxyindolimine)propoxy}ethane, bis[2'-{3'-(allylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxyindolimine)propoxy}ethyl]ether, bis[2'-{3'-(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxy quinone imine) propoxy}ethyl]ether, 1,4-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyfluorene Imine) propoxy}butane, 1,4-bis{3'-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine)propoxy }Butane, N,N'-p-phenyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-p-phenylene Base-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyfluorene Amine), N,N'-interphenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-m-phenylene - bis (allylmethyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine), N, N'-{(1-methyl)-2,4-phenylene }--bis (allyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine), N, N'-p-xylylene-bis (allyl bicyclo [2.2 .1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene- 2,3-dicarboxy quinone imine), N,N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinazoline), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), 2,2-bis[4-{ 4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(ene Propylmethylbicyclo[2.2.1]hept-5- Alkene-2,3-dicarboxy quinone imine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(methylallylbicyclo[2.2.1]hept-5-ene- 2,3-Dicarboxy quinone imine) phenoxy} phenyl] propane, bis {4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine) benzene Methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarsenazo)phenyl}methane, double {4-(methylallyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenyl}methane, bis{4-(methylallylmethylbicyclo[2.2.1]hept-5- Alkene-2,3-dicarboxy quinone imine) phenyl}methane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinazoline)phenyl} Ether, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)phenyl}ether, bis{4-(methylallylbicyclo) [2.2.1]hept-5-ene-2,3-dicarboxyindenine)phenyl}ether, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3- Dicarboxy quinone imine) phenyl} fluorene, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinazoline)phenyl} fluorene, double { 4-(Methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)phenyl}indole, 1,6-bis(allylbicyclo[2.2.1] Geng-5- Alkene-2,3-dicarboxy quinone imine)-3-hydroxy-hexane, 1,12-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyfluorene Imine)-3,6-dihydroxy-dodecane, 1,3-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine)-5-hydroxyl -cyclohexane, 1,5-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)propoxy}-3-hydroxy-pentyl Alkane, 1,4-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)-2-hydroxy-benzene, 1,4-bis(allylyl) Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)-2,5-dihydroxy-benzene, N,N'-p-(2-hydroxy)benzenedimethyl-double (allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-p-(2-hydroxy)benzenedimethyl-bis(allylmethyl) Ring [2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-m-(2-hydroxy)benzenedimethyl-bis(allylbicyclo[2.2.1] Hg-5-ene-2,3-dicarboxy quinone imine), N, N'- (2-hydroxy)benzenedimethyl-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-pair (2,3 -dihydroxy)benzenedimethyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), 2,2-bis[4-{4-(ene Propylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)-2-hydroxy-phenoxy}phenyl]propane, bis{4-(allylmethylbicyclo[ 2.2.1]hept-5-ene-2,3-dicarboxyindolimine)-2-hydroxy-phenyl}methane, bis{3-(allylbicyclo[2.2.1]hept-5-ene- 2,3-Dicarboxy quinone imine)-4-hydroxy-phenyl}ether, bis{3-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy fluorene Amine)-5-hydroxy-phenyl}indole, 1,1,1-tris{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine) }Phenoxymethylpropane, N,N',N"-tris(ethylethylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmine) Polycyanates, oligomers thereof, and the like.

進而,本發明中所使用的烯基取代納迪克醯亞胺化合物可為含有非對稱的伸烷基.伸苯基的由下述的式所表示的化合物。 Further, the alkenyl-substituted nadicylimine compound used in the present invention may be an asymmetric alkyl group. A compound represented by the following formula which is a phenyl group.

以下表示烯基取代納迪克醯亞胺化合物中的優選的化合物。 Preferred compounds among the alkenyl substituted nadic quinone imine compounds are shown below.

N,N'-伸乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-{(1-甲基)-2,4-伸苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基] 丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷。 N,N'-Extended ethyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-extended ethyl-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-extended ethyl-bis(methylallylbicyclo[2.2.1]heptane- 5-ene-2,3-dicarboxy quinone imine), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine ), N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-dodecyl-bis(allylbicyclo[2.2. 1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 ,3-dicarboxy quinone imine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine), N,N '-Extended cyclohexyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-p-phenylene-bis(allyl Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-p-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxy quinone imine), N,N'- Phenyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-meta-phenyl-bis(allylmethylbicyclo) [2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-{(1-methyl)-2,4-phenylene}-bis(allyl bicyclol) [2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene- 2,3-dicarboxy quinone imine), N,N'-p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine ), N, N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide), N,N'-m-xylylene Base-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), 2,2-bis[4-{4-(allylbicyclo[2.2 .1]hept-5-ene-2,3-dicarboxy quinone imine)phenoxy}phenyl] Propane, 2,2-bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, double { 4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyinlimine)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine) phenyl}methane.

雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}醚、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}碸。 Double {4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)phenyl}methane, bis{4-(methylallylmethylbicyclo) [2.2.1]hept-5-ene-2,3-dicarboxyinimide)phenyl}methane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3- Dicarboxy quinone imine) phenyl} ether, bis {4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine) phenyl} ether, double { 4-(Methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)phenyl}ether, bis{4-(allylbicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine) phenyl} fluorene, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy fluorene Amine) phenyl} hydrazine, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine)phenyl}indole.

以下表示更優選的烯基取代納迪克醯亞胺化合物。 More preferred alkenyl substituted nadic quinone imine compounds are shown below.

N,N'-伸乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基雙環[2.2.1]庚-5-烯 -2,3-二羧基醯亞胺)、N,N'-伸環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)。 N,N'-Extended ethyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-extended ethyl-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-extended ethyl-bis(methylallylbicyclo[2.2.1]heptane- 5-ene-2,3-dicarboxy quinone imine), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine ), N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-dodecyl-bis(allylbicyclo[2.2. 1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 ,3-dicarboxy quinone imine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene -2,3-dicarboxy quinone imine), N,N'-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinazoline) .

N,N'-對伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間伸苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-{(1-甲基)-2,4-伸苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-對苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、N,N'-間苯二甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)。 N,N'-p-phenyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-p-phenylene-bis( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N'-meta-phenyl-bis(allylbicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine), N,N'-meta-phenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimine), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di Carboxylimine), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'- P-Benzyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'-m-xylylene-bis(ene) Propyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1]g -5-ene-2,3-dicarboxy quinone imine).

2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷。 2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, 2,2- Bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, 2,2-dual [ 4-{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenoxy}phenyl]propane, double {4-(allyl) Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2 ,3-dicarboxy quinone imine)phenyl}methane, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxy quinone imine)phenyl}methane , bis{4-(methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine)phenyl}methane.

而且,作為特優選的烯基取代納迪克醯亞胺化合物,可列舉:由下述式(NA-1)所表示的雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、由式(NA-2)所表示的N,N'- 間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、及由式(NA-3)所表示的N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)。 Further, as a particularly preferred alkenyl-substituted nadicylimine compound, a bis{4-(allylbicyclo[2.2.1]hept-5-ene represented by the following formula (NA-1) is exemplified. -2,3-dicarboxy quinazoline)phenyl}methane, N,N'- represented by formula (NA-2) Meta-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyinlimine), and N,N'- represented by formula (NA-3) Hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyinylimine).

<具有自由基聚合性不飽和雙鍵的化合物> <Compound having a radical polymerizable unsaturated double bond>

例如,就使液晶顯示元件的電特性長期穩定的目的而言,本發明的液晶配向劑可進一步含有具有自由基聚合性不飽和雙鍵的化合物。具有自由基聚合性不飽和雙鍵的化合物可以是一種化合物,也可以是兩種以上的化合物。再者,在具有自由基聚合性不飽和雙鍵的化合物中不含烯基取代納迪克醯亞胺化合物。就所述目的而言,相對於聚醯胺酸或其衍生物,具有自由基聚合性不飽和雙鍵的化合物的含量優選1wt%~100wt%,更優選1wt%~70wt%,進而更優選1wt%~50wt%。 For example, the liquid crystal alignment agent of the present invention may further contain a compound having a radical polymerizable unsaturated double bond for the purpose of stabilizing the electrical properties of the liquid crystal display element for a long period of time. The compound having a radical polymerizable unsaturated double bond may be one kind of compound or two or more types of compounds. Further, an alkenyl-substituted nadic quinone imine compound is not contained in the compound having a radical polymerizable unsaturated double bond. For the purpose, the content of the compound having a radical polymerizable unsaturated double bond is preferably from 1% by weight to 100% by weight, more preferably from 1% by weight to 70% by weight, still more preferably 1% by weight with respect to the polyaminic acid or a derivative thereof. %~50wt%.

再者,關於相對於烯基取代納迪克醯亞胺化合物的具有自由基聚合性不飽和雙鍵的化合物的比率,為了降低液晶顯示元件的離子密度、抑制離子密度的經時的增加、進而抑制殘像的產 生,具有自由基聚合性不飽和雙鍵的化合物/烯基取代納迪克醯亞胺化合物以重量比計優選0.1~10,更優選0.5~5。 In addition, the ratio of the compound having a radically polymerizable unsaturated double bond to the alkenyl substituted imidide compound is reduced in order to reduce the ion density of the liquid crystal display element, suppress the increase in the ion density over time, and further suppress Production of afterimage The compound/alkenyl-substituted nadic ylidene compound having a radical polymerizable unsaturated double bond is preferably 0.1 to 10, more preferably 0.5 to 5 by weight.

以下對具有自由基聚合性不飽和雙鍵的化合物進行具體說明。作為具有自由基聚合性不飽和雙鍵的化合物,可列舉:(甲基)丙烯酸酯、(甲基)丙烯醯胺等(甲基)丙烯酸衍生物、及雙馬來醯亞胺。具有自由基聚合性不飽和雙鍵的化合物更優選具有2個以上的自由基聚合性不飽和雙鍵的(甲基)丙烯酸衍生物。 The compound having a radical polymerizable unsaturated double bond will be specifically described below. Examples of the compound having a radical polymerizable unsaturated double bond include a (meth) acrylate, a (meth)acrylic acid derivative such as (meth) acrylamide, and a bismaleimide. The compound having a radical polymerizable unsaturated double bond is more preferably a (meth)acrylic acid derivative having two or more radically polymerizable unsaturated double bonds.

作為(甲基)丙烯酸酯的具體例,例如可列舉:(甲基)丙烯酸環己酯、(甲基)丙烯酸-2-甲基環己酯、(甲基)丙烯酸二環戊酯、(甲基)丙烯酸二環戊氧基乙酯、(甲基)丙烯酸異冰片酯、(甲基)丙烯酸苯酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸-2-羥基乙酯、及(甲基)丙烯酸-2-羥基丙酯。 Specific examples of the (meth) acrylate include cyclohexyl (meth)acrylate, 2-methylcyclohexyl (meth)acrylate, and dicyclopentanyl (meth)acrylate. Dicyclopentyloxyethyl acrylate, isobornyl (meth)acrylate, phenyl (meth)acrylate, benzyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, and 2-hydroxypropyl methacrylate.

作為二官能(甲基)丙烯酸酯的具體例,例如可列舉:伸乙基雙丙烯酸酯,作為東亞合成化學工業(股份)的製品的Aronix M-210、Aronix M-240及Aronix M-6200,作為日本化藥(股份)的製品的KAYARAD HDDA、KAYARAD HX-220、KAYARAD R-604及KAYARAD R-684,作為大阪有機化學工業(股份)的製品的V260、V312及V335HP,以及作為共榮社油脂化學工業(股份)的製品的Light Acrylate BA-4EA,Light Acrylate BP-4PA及Light Acrylate BP-2PA。 Specific examples of the difunctional (meth) acrylate include, for example, exoethyl diacrylate, Aronix M-210, Aronix M-240, and Aronix M-6200, which are products of the East Asian synthetic chemical industry. KAYARAD HDDA, KAYARAD HX-220, KAYARAD R-604, and KAYARAD R-684, which are products of Nippon Kayaku (shares), V260, V312, and V335HP, which are products of Osaka Organic Chemical Industry Co., Ltd., and Co., Ltd. Light Acrylate BA-4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA for the products of the Grease Chemical Industry (stock).

作為三官能以上的多官能(甲基)丙烯酸酯的具體例,例如可列舉:4,4'-亞甲基雙(N,N-二羥基伸乙基丙烯酸酯苯胺),作為東亞合成化學工業(股份)的製品的Aronix M-400、Aronix M-405、Aronix M-450、Aronix M-7100、Aronix M-8030、Aronix M-8060, 作為日本化藥(股份)的製品的KAYARAD TMPTA、KAYARAD DPCA-20、KAYARAD DPCA-30、KAYARAD DPCA-60、KAYARAD DPCA-120,及作為大阪有機化學工業(股份)的製品的VGPT。 Specific examples of the trifunctional or higher polyfunctional (meth) acrylate include, for example, 4,4′-methylenebis(N,N-dihydroxyethyl acrylate), which is a synthetic chemical industry in East Asia. (shares) products of Aronix M-400, Aronix M-405, Aronix M-450, Aronix M-7100, Aronix M-8030, Aronix M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD DPCA-30, KAYARAD DPCA-60, KAYARAD DPCA-120, and VGPT, which are products of Osaka Organic Chemical Industry Co., Ltd., are products of Nippon Chemical Co., Ltd.

作為(甲基)丙烯醯胺衍生物的具體例,例如可列舉:N-異丙基丙烯醯胺、N-異丙基甲基丙烯醯胺、N-正丙基丙烯醯胺、N-正丙基甲基丙烯醯胺、N-環丙基丙烯醯胺、N-環丙基甲基丙烯醯胺、N-乙氧基乙基丙烯醯胺、N-乙氧基乙基甲基丙烯醯胺、N-四氫糠基丙烯醯胺、N-四氫糠基甲基丙烯醯胺、N-乙基丙烯醯胺、N-乙基-N-甲基丙烯醯胺、N,N-二乙基丙烯醯胺、N-甲基-N-正丙基丙烯醯胺、N-甲基-N-異丙基丙烯醯胺、N-丙烯醯基哌啶、N-丙烯醯基吡咯烷、N,N'-亞甲基雙丙烯醯胺、N,N'-伸乙基雙丙烯醯胺、N,N'-二羥基伸乙基雙丙烯醯胺、N-(4-羥苯基)甲基丙烯醯胺、N-苯基甲基丙烯醯胺、N-丁基甲基丙烯醯胺、N-(異丁氧基甲基)甲基丙烯醯胺、N-[2-(N,N-二甲胺基)乙基]甲基丙烯醯胺、N,N-二甲基甲基丙烯醯胺、N-[3-(二甲胺基)丙基]甲基丙烯醯胺、N-(甲氧基甲基)甲基丙烯醯胺、N-(羥甲基)-2-甲基丙烯醯胺、N-苄基-2-甲基丙烯醯胺、及N,N'-亞甲基雙甲基丙烯醯胺。 Specific examples of the (meth) acrylamide derivative include N-isopropyl acrylamide, N-isopropyl methacrylamide, N-n-propyl acrylamide, and N-positive Propyl methacrylamide, N-cyclopropyl acrylamide, N-cyclopropyl methacrylamide, N-ethoxyethyl acrylamide, N-ethoxyethyl methacrylate Amine, N-tetrahydrofurfuryl acrylamide, N-tetrahydrofurfuryl methacrylamide, N-ethyl acrylamide, N-ethyl-N-methyl acrylamide, N, N-di Ethyl acrylamide, N-methyl-N-n-propyl acrylamide, N-methyl-N-isopropyl acrylamide, N-propylene hydrazinopyridine, N-propenylpyrrolidine, N,N'-methylenebispropene decylamine, N,N'-extended ethyl bis acrylamide, N,N'-dihydroxyethylidene bis decylamine, N-(4-hydroxyphenyl) Methacrylamide, N-phenylmethacrylamide, N-butylmethacrylamide, N-(isobutoxymethyl)methacrylamide, N-[2-(N,N- Dimethylamino)ethyl]methacrylamide, N,N-dimethylmethacrylamide, N-[3-(dimethylamino)propyl]methacrylamide, N-( Methoxymethyl)methacrylamide, N-(hydroxyl Yl) -2-methyl-acrylamide, N- benzyl-2-methyl acrylamide, and N, N'- methylene bis methyl acrylamide.

所述(甲基)丙烯酸衍生物之中,特優選N,N'-亞甲基雙丙烯醯胺、N,N'-二羥基伸乙基-雙丙烯醯胺、伸乙基雙丙烯酸酯、及4,4'-亞甲基雙(N,N-二羥基伸乙基丙烯酸酯苯胺)。 Among the (meth)acrylic acid derivatives, N,N'-methylenebisacrylamide, N,N'-dihydroxyethylidene-bispropenylamine, ethylidene diacrylate, And 4,4'-methylenebis(N,N-dihydroxyethyl acrylate).

作為雙馬來醯亞胺,例如可列舉:作為KI化成(股份)的製品的BMI-70及BMI-80、以及作為大和化成工業(股份)的製品的BMI-1000、BMI-3000、BMI-4000、BMI-5000及BMI-7000。 For example, BMI-70 and BMI-80 which are products of KI Chemicals Co., Ltd., and BMI-1000, BMI-3000, BMI- which are products of Daiwa Kasei Industrial Co., Ltd. 4000, BMI-5000 and BMI-7000.

<噁嗪化合物> <oxazine compound>

例如,就使液晶顯示元件的電特性長期穩定的目的而言,本發明的液晶配向劑可進一步含有噁嗪化合物。噁嗪化合物可以是一種化合物,也可以是兩種以上的化合物。就所述目的而言,相對於聚醯胺酸或其衍生物,噁嗪化合物的含量優選0.1wt%~50wt%,更優選1wt%~40wt%,進而更優選1wt%~20wt%。 For example, the liquid crystal alignment agent of the present invention may further contain an oxazine compound for the purpose of stabilizing the electrical characteristics of the liquid crystal display element for a long period of time. The oxazine compound may be one compound or two or more compounds. For the purpose described, the content of the oxazine compound is preferably from 0.1% by weight to 50% by weight, more preferably from 1% by weight to 40% by weight, still more preferably from 1% by weight to 20% by weight, based on the polyaminic acid or a derivative thereof.

以下對噁嗪化合物進行具體說明。 The oxazine compound will be specifically described below.

噁嗪化合物優選可溶於使聚醯胺酸或其衍生物溶解的溶劑中、且具有開環聚合性的噁嗪化合物。 The oxazine compound is preferably an oxazine compound which is soluble in a solvent which dissolves poly-proline or a derivative thereof and has ring-opening polymerizability.

另外,噁嗪化合物中的噁嗪結構的數量並無特別限定。 Further, the number of the oxazine structure in the oxazine compound is not particularly limited.

噁嗪的結構已知有各種結構。本發明中,噁嗪的結構並無特別限定,在噁嗪化合物中的噁嗪結構中,可列舉苯並噁嗪或萘並噁嗪等具有含有縮合多環芳香族基的芳香族基的噁嗪的結構。 The structure of the oxazine is known in various structures. In the present invention, the structure of the oxazine is not particularly limited, and examples of the oxazine structure in the oxazine compound include an aldehyde having a condensed polycyclic aromatic group such as benzoxazine or naphthoxazine. The structure of the azine.

作為噁嗪化合物,例如可列舉下述式(OX-1)~式(OX-6)所示的化合物。再者,在下述式中,朝向環的中心所表示的鍵表示鍵結在構成環且可鍵結取代基的任一個碳上。 Examples of the oxazine compound include compounds represented by the following formula (OX-1) to formula (OX-6). Further, in the following formula, a bond represented toward the center of the ring means that the bond is bonded to any one of the carbons constituting the ring and the bondable substituent.

式(OX-1)~式(OX-3)中,L3及L4為碳數1~30的有機基,式(OX-1)~式(OX-6)中,L5~L8為氫或碳數1~6的烴基,式(OX-3)、式(OX-4)及式(OX-6)中,Q1為單鍵、-O-、-S-、-S-S-、-SO2-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-(CH2)v-、-O-(CH2)v-O-、-S-(CH2)v-S-,此處,v為1~6的整數,式(OX-5)及式(OX-6)中,Q2獨立為單鍵、-O-、-S-、-CO-、-C(CH3)2-、-C(CF3)2-或碳數1~3的伸烷基,Q2中的苯環、萘環上所鍵結的氫獨立且可由-F、-CH3、-OH、-COOH、-SO3H、-PO3H2取代。 In the formula (OX-1)~(OX-3), L 3 and L 4 are an organic group having 1 to 30 carbon atoms, and in the formula (OX-1) to (OX-6), L 5 to L 8 It is hydrogen or a hydrocarbon group having 1 to 6 carbon atoms. In the formula (OX-3), formula (OX-4) and formula (OX-6), Q 1 is a single bond, -O-, -S-, -SS- , -SO 2 -, -CO-, -CONH-, -NHCO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) v -, -O-(CH 2 v -O-, -S-(CH 2 ) v -S-, where v is an integer from 1 to 6, in the formula (OX-5) and the formula (OX-6), Q 2 is independently a single bond , -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 - or an alkylene group having 1 to 3 carbon atoms, a benzene ring and a naphthalene ring in Q 2 The hydrogen bonded thereto is independently and may be substituted by -F, -CH 3 , -OH, -COOH, -SO 3 H, -PO 3 H 2 .

另外,噁嗪化合物包括側鏈上具有噁嗪結構的寡聚物或聚合物、主鏈中具有噁嗪結構的寡聚物或聚合物。 Further, the oxazine compound includes an oligomer or polymer having an oxazine structure in a side chain, and an oligomer or polymer having an oxazine structure in the main chain.

作為由式(OX-1)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 Examples of the oxazine compound represented by the formula (OX-1) include the following oxazine compounds.

式(OX-1-2)中,L3優選碳數1~30的烷基,更優選碳數1~20的烷基。 In the formula (OX-1-2), L 3 is preferably an alkyl group having 1 to 30 carbon atoms, and more preferably an alkyl group having 1 to 20 carbon atoms.

作為由式(OX-2)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 Examples of the oxazine compound represented by the formula (OX-2) include the following oxazine compounds.

式中,L3優選碳數1~30的烷基,更優選碳數1~20的烷基。 In the formula, L 3 is preferably an alkyl group having 1 to 30 carbon atoms, more preferably an alkyl group having 1 to 20 carbon atoms.

作為由式(OX-3)所表示的噁嗪化合物,可列舉由下述式(OX-3-I)所表示的噁嗪化合物。 The oxazine compound represented by the formula (OX-3) includes an oxazine compound represented by the following formula (OX-3-I).

式(OX-3-I)中,L3及L4為碳數1~30的有機基,L5~L8為氫或碳數1~6的烴基,Q1為單鍵、-CH2-、-C(CH3)2-、-CO-、-O-、-SO2-、-C(CH3)2-或-C(CF3)2-。作為由式(OX-3-I)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 In the formula (OX-3-I), L 3 and L 4 are an organic group having 1 to 30 carbon atoms, L 5 to L 8 are hydrogen or a hydrocarbon group having 1 to 6 carbon atoms, and Q 1 is a single bond, -CH 2 -, -C(CH 3 ) 2 -, -CO-, -O-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -. Examples of the oxazine compound represented by the formula (OX-3-I) include the following oxazine compounds.

式中,L3及L4優選碳數1~30的烷基,更優選碳數1~20的烷基。 In the formula, L 3 and L 4 are preferably an alkyl group having 1 to 30 carbon atoms, and more preferably an alkyl group having 1 to 20 carbon atoms.

作為由式(OX-4)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 Examples of the oxazine compound represented by the formula (OX-4) include the following oxazine compounds.

作為由式(OX-5)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 Examples of the oxazine compound represented by the formula (OX-5) include the following oxazine compounds.

作為由式(OX-6)所表示的噁嗪化合物,例如可列舉以下的噁嗪化合物。 Examples of the oxazine compound represented by the formula (OX-6) include the following oxazine compounds.

這些之中,更優選可列舉由式(OX-2-1)、式(OX-3-1)、式(OX-3-3)、式(OX-3-5)、式(OX-3-7)、式(OX-3-9)、式(OX-4-1)~式(OX-4-6)、式(OX-5-3)、式(OX-5-4)、及式(OX-6-2)~式(OX-6-4)所表示的噁嗪化合物。 Among these, more preferably, it is exemplified by the formula (OX-2-1), the formula (OX-3-1), the formula (OX-3-3), the formula (OX-3-5), and the formula (OX-3). -7), formula (OX-3-9), formula (OX-4-1)~form (OX-4-6), formula (OX-5-3), formula (OX-5-4), and An oxazine compound represented by the formula (OX-6-2) to (OX-6-4).

噁嗪化合物可通過與國際公開2004/009708、日本專利特開平11-12258、日本專利特開2004-352670中所記載的方法相同的方法來製造。 The oxazine compound can be produced by the same method as the method described in International Publication No. 2004/009708, Japanese Patent Laid-Open No. Hei 11-12258, and Japanese Patent Laid-Open No. 2004-352670.

由式(OX-1)所表示的噁嗪化合物可通過使酚化合物與一級胺及醛進行反應而獲得(參照國際公開2004/009708)。 The oxazine compound represented by the formula (OX-1) can be obtained by reacting a phenol compound with a primary amine and an aldehyde (refer to International Publication No. 2004/009708).

由式(OX-2)所表示的噁嗪化合物可通過如下方式獲得:通過向甲醛中緩慢地添加一級胺的方法進行反應後,添加具有萘酚系羥基的化合物進行反應(參照國際公開2004/009708)。 The oxazine compound represented by the formula (OX-2) can be obtained by reacting a compound having a naphthol-based hydroxyl group by a method in which a primary amine is slowly added to formaldehyde, and reacting (refer to International Publication 2004/ 009708).

由式(OX-3)所表示的噁嗪化合物可通過如下方式獲得:在二級脂肪族胺、三級脂肪族胺或鹼性含氮雜環化合物的存在下,使酚化合物1莫耳、相對於該酚化合物的1個酚性羥基至少為2莫耳以上的醛、以及1莫耳的一級胺在有機溶劑中進行反應(參照國際公開2004/009708及日本專利特開平11-12258)。 The oxazine compound represented by the formula (OX-3) can be obtained by subjecting the phenol compound to 1 mol in the presence of a secondary aliphatic amine, a tertiary aliphatic amine or a basic nitrogen-containing heterocyclic compound. The aldehyde having at least 2 mols or more of the phenolic hydroxyl group of the phenol compound and the 1 mol of the primary amine are reacted in an organic solvent (refer to International Publication No. 2004/009708 and Japanese Patent Laid-Open No. Hei 11-12258).

由式(OX-4)~式(OX-6)所表示的噁嗪化合物可通過如下方式獲得:在90℃以上的溫度下,使4,4'-二胺基二苯基甲烷等具有多個苯環及與這些苯環鍵結的有機基的二胺、甲醛等醛、以及苯酚在正丁醇中進行脫水縮合反應(參照日本專利特開2004-352670)。 The oxazine compound represented by the formula (OX-4) to the formula (OX-6) can be obtained by having 4,4'-diaminodiphenylmethane or the like at a temperature of 90 ° C or higher. A benzene ring and an organic group-containing diamine bonded to these benzene rings, an aldehyde such as formaldehyde, and a phenol are subjected to a dehydration condensation reaction in n-butanol (refer to Japanese Patent Laid-Open No. 2004-352670).

<噁唑啉化合物> <oxazoline compound>

例如,就使液晶顯示元件的電特性長期穩定的目的而言,本發明 的液晶配向劑可進一步含有噁唑啉化合物。噁唑啉化合物為具有噁唑啉結構的化合物。噁唑啉化合物可以是一種化合物,也可以是兩種以上的化合物。就所述目的而言,相對於聚醯胺酸或其衍生物,噁唑啉化合物的含量優選0.1wt%~50wt%,更優選1wt%~40wt%,進而優選1wt%~20wt%。或者,當將噁唑啉化合物中的噁唑啉結構換算成噁唑啉時,就所述目的而言,相對於聚醯胺酸或其衍生物,噁唑啉化合物的含量優選0.1wt%~40wt%。 For example, in order to stabilize the electrical characteristics of the liquid crystal display element for a long period of time, the present invention The liquid crystal alignment agent may further contain an oxazoline compound. The oxazoline compound is a compound having an oxazoline structure. The oxazoline compound may be one compound or two or more compounds. For the purpose, the content of the oxazoline compound is preferably from 0.1% by weight to 50% by weight, more preferably from 1% by weight to 40% by weight, even more preferably from 1% by weight to 20% by weight, based on the polyphthalic acid or a derivative thereof. Alternatively, when the oxazoline structure in the oxazoline compound is converted to an oxazoline, the content of the oxazoline compound is preferably 0.1% by weight based on the purpose of the polyaminic acid or its derivative. 40wt%.

以下對噁唑啉化合物進行具體說明。 The oxazoline compound will be specifically described below.

噁唑啉化合物可在1個化合物中僅具有1種噁唑啉結構,也可以具有2種以上。另外,噁唑啉化合物只要在1個化合物中具有1個噁唑啉結構即可,但優選具有2個以上。另外,噁唑啉化合物可以是側鏈上具有噁唑啉環結構的聚合物,也可以是共聚物。側鏈上具有噁唑啉結構的聚合物可以是側鏈上具有噁唑啉結構的單體的均聚物,也可以是側鏈上具有噁唑啉結構的單體與不具有噁唑啉結構的單體的共聚物。側鏈上具有噁唑啉結構的共聚物可以是側鏈上具有噁唑啉結構的2種以上的單體的共聚物,也可以是側鏈上具有噁唑啉結構的2種以上的單體與不具有噁唑啉結構的單體的共聚物。 The oxazoline compound may have only one oxazoline structure in one compound, or may have two or more kinds. Further, the oxazoline compound may have one oxazoline structure in one compound, but preferably has two or more. Further, the oxazoline compound may be a polymer having an oxazoline ring structure in a side chain, or may be a copolymer. The polymer having an oxazoline structure on the side chain may be a homopolymer of a monomer having an oxazoline structure in a side chain, or a monomer having an oxazoline structure in a side chain and having no oxazoline structure. Copolymer of monomer. The copolymer having an oxazoline structure in a side chain may be a copolymer of two or more kinds of monomers having an oxazoline structure in a side chain, or two or more kinds of monomers having an oxazoline structure in a side chain. Copolymer with a monomer having no oxazoline structure.

噁唑啉結構優選以噁唑啉結構中的氧及氮的一者或兩者與聚醯胺酸的羰基可進行反應的方式存在於噁唑啉化合物中的結構。 The oxazoline structure is preferably a structure which exists in the oxazoline compound in such a manner that one or both of oxygen and nitrogen in the oxazoline structure can react with the carbonyl group of the polyphthalic acid.

作為噁唑啉化合物,例如可列舉:2,2'-雙(2-噁唑啉)、1,2,4-三-(2-噁唑啉基-2)-苯、4-呋喃-2-基亞甲基-2-苯基-4H-噁唑-5-酮、1,4-雙(4,5-二氫-2-噁唑基)苯、1,3-雙(4,5-二氫-2-噁唑基) 苯、2,3-雙(4-異丙烯基-2-噁唑啉-2-基)丁烷、2,2'-雙-4-苄基-2-噁唑啉、2,6-雙(異丙基-2-噁唑啉-2-基)吡啶、2,2'-亞異丙基雙(4-第三丁基-2-噁唑啉)、2,2'-亞異丙基雙(4-苯基-2-噁唑啉)、2,2'-亞甲基雙(4-第三丁基-2-噁唑啉)、及2,2'-亞甲基雙(4-苯基-2-噁唑啉)。除這些噁唑啉化合物以外,也可以列舉如Epocros(商品名,日本觸媒(股份)製造)般的具有噁唑基的聚合物或寡聚物。這些噁唑啉化合物之中,更優選可列舉1,3-雙(4,5-二氫-2-噁唑基)苯。 Examples of the oxazoline compound include 2,2'-bis(2-oxazoline), 1,2,4-tris-(2-oxazolinyl-2)-benzene, and 4-furan-2. - benzylidene-2-phenyl-4H-oxazol-5-one, 1,4-bis(4,5-dihydro-2-oxazolyl)benzene, 1,3-bis (4,5 -dihydro-2-oxazolyl) Benzene, 2,3-bis(4-isopropenyl-2-oxazolin-2-yl)butane, 2,2'-bis-4-benzyl-2-oxazoline, 2,6-double (isopropyl-2-oxazolin-2-yl)pyridine, 2,2'-isopropylidene bis(4-tert-butyl-2-oxazoline), 2,2'-isopropylidene Bis(4-phenyl-2-oxazoline), 2,2'-methylenebis(4-tert-butyl-2-oxazoline), and 2,2'-methylenebis ( 4-phenyl-2-oxazoline). In addition to these oxazoline compounds, a polymer or oligomer having an oxazolyl group such as Epocros (trade name, manufactured by Nippon Shokubai Co., Ltd.) may be mentioned. Among these oxazoline compounds, 1,3-bis(4,5-dihydro-2-oxazolyl)benzene is more preferable.

<環氧化合物> <epoxy compound>

例如,就使液晶顯示元件的電特性長期穩定的目的而言,本發明的液晶配向劑可進一步含有環氧化合物。環氧化合物可以是一種化合物,也可以是兩種以上的化合物。就所述目的而言,相對於聚醯胺酸或其衍生物,環氧化合物的含量優選0.1wt%~50wt%,更優選1wt%~40wt%,進而更優選1wt%~20wt%。 For example, the liquid crystal alignment agent of the present invention may further contain an epoxy compound for the purpose of stabilizing the electrical properties of the liquid crystal display element for a long period of time. The epoxy compound may be one compound or two or more compounds. For the purpose, the content of the epoxy compound is preferably from 0.1% by weight to 50% by weight, more preferably from 1% by weight to 40% by weight, even more preferably from 1% by weight to 20% by weight, based on the polyaminic acid or a derivative thereof.

以下對環氧化合物進行具體說明。 The epoxy compound will be specifically described below.

作為環氧化合物,可列舉分子內具有1個或2個以上的環氧環的各種化合物。作為分子內具有1個環氧環的化合物,例如可列舉:苯基縮水甘油醚、丁基縮水甘油醚、3,3,3-三氟甲基環氧丙烷、氧化苯乙烯、六氟環氧丙烷、環氧環己烷、3-縮水甘油氧基丙基三甲氧基矽烷、2-(3,4-環氧基環己基)乙基三甲氧基矽烷、N-縮水甘油基鄰苯二甲醯亞胺、(九氟-N-丁基)環氧化物、全氟乙基縮水甘油醚、表氯醇、表溴醇、N,N-二縮水甘油基苯胺、及3-[2-(全氟己基)乙氧基]-1,2-環氧基丙烷。 Examples of the epoxy compound include various compounds having one or two or more epoxy rings in the molecule. Examples of the compound having one epoxy ring in the molecule include phenyl glycidyl ether, butyl glycidyl ether, 3,3,3-trifluoromethyl propylene oxide, styrene oxide, and hexafluoroepoxy. Propane, epoxycyclohexane, 3-glycidoxypropyltrimethoxydecane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane, N-glycidylphthalate Yttrium, (nonafluoro-N-butyl) epoxide, perfluoroethyl glycidyl ether, epichlorohydrin, epibromohydrin, N,N-diglycidylaniline, and 3-[2-( Perfluorohexyl)ethoxy]-1,2-epoxypropane.

作為分子內具有2個環氧環的化合物,例如可列舉:乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油 醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯及3-(N,N-二縮水甘油基)胺基丙基三甲氧基矽烷。 Examples of the compound having two epoxy rings in the molecule include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, and propylene glycol diglycidyl glycol. Ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo new Pentyl glycol diglycidyl ether, 3,4-epoxycyclohexenylmethyl-3',4'-epoxycyclohexenecarboxylate and 3-(N,N-diglycidyl) Aminopropyltrimethoxydecane.

作為分子內具有3個環氧環的化合物,例如可列舉:2-[4-(2,3-環氧基丙氧基)苯基]-2-[4-[1,1-雙[4-([2,3-環氧基丙氧基]苯基)]乙基]苯基]丙烷(商品名“Techmore VG3101L”,(三井化學(股份)製造))。 Examples of the compound having three epoxy rings in the molecule include 2-[4-(2,3-epoxypropoxy)phenyl]-2-[4-[1,1-bis[4] -([2,3-Epoxypropoxy]phenyl)]ethyl]phenyl]propane (trade name "Techmore VG3101L", manufactured by Mitsui Chemicals, Inc.).

作為分子內具有4個環氧環的化合物,例如可列舉:1,3,5,6-四縮水甘油基-2,4-己二醇、N,N,N',N'-四縮水甘油基-間二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷、及3-(N-烯丙基-N-縮水甘油基)胺基丙基三甲氧基矽烷。 Examples of the compound having four epoxy rings in the molecule include 1,3,5,6-tetraglycidyl-2,4-hexanediol, N,N,N',N'-tetraglycidyl. Base-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4' -Diaminodiphenylmethane, and 3-(N-allyl-N-glycidyl)aminopropyltrimethoxydecane.

除所述以外,也可以列舉具有環氧環的寡聚物或聚合物作為分子內具有環氧環的化合物的例子。作為具有環氧環的單體,例如可列舉:(甲基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧基環己酯、及(甲基)丙烯酸甲基縮水甘油酯。 In addition to the above, an oligomer having an epoxy ring or a polymer may be exemplified as a compound having an epoxy ring in the molecule. Examples of the monomer having an epoxy ring include glycidyl (meth)acrylate, 3,4-epoxycyclohexyl (meth)acrylate, and methyl glycidyl (meth)acrylate.

作為與具有環氧環的單體進行共聚的其他單體,例如可列舉:(甲基)丙烯酸、(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸異丙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸異丁酯、(甲基)丙烯酸第三丁酯、(甲基)丙烯酸環己酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯、(甲基)丙烯酸2-羥基丙酯、苯乙烯、甲基苯乙烯、氯甲基苯乙烯、(甲基)丙烯酸(3-乙基-3-氧雜環丁基)甲酯、N-環己基馬來醯亞胺及N-苯基馬來醯亞胺。 Examples of the other monomer copolymerized with the monomer having an epoxy ring include (meth)acrylic acid, methyl (meth)acrylate, ethyl (meth)acrylate, and isopropyl (meth)acrylate. , (butyl) (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, (meth)acrylic acid 2-hydroxyethyl ester, 2-hydroxypropyl (meth)acrylate, styrene, methylstyrene, chloromethylstyrene, (meth)acrylic acid (3-ethyl-3-oxetanyl) Methyl ester, N-cyclohexylmaleimide and N-phenylmaleimide.

作為具有環氧環的單體的聚合物的優選的具體例,可列舉聚甲基丙烯酸縮水甘油酯等。另外,作為具有環氧環的單體與其他單體的共聚物的優選的具體例,可列舉:N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、N-環己基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸苄酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸丁酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸2-羥基乙酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸(3-乙基-3-氧雜環丁基)甲酯-甲基丙烯酸縮水甘油酯共聚物、及苯乙烯-甲基丙烯酸縮水甘油酯共聚物。 Preferable specific examples of the polymer of the monomer having an epoxy ring include polyglycidyl methacrylate and the like. Further, preferred examples of the copolymer of the monomer having an epoxy ring and another monomer include N-phenylmaleimide-glycidyl methacrylate copolymer and N-cyclohexyl horse.醯imino-glycidyl methacrylate copolymer, benzyl methacrylate-glycidyl methacrylate copolymer, butyl methacrylate-glycidyl methacrylate copolymer, 2-hydroxy methacrylate Ethyl ester-glycidyl methacrylate copolymer, (3-ethyl-3-oxetanyl)methyl methacrylate-glycidyl methacrylate copolymer, and styrene-glycidyl methacrylate Ester copolymer.

這些例之中,特優選N,N,N',N'-四縮水甘油基-間二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷、商品名“Techmore VG3101L”、3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯、N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、及2-(3,4-環氧基環己基)乙基三甲氧基矽烷。 Among these, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane is particularly preferred. , N, N, N', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, trade name "Techmore VG3101L", 3,4-epoxycyclohexenylmethyl- 3',4'-Epoxycyclohexenecarboxylate, N-phenylmaleimide-glycidyl methacrylate copolymer, and 2-(3,4-epoxycyclohexyl)B Trimethoxy decane.

更系統地說,作為環氧化合物,例如可列舉:縮水甘油醚、縮水甘油酯、縮水甘油胺、含有環氧基的丙烯酸系樹脂、縮水甘油基醯胺、異三聚氰酸縮水甘油脂、鏈狀脂肪族型環氧化合物、及環狀脂肪族型環氧化合物。再者,環氧化合物是指具有環氧基的化合物,環氧樹脂是指具有環氧基的樹脂。 More specifically, examples of the epoxy compound include glycidyl ether, glycidyl ester, glycidylamine, epoxy group-containing acrylic resin, glycidyl decylamine, and isocyanuric glycidyl glycol. A chain aliphatic epoxy compound and a cyclic aliphatic epoxy compound. Further, the epoxy compound means a compound having an epoxy group, and the epoxy resin means a resin having an epoxy group.

作為環氧化合物,例如可列舉:縮水甘油醚、縮水甘油脂、縮水甘油胺、含有環氧基的丙烯酸系樹脂、縮水甘油基醯胺、異三聚氰酸縮水甘油酯、鏈狀脂肪族型環氧化合物、及環狀脂肪族型環氧化合物。 Examples of the epoxy compound include glycidyl ether, glycidyl glycol, glycidylamine, epoxy group-containing acrylic resin, glycidyl decylamine, glycidyl isocyanurate, and chain aliphatic. An epoxy compound and a cyclic aliphatic epoxy compound.

作為縮水甘油醚,例如可列舉:雙酚A型環氧化合物、雙酚F型環氧化合物、雙酚S型環氧化合物、雙酚型環氧化合物、氫化雙酚-A型環氧化合物、氫化雙酚-F型環氧化合物、氫化雙酚-S型環氧化合物、氫化雙酚型環氧化合物、溴化雙酚-A型環氧化合物、溴化雙酚-F型環氧化合物、苯酚酚醛清漆型環氧化合物、甲酚酚醛清漆型環氧化合物、溴化苯酚酚醛清漆型環氧化合物、溴化甲酚酚醛清漆型環氧化合物、雙酚A酚醛清漆型環氧化合物、含有萘骨架的環氧化合物、芳香族聚縮水甘油醚化合物、二環戊二烯苯酚型環氧化合物、脂環式二縮水甘油醚化合物、脂肪族聚縮水甘油醚化合物、多硫化物型二縮水甘油醚化合物、及聯苯酚型環氧化合物。 Examples of the glycidyl ether include a bisphenol A epoxy compound, a bisphenol F epoxy compound, a bisphenol S epoxy compound, a bisphenol epoxy compound, and a hydrogenated bisphenol-A epoxy compound. Hydrogenated bisphenol-F type epoxy compound, hydrogenated bisphenol-S type epoxy compound, hydrogenated bisphenol type epoxy compound, brominated bisphenol-A type epoxy compound, brominated bisphenol-F type epoxy compound, Phenolic novolak type epoxy compound, cresol novolak type epoxy compound, brominated phenol novolac type epoxy compound, brominated cresol novolak type epoxy compound, bisphenol A novolac type epoxy compound, containing naphthalene Skeleton epoxy compound, aromatic polyglycidyl ether compound, dicyclopentadiene phenol type epoxy compound, alicyclic diglycidyl ether compound, aliphatic polyglycidyl ether compound, polysulfide type diglycidyl ether A compound and a biphenol type epoxy compound.

作為縮水甘油酯,例如可列舉:二縮水甘油酯化合物及縮水甘油酯環氧化合物。 Examples of the glycidyl ester include a diglycidyl ester compound and a glycidyl ester epoxy compound.

作為縮水甘油胺,例如可列舉:聚縮水甘油胺化合物及縮水甘油胺型環氧樹脂。 Examples of the glycidylamine include a polyglycidylamine compound and a glycidylamine type epoxy resin.

作為含有環氧基的丙烯酸系化合物,例如可列舉:具有環氧乙烷基(oxiranyl)的單體的均聚物及共聚物。 Examples of the epoxy group-containing acrylic compound include a homopolymer and a copolymer of a monomer having an oxiranyl group.

作為縮水甘油基醯胺,例如可列舉:縮水甘油基醯胺型環氧化合物。 Examples of the glycidyl decylamine include a glycidyl guanamine type epoxy compound.

作為鏈狀脂肪族型環氧化合物,例如可列舉:將烯烴化合物的碳-碳雙鍵氧化而獲得的含有環氧基的化合物。 Examples of the chain aliphatic epoxy compound include an epoxy group-containing compound obtained by oxidizing a carbon-carbon double bond of an olefin compound.

作為環狀脂肪族型環氧化合物,例如可列舉:將環烯烴化合物的碳-碳雙鍵氧化而獲得的含有環氧基的化合物。 Examples of the cyclic aliphatic epoxy compound include an epoxy group-containing compound obtained by oxidizing a carbon-carbon double bond of a cycloolefin compound.

作為雙酚A型環氧化合物,例如可列舉:jER828、 jER1001、jER1002、jER1003、jER1004、jER1007、jER1010(均為三菱化學(股份)製造),Epotohto YD-128(東都化成(股份)製造),DER-331、DER-332、DER-324(均為陶氏化學公司(The Dow Chemical Company)製造),Epiclon840、Epiclon850、Epiclon1050(均為迪愛生(DIC)(股份)製造),Epomik R-140、Epomik R-301、及Epomik R-304(均為三井化學(公司)製造)。 Examples of the bisphenol A type epoxy compound include jER828. jER1001, jER1002, jER1003, jER1004, jER1007, jER1010 (all manufactured by Mitsubishi Chemical Corporation), Epotohto YD-128 (manufactured by Tohto Kasei Co., Ltd.), DER-331, DER-332, DER-324 Manufactured by The Dow Chemical Company, Epiclon 840, Epiclon 850, Epiclon 1050 (both manufactured by Di Ai Sheng (DIC)), Epomik R-140, Epomik R-301, and Epomik R-304 (all Mitsui Chemical (company) manufacturing).

作為雙酚F型環氧化合物,例如可列舉:jER806、jER807、jER4004P(均為三菱化學(股份)製造),Epotohto YDF-170、Epotohto YDF-175S、Epotohto YDF-2001(均為東都化成(股份)製造),DER-354(陶氏化學公司製造),Epiclon830、及Epiclon835(均為迪愛生(股份)製造)。 Examples of the bisphenol F-type epoxy compound include jER806, jER807, and jER4004P (all manufactured by Mitsubishi Chemical Corporation), Epotohto YDF-170, Epotohto YDF-175S, and Epotohto YDF-2001 (all of which are Dongdu Huacheng (shares) ) Manufacturing), DER-354 (manufactured by The Dow Chemical Company), Epiclon 830, and Epiclon 835 (all manufactured by Di Ai Sheng (share)).

作為雙酚型環氧化合物,例如可列舉:2,2-雙(4-羥苯基)-1,1,1,3,3,3-六氟丙烷的環氧化物。 Examples of the bisphenol type epoxy compound include an epoxide of 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane.

作為氫化雙酚-A型環氧化合物,例如可列舉:Suntohto ST-3000(東都化成(股份)製造)、Rikaresin HBE-100(新日本理化(股份)製造)、及Denacol EX-252(長瀨化成(Nagase chemteX)(股份)製造)。 Examples of the hydrogenated bisphenol-A type epoxy compound include Suntohto ST-3000 (manufactured by Tohto Kasei Co., Ltd.), Rikaresin HBE-100 (manufactured by Shin-Nihon Chemical Co., Ltd.), and Denacol EX-252 (long 濑) Nagase chemteX (manufacturing).

作為氫化雙酚型環氧化合物,例如可列舉:氫化2,2-雙(4-羥苯基)-1,1,1,3,3,3-六氟丙烷的環氧化物。 Examples of the hydrogenated bisphenol type epoxy compound include an epoxide of hydrogenated 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane.

作為溴化雙酚-A型環氧化合物,例如可列舉:jER5050、jER5051(均為三菱化學(股份)製造),Epotohto YDB-360、Epotohto YDB-400(均為東都化成(股份)製造),DER-530、DER-538(均為陶氏化學公司製造),Epiclon152、及Epiclon153(均為迪愛生(股份)製造)。 Examples of the brominated bisphenol-A type epoxy compound include jER5050 and jER5051 (all manufactured by Mitsubishi Chemical Corporation), Epotohto YDB-360, and Epotohto YDB-400 (all manufactured by Toho Chemical Co., Ltd.). DER-530, DER-538 (all manufactured by The Dow Chemical Company), Epiclon 152, and Epiclon 153 (all manufactured by Di Ai Sheng (share)).

作為苯酚酚醛清漆型環氧化合物,例如可列舉:jER152、jER154(均為三菱化學(股份)製造),YDPN-638(東都化成公司製造),DEN431、DEN438(均為陶氏化學公司製造),Epiclon N-770(迪愛生(股份)製造),EPPN-201、及EPPN-202(均為日本化藥(股份)製造)。 Examples of the phenol novolac type epoxy compound include jER152 and jER154 (all manufactured by Mitsubishi Chemical Corporation), YDPN-638 (manufactured by Tohto Kasei Co., Ltd.), DEN431 and DEN438 (all manufactured by Dow Chemical Co., Ltd.). Epiclon N-770 (made by Di Ai Sheng (share)), EPPN-201, and EPPN-202 (both manufactured by Nippon Kayaku Co., Ltd.).

作為甲酚酚醛清漆型環氧化合物,例如可列舉:jER180S75(三菱化學(股份)製造),YDCN-701、YDCN-702(均為東都化成公司製造),Epiclon N-665、Epiclon N-695(均為迪愛生(股份)製造),EOCN-102S、EOCN-103S、EOCN-104S、EOCN-1020、EOCN-1025、及EOCN-1027(均為日本化藥(股份)製造)。 Examples of the cresol novolac type epoxy compound include jER180S75 (manufactured by Mitsubishi Chemical Corporation), YDCN-701, YDCN-702 (all manufactured by Dongdu Chemical Co., Ltd.), Epiclon N-665, and Epiclon N-695 ( All are manufactured by Di Ai Sheng (share), EOCN-102S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025, and EOCN-1027 (all manufactured by Nippon Kayaku Co., Ltd.).

作為雙酚A酚醛清漆型環氧化合物,例如可列舉:jER157S70(三菱化學(股份)製造)、及Epiclon N-880(迪愛生(股份)製造)。 Examples of the bisphenol A novolac type epoxy compound include jER157S70 (manufactured by Mitsubishi Chemical Corporation) and Epiclon N-880 (manufactured by Di Aisheng (stock)).

作為含有萘骨架的環氧化合物,例如可列舉:Epiclon HP-4032、Epiclon HP-4700、Epiclon HP-4770(均為迪愛生(股份)製造),及NC-7000(日本化藥公司製造)。 Examples of the epoxy compound containing a naphthalene skeleton include Epiclon HP-4032, Epiclon HP-4700, and Epiclon HP-4770 (all manufactured by Di Aisin Co., Ltd.), and NC-7000 (manufactured by Nippon Kayaku Co., Ltd.).

作為芳香族聚縮水甘油醚化合物,例如可列舉:對苯二酚二縮水甘油醚(下述式EP-1),兒茶酚二縮水甘油醚(下述式EP-2),間苯二酚二縮水甘油醚(下述式EP-3),2-[4-(2,3-環氧基丙氧基)苯基]-2-[4-[1,1-雙[4-([2,3-環氧基丙氧基]苯基)]乙基]苯基]丙烷(下述式EP-4),三(4-縮水甘油氧基苯基)甲烷(下述式EP-5),jER1031S、jER1032H60(均為三菱化學(股份)製造),TACTIX-742(陶氏化學公司製造),Denacol EX-201(長瀨化成(股 份)製造),DPPN-503、DPPN-502H、DPPN-501H、NC6000(均為日本化藥(股份)製造),Techmore VG3101L(三井化學(股份)製造),由下述式EP-6所表示的化合物,及由下述式EP-7所表示的化合物。 Examples of the aromatic polyglycidyl ether compound include hydroquinone diglycidyl ether (formula: EP-1), catechol diglycidyl ether (formula: EP-2), and resorcinol. Diglycidyl ether (formula EP-3), 2-[4-(2,3-epoxypropoxy)phenyl]-2-[4-[1,1-bis[4-([ 2,3-epoxypropoxy]phenyl)]ethyl]phenyl]propane (formula EP-4), tris(4-glycidoxyphenyl)methane (formula EP-5 below) ), jER1031S, jER1032H60 (all manufactured by Mitsubishi Chemical Corporation), TACTIX-742 (manufactured by The Dow Chemical Company), Denacol EX-201 (长濑化成(股) (manufacturing), DPPN-503, DPPN-502H, DPPN-501H, NC6000 (all manufactured by Nippon Kayaku Co., Ltd.), Techmore VG3101L (manufactured by Mitsui Chemicals Co., Ltd.), represented by the following formula EP-6 a compound and a compound represented by the following formula EP-7.

作為二環戊二烯苯酚型環氧化合物,例如可列舉:TACTIX-556(陶氏化學公司製造)、及Epiclon HP-7200(迪愛生(股份)製造)。 Examples of the dicyclopentadiene phenol type epoxy compound include TACTIX-556 (manufactured by The Dow Chemical Company) and Epiclon HP-7200 (manufactured by Di Aisheng (stock)).

作為脂環式二縮水甘油醚化合物,例如可列舉:環己烷二甲醇二縮水甘油醚化合物、及Rikaresin DME-100(新日本理化(股份)製造)。 Examples of the alicyclic diglycidyl ether compound include a cyclohexane dimethanol diglycidyl ether compound and Rikaresin DME-100 (manufactured by Shin Nippon Chemical and Chemical Co., Ltd.).

作為脂肪族聚縮水甘油醚化合物,例如可列舉:乙二醇二縮水甘油醚(下述式EP-8),二乙二醇二縮水甘油醚(下述式EP-9),聚乙二醇二縮水甘油醚,丙二醇二縮水甘油醚(下述式EP-10),三丙二醇二縮水甘油醚(下述式EP-11),聚丙二醇二縮水甘油醚,新戊二醇二縮水甘油醚(下述式EP-12),1,4-丁二醇二縮水甘油醚(下述式EP-13),1,6-己二醇二縮水甘油醚(下述式EP-14),二溴新戊二醇二縮水甘油醚(下述式EP-15),Denacol EX-810、Denacol EX-851、Denacol EX-8301、Denacol EX-911、Denacol EX-920、Denacol EX-931、Denacol EX-211、Denacol EX-212、Denacol EX-313(均為長瀨化成(股份)製造),DD-503(艾迪科(ADEKA)(股份)製造),Rikaresin W-100(新日本理化(股份)製造),1,3,5,6-四縮水甘油基-2,4-己二醇(下述式EP-16),甘油聚縮水甘油醚,山梨醇聚縮水甘油醚,三羥甲基丙烷聚縮水甘油醚,季戊四醇聚縮水甘油醚,Denacol EX-313、Denacol EX-611、Denacol EX-321、及Denacol EX-411(均為長瀨化成(股份)製造)。 Examples of the aliphatic polyglycidyl ether compound include ethylene glycol diglycidyl ether (hereinafter, EP-8), diethylene glycol diglycidyl ether (hereinafter, EP-9), and polyethylene glycol. Diglycidyl ether, propylene glycol diglycidyl ether (formula EP-10), tripropylene glycol diglycidyl ether (formula EP-11 below), polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether ( Formula EP-12), 1,4-butanediol diglycidyl ether (formula EP-13 below), 1,6-hexanediol diglycidyl ether (formula EP-14 below), dibromo Neopentyl glycol diglycidyl ether (formula EP-15 below), Denacol EX-810, Denacol EX-851, Denacol EX-8301, Denacol EX-911, Denacol EX-920, Denacol EX-931, Denacol EX-211, Denacol EX-212, Denacol EX-313 Manufactured by the company), DD-503 (made by ADEKA), Rikaresin W-100 (manufactured by Nippon Chemical and Chemical Co., Ltd.), 1,3,5,6-tetraglycidyl-2, 4-hexanediol (formula EP-16), glycerol polyglycidyl ether, sorbitol polyglycidyl ether, trimethylolpropane polyglycidyl ether, pentaerythritol polyglycidyl ether, Denacol EX-313, Denacol EX -611, Denacol EX-321, and Denacol EX-411 (all manufactured by Changchun Huacheng (share)).

作為多硫化物型二縮水甘油醚化合物,例如可列舉: FLDP-50、及FLDP-60(均為東麗巧固樂(Toray Thiokol)(股份)製造)。 As the polysulfide type diglycidyl ether compound, for example, FLDP-50, and FLDP-60 (both manufactured by Toray Thiokol (share)).

作為聯苯酚型環氧化合物,例如可列舉:YX-4000、YL-6121H(均為三菱化學(股份)製造),NC-3000P、及NC-3000S(均為日本化藥(股份)製造)。 Examples of the biphenol-type epoxy compound include YX-4000 and YL-6121H (all manufactured by Mitsubishi Chemical Corporation), NC-3000P, and NC-3000S (all manufactured by Nippon Kayaku Co., Ltd.).

作為二縮水甘油酯化合物,例如可列舉:對苯二甲酸二縮水甘油酯(下述式EP-17)、鄰苯二甲酸二縮水甘油酯(下述式EP-18)、鄰苯二甲酸雙(2-甲基環氧乙烷基甲基)酯(下述式EP-19)、六氫鄰苯二甲酸二縮水甘油酯(下述式EP-20)、由下述式EP-21所表示的化合物、由下述式EP-22所表示的化合物、及由下述式EP-23所表示的化合物。 Examples of the diglycidyl ester compound include diglycidyl terephthalate (formula: EP-17), diglycidyl phthalate (formula: EP-18), and phthalic acid (2-methyloxiranylmethyl) ester (Equation EP-19), hexahydrophthalic acid diglycidyl ester (Equation EP-20), and the following formula EP-21 The compound represented by the formula, the compound represented by the following formula EP-22, and the compound represented by the following formula EP-23.

作為縮水甘油酯環氧化合物,例如可列舉:jER871、 jER872(均為三菱化學(股份)製造),Epiclon 200、Epiclon 400(均為迪愛生(股份)製造),Denacol EX-711、及Denacol EX-721(均為長瀨化成(股份)製造)。 Examples of the glycidyl ester epoxy compound include jER871. jER872 (all manufactured by Mitsubishi Chemical Co., Ltd.), Epiclon 200, Epiclon 400 (all manufactured by Di Aisheng (share)), Denacol EX-711, and Denacol EX-721 (all manufactured by Changchun Huacheng (share)).

作為聚縮水甘油胺化合物,例如可列舉:N,N-二縮水甘油基苯胺(下述式EP-24)、N,N-二縮水甘油基-鄰甲苯胺(下述式EP-25)、N,N-二縮水甘油基-間甲苯胺(下述式EP-26)、N,N-二縮水甘油基-2,4,6-三溴苯胺(下述式EP-27)、3-(N,N-二縮水甘油基)胺基丙基三甲氧基矽烷(下述式EP-28)、N,N,O-三縮水甘油基-對胺基苯酚(下述式EP-29)、N,N,O-三縮水甘油基-間胺基苯酚(下述式EP-30)、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷(下述式EP-31)、N,N,N',N'-四縮水甘油基-間苯二甲胺(TETRAD-X(三菱瓦斯化學(股份)製造),下述式EP-32)、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷(TETRAD-C(三菱瓦斯化學(股份)製造),下述式EP-33)、1,4-雙(N,N-二縮水甘油基胺基甲基)環己烷(下述式EP-34)、1,3-雙(N,N-二縮水甘油基胺基)環己烷(下述式EP-35)、1,4-雙(N,N-二縮水甘油基胺基)環己烷(下述式EP-36)、1,3-雙(N,N-二縮水甘油基胺基)苯(下述式EP-37)、1,4-雙(N,N-二縮水甘油基胺基)苯(下述式EP-38)、2,6-雙(N,N-二縮水甘油基胺基甲基)雙環[2.2.1]庚烷(下述式EP-39)、N,N,N',N'-四縮水甘油基-4,4'-二胺基二環己基甲烷(下述式EP-40)、2,2'-二甲基-(N,N,N',N'-四縮水甘油基)-4,4'-二胺基聯苯(下述式EP-41)、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯醚(下述式EP-42)、1,3,5-三(4-(N,N-二縮水甘油基)胺基苯氧基)苯(下述式EP-43)、2,4,4'-三(N,N-二縮水甘油基胺基)二苯醚(下述式EP-44)、三(4-(N,N- 二縮水甘油基)胺基苯基)甲烷(下述式EP-45)、3,4,3',4'-四(N,N-二縮水甘油基胺基)聯苯(下述式EP-46)、3,4,3',4'-四(N,N-二縮水甘油基胺基)二苯醚(下述式EP-47)、由下述式EP-48所表示的化合物、及由下述式EP-49所表示的化合物。 Examples of the polyglycidylamine compound include N,N-diglycidylaniline (Equation EP-24), N,N-diglycidyl-o-toluidine (Equation EP-25), N,N-diglycidyl-m-toluidine (formula EP-26), N,N-diglycidyl-2,4,6-tribromoaniline (formula EP-27), 3- (N,N-diglycidyl)aminopropyltrimethoxydecane (formula EP-28), N,N,O-triglycidyl-p-aminophenol (formula EP-29) , N, N, O-triglycidyl-m-aminophenol (formula EP-30), N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenyl Methane (formula EP-31), N,N,N',N'-tetraglycidyl-m-xylylenediamine (TETRAD-X (manufactured by Mitsubishi Gas Chemical Co., Ltd.), the following formula EP- 32), 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane (TETRAD-C (manufactured by Mitsubishi Gas Chemical Co., Ltd.), the following formula EP-33), 1, 4 - bis(N,N-diglycidylaminomethyl)cyclohexane (formula EP-34 below), 1,3-bis(N,N-diglycidylamino)cyclohexane (bottom Illustrative formula EP-35), 1,4-bis(N,N-diglycidylamino)cyclohexane (formula EP-36 below), 1,3-bis(N,N-diglycidyl) Amine Benzene (formula EP-37 below), 1,4-bis(N,N-diglycidylamino)benzene (formula EP-38 below), 2,6-bis (N,N-diverted water) Glycerylaminomethyl)bicyclo[2.2.1]heptane (formula EP-39 below), N,N,N',N'-tetraglycidyl-4,4'-diaminodicyclohexyl Methane (formula EP-40), 2,2'-dimethyl-(N,N,N',N'-tetraglycidyl)-4,4'-diaminobiphenyl (the following formula) EP-41), N, N, N', N'-tetraglycidyl-4,4'-diaminodiphenyl ether (formula EP-42), 1,3,5-tri (4- (N,N-diglycidyl)aminophenoxy)benzene (formula EP-43 below), 2,4,4'-tris(N,N-diglycidylamino)diphenyl ether ( The following formula EP-44), three (4-(N, N-) Diglycidyl)aminophenyl)methane (formula EP-45 below), 3,4,3',4'-tetrakis (N,N-diglycidylamino)biphenyl (formula EP below) -46), 3,4,3',4'-tetrakis(N,N-diglycidylamino)diphenyl ether (formula: EP-47), a compound represented by the following formula EP-48 And a compound represented by the following formula EP-49.

作為具有環氧乙烷基的單體的均聚物,例如可列舉聚甲基丙烯酸縮水甘油酯。作為具有環氧乙烷基的單體的共聚物,例如可列舉:N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、N-環己基馬來醯亞胺-甲基丙烯酸縮水甘油脂共聚物、甲基丙烯酸苄酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸丁酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸2-羥基乙酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸(3-乙基-3-氧雜環丁基)甲酯-甲基丙烯酸縮水甘油脂共聚物、及苯乙烯-甲基丙烯酸縮水甘油脂共聚物。 Examples of the homopolymer of the monomer having an oxiranyl group include polyglycidyl methacrylate. Examples of the copolymer of the monomer having an oxiranyl group include N-phenylmaleimide-glycidyl methacrylate copolymer and N-cyclohexylmaleimide-methacrylic acid. Glycidylglyceride copolymer, benzyl methacrylate-glycidyl methacrylate copolymer, butyl methacrylate-glycidyl methacrylate copolymer, 2-hydroxyethyl methacrylate-glycidyl methacrylate Ester copolymer, (3-ethyl-3-oxetanyl)methyl methacrylate-glycidyl methacrylate copolymer, and styrene-glycidyl methacrylate copolymer.

作為具有環氧乙烷基的單體,例如可列舉:(甲基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧基環己酯、及(甲基)丙烯酸甲基縮水甘油酯。 Examples of the monomer having an oxiranyl group include glycidyl (meth)acrylate, 3,4-epoxycyclohexyl (meth)acrylate, and methyl glycidol (meth)acrylate. ester.

作為具有環氧乙烷基的單體的共聚物中的具有環氧乙烷基的單體以外的其他單體,例如可列舉:(甲基)丙烯酸、(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸異丙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸異丁酯、(甲基)丙烯酸第三丁酯、(甲基)丙烯酸環己酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯、(甲基)丙烯酸2-羥基丙酯、苯乙烯、甲基苯乙烯、氯甲基苯乙烯、(甲基)丙烯酸(3-乙基-3-氧雜環丁基)甲酯、N-環己基馬來醯亞胺、及N-苯基馬來醯亞胺。 Examples of the monomer other than the monomer having an oxiranyl group in the copolymer of the monomer having an oxiranyl group include (meth)acrylic acid, methyl (meth)acrylate, and (a) Ethyl acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, cyclohexyl (meth)acrylate Benzyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, styrene, methylstyrene, chloromethylstyrene, (meth)acrylic acid (3-Ethyl-3-oxetanyl)methyl ester, N-cyclohexylmaleimide, and N-phenylmaleimide.

作為異三聚氰酸縮水甘油酯,例如可列舉:1,3,5-三縮水甘油基-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮(下述式EP-50)、1,3-二縮水甘油基-5-烯丙基-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮(下述式EP-51)、及異三聚氰酸縮水甘油酯型環氧樹脂。 As the glycidyl iso-glycidyl cyanide, for example, 1,3,5-triglycidyl-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione (EP-50 of the following formula), 1,3-diglycidyl-5-allyl-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione ( The following formula EP-51) and an isomeric isocyanurate type epoxy resin.

作為鏈狀脂肪族型環氧化合物,例如可列舉:環氧化聚丁二烯、及Epolead PB3600(大賽璐(Daicel)(股份)製造)。 Examples of the chain aliphatic epoxy compound include epoxidized polybutadiene and Epolead PB3600 (manufactured by Daicel).

作為環狀脂肪族型環氧化合物,例如可列舉:3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯(Celloxide2021(大賽璐(股份)製造),下述式EP-52),2-甲基-3,4-環氧基環己基甲基-2'-甲基-3',4'-環氧基環己基羧酸酯(下述式EP-53),2,3-環氧基環戊烷-2',3'-環氧基環戊烷醚(下述式EP-54),ε-己內酯改質3,4-環氧基環己基甲基-3',4'-環氧基環己烷羧酸酯,1,2:8,9-二環氧基檸檬烯(Celloxide3000(大賽璐(股份)製造),下述式EP-55),由下述式EP-56所表示的化合物,CY-175、CY-177、CY-179(均為汽巴嘉基化學公司(The Ciba-Geigy Chemical Corp.)製造(可從日本亨斯邁(Huntsman.Japan)(股份)獲得)),EHPD-3150(大賽璐(股份)製造),及環狀脂肪族型環氧樹脂。 Examples of the cyclic aliphatic epoxy compound include 3,4-epoxycyclohexenylmethyl-3',4'-epoxycyclohexenecarboxylate (Celloxide 2021 (Dai Sai (share) ))), 2-methyl-3,4-epoxycyclohexylmethyl-2'-methyl-3',4'-epoxycyclohexylcarboxylate (formula: EP-52) Formula EP-53), 2,3-epoxycyclopentane-2',3'-epoxycyclopentane ether (Equation EP-54), ε-caprolactone modified 3, 4-epoxycyclohexylmethyl-3',4'-epoxycyclohexanecarboxylate, 1,2:8,9-diethoxylated limonene (Celloxide 3000 (manufactured by Daicel) The following formula EP-55) is a compound represented by the following formula EP-56, CY-175, CY-177, CY-179 (all manufactured by The Ciba-Geigy Chemical Corp.). (available from Huntsman. Japan (shares)), EHPD-3150 (manufactured by Daicel), and a cyclic aliphatic epoxy resin.

環氧化合物優選聚縮水甘油胺化合物、雙酚A酚醛清漆 型環氧化合物、甲酚酚醛清漆型環氧化合物、及環狀脂肪族型環氧化合物的一種以上,更優選N,N,N',N'-四縮水甘油基-間二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷、商品名“Techmore VG3101L”、3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯、N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、N,N,O-三縮水甘油基-對胺基苯酚、雙酚A酚醛清漆型環氧化合物、及甲酚酚醛清漆型環氧化合物的一種以上。 The epoxy compound is preferably a polyglycidylamine compound, a bisphenol A novolac More than one type of epoxy compound, cresol novolak type epoxy compound, and cyclic aliphatic type epoxy compound, more preferably N,N,N',N'-tetraglycidyl-m-xylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane , trade name "Techmore VG3101L", 3,4-epoxycyclohexenylmethyl-3',4'-epoxycyclohexene carboxylate, N-phenylmaleimide-methyl One or more of glycidyl acrylate copolymer, N, N, O-triglycidyl-p-aminophenol, bisphenol A novolac type epoxy compound, and cresol novolak type epoxy compound.

另外,例如本發明的液晶配向劑可進一步含有各種添加劑。作為各種添加劑,例如可列舉聚醯胺酸及其衍生物以外的高分子化合物、及低分子化合物,可根據各個目的而選擇使用。 Further, for example, the liquid crystal alignment agent of the present invention may further contain various additives. Examples of the various additives include a polymer compound other than polyglycine and a derivative thereof, and a low molecular compound, and can be selected and used according to each purpose.

例如,作為所述高分子化合物,可列舉可溶於有機溶劑的高分子化合物。就控制所形成的液晶配向膜的電特性或配向性的觀點而言,優選將此種高分子化合物添加至本發明的液晶配向劑中。作為該高分子化合物,例如可列舉:聚醯胺、聚氨酯、聚脲、聚酯、聚環氧化物、聚酯多元醇、矽酮改質聚氨酯、及矽酮改質聚酯。 For example, examples of the polymer compound include polymer compounds which are soluble in an organic solvent. From the viewpoint of controlling the electrical characteristics or the alignment property of the liquid crystal alignment film formed, it is preferred to add such a polymer compound to the liquid crystal alignment agent of the present invention. Examples of the polymer compound include polyamine, polyurethane, polyurea, polyester, polyepoxide, polyester polyol, anthrone modified polyurethane, and anthrone modified polyester.

另外,作為所述低分子化合物,例如1)當期望提升塗布性時可列舉符合該目的之界面活性劑,2)當需要提升抗靜電時可列舉抗靜電劑,3)當期望提升與基板的密接性時可列舉矽烷偶聯劑或鈦系的偶聯劑,另外,4)當在低溫下進行醯亞胺化時可列舉醯亞胺化催化劑。 Further, as the low molecular compound, for example, 1) when it is desired to improve the coatability, a surfactant suitable for the purpose may be mentioned, 2) an antistatic agent may be cited when it is desired to raise the antistatic property, and 3) when it is desired to lift the substrate. In the case of adhesion, a decane coupling agent or a titanium-based coupling agent may be mentioned, and 4) a ruthenium imidization catalyst may be mentioned when ruthenium imidization is carried out at a low temperature.

作為矽烷偶聯劑,例如可列舉:乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽 烷、N-(2-胺基乙基)-3-胺基丙基甲基三甲氧基矽烷、對胺基苯基三甲氧基矽烷、對胺基苯基三乙氧基矽烷、間胺基苯基三甲氧基矽烷、間胺基苯基三乙氧基矽烷、3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基甲基二甲氧基矽烷、3-氯丙基甲基二甲氧基矽烷、3-氯丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-巰基丙基三甲氧基矽烷、N-(1,3-二甲基亞丁基)-3-(三乙氧基矽烷基)-1-丙胺、及N,N'-雙[3-(三甲氧基矽烷基)丙基]乙二胺。優選的矽烷偶聯劑為3-胺基丙基三乙氧基矽烷。 As the decane coupling agent, for example, vinyl trimethoxy decane, vinyl triethoxy decane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxy oxime Alkane, N-(2-aminoethyl)-3-aminopropylmethyltrimethoxydecane, p-aminophenyltrimethoxydecane, p-aminophenyltriethoxydecane, m-amino Phenyltrimethoxydecane, m-aminophenyltriethoxydecane, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 3-glycidoxypropyltrimethyl Oxydecane, 3-glycidoxypropylmethyldimethoxydecane, 3-chloropropylmethyldimethoxydecane, 3-chloropropyltrimethoxydecane, 3-methylpropene oxime Propyltrimethoxydecane, 3-mercaptopropyltrimethoxydecane, N-(1,3-dimethylbutylidene)-3-(triethoxydecyl)-1-propylamine, and N, N'-bis[3-(trimethoxydecyl)propyl]ethylenediamine. A preferred decane coupling agent is 3-aminopropyltriethoxydecane.

作為醯亞胺化催化劑,例如可列舉:三甲胺、三乙胺、三丙胺、三丁胺等脂肪族胺類;N,N-二甲基苯胺、N,N-二乙基苯胺、甲基取代苯胺、羥基取代苯胺等芳香族胺類;吡啶、甲基取代吡啶、羥基取代吡啶、喹啉、甲基取代喹啉、羥基取代喹啉、異喹啉、甲基取代異喹啉、羥基取代異喹啉、咪唑、甲基取代咪唑、羥基取代咪唑等環式胺類。所述醯亞胺化催化劑優選選自N,N-二甲基苯胺、鄰羥基苯胺、間羥基苯胺、對羥基苯胺、鄰羥基吡啶、間羥基吡啶、對羥基吡啶、及異喹啉中的一種或兩種以上。 Examples of the ruthenium amide catalyst include aliphatic amines such as trimethylamine, triethylamine, tripropylamine, and tributylamine; N,N-dimethylaniline, N,N-diethylaniline, and methyl group. Aromatic amines such as aniline and hydroxy-substituted aniline; pyridine, methyl-substituted pyridine, hydroxy-substituted pyridine, quinoline, methyl-substituted quinoline, hydroxy-substituted quinoline, isoquinoline, methyl-substituted isoquinoline, hydroxy substitution Cyclic amines such as isoquinoline, imidazole, methyl substituted imidazole, and hydroxy substituted imidazole. The ruthenium amide catalyst is preferably selected from the group consisting of N,N-dimethylaniline, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-hydroxypyridine, m-hydroxypyridine, p-hydroxypyridine, and isoquinoline. Or two or more.

矽烷偶聯劑的添加量通常為聚醯胺酸或其衍生物的總重量的0wt%~20wt%,優選0.1wt%~10wt%。 The amount of the decane coupling agent to be added is usually from 0% by weight to 20% by weight, preferably from 0.1% by weight to 10% by weight based on the total mass of the polyaminic acid or its derivative.

相對於聚醯胺酸或其衍生物的碳基,醯亞胺化催化劑的添加量通常為0.01當量~5當量,優選0.05當量~3當量。 The amount of the ruthenium imidization catalyst added is usually from 0.01 equivalents to 5 equivalents, preferably from 0.05 equivalents to 3 equivalents, based on the carbon group of the polyamic acid or a derivative thereof.

其他添加劑的添加量根據其用途而不同,但通常為聚醯胺酸或其衍生物的總重量的0wt%~100wt%,優選0.1wt%~50wt%。 The amount of the other additives to be added varies depending on the use thereof, but is usually 0% by weight to 100% by weight, preferably 0.1% by weight to 50% by weight based on the total weight of the polyaminic acid or its derivative.

另外,例如在無損本發明的效果的範圍(優選所述聚醯胺酸或其衍生物的20wt%以內的量)內,本發明的液晶配向劑可進一步含有丙烯酸聚合物、丙烯酸酯聚合物、及四羧酸二酐、作為二羧酸或其衍生物與二胺的反應產物的聚醯胺醯亞胺等其他聚合物成分。 Further, the liquid crystal alignment agent of the present invention may further contain an acrylic polymer, an acrylate polymer, for example, in a range not detracting from the effects of the present invention (preferably within 20% by weight of the polyaminic acid or a derivative thereof). And a tetracarboxylic dianhydride, another polymer component such as a polyamidoximine which is a reaction product of a dicarboxylic acid or a derivative thereof and a diamine.

另外,例如就液晶配向劑的塗布性或所述聚醯胺酸或其衍生物的濃度的調整的觀點而言,所述液晶配向劑可進一步含有溶劑。所述溶劑只要是具有溶解高分子成分的能力的溶劑,則可無特別限制地應用。所述溶劑廣泛包含通常用於聚醯胺酸、可溶性聚醯亞胺等高分子成分的製造步驟或用途方面的溶劑,可根據使用目的而適宜選擇。所述溶劑可以是1種,也可以是2種以上的混合溶劑。 Further, the liquid crystal alignment agent may further contain a solvent, for example, from the viewpoint of applicability of the liquid crystal alignment agent or adjustment of the concentration of the polyamic acid or a derivative thereof. The solvent is not particularly limited as long as it has a solvent having the ability to dissolve a polymer component. The solvent widely includes a solvent which is generally used for a production step or a use of a polymer component such as polyacrylic acid or a soluble polyimine, and can be appropriately selected depending on the purpose of use. The solvent may be one type or a mixture of two or more types.

所述配向劑中的聚醯胺酸的濃度優選0.1wt%~40wt%。當將該配向劑塗布在基板上時,為了調整膜厚,有時需要事先利用溶劑對所含有的聚醯胺酸進行稀釋的操作。 The concentration of the poly-proline in the alignment agent is preferably from 0.1% by weight to 40% by weight. When the alignment agent is applied onto a substrate, in order to adjust the film thickness, it is necessary to perform an operation of diluting the contained polyamic acid with a solvent in advance.

所述配向劑中的固體成分濃度並無特別限定,只要結合下述的各種塗布法而選擇最合適的值即可。通常,為了抑制塗布時的不均或針孔等,相對於清漆重量,優選0.1wt%~30wt%,更優選1wt%~10wt%。 The solid content concentration in the alignment agent is not particularly limited, and may be selected in accordance with various coating methods described below. In general, in order to suppress unevenness at the time of coating, pinholes, and the like, it is preferably 0.1% by weight to 30% by weight, and more preferably 1% by weight to 10% by weight based on the weight of the varnish.

本發明的液晶配向劑中所使用的溶劑為含有由所述式(A)所表示的化合物作為溶劑成分的溶液。作為所述式(A)的具體例,例如可列舉由所述式(A-1)~式(A-6)所表示的溶劑。就聚醯胺酸的溶解性的觀點而言,優選(A-1)、(A-4)及(A-6)。 The solvent used in the liquid crystal alignment agent of the present invention is a solution containing a compound represented by the above formula (A) as a solvent component. Specific examples of the formula (A) include a solvent represented by the above formula (A-1) to formula (A-6). From the viewpoint of solubility of polyproline, (A-1), (A-4) and (A-6) are preferred.

所述配向劑中的由所述式(A)所表示的溶劑的比例優 選0.1wt%~90wt%,更優選10wt%~85wt%。 The ratio of the solvent represented by the formula (A) in the alignment agent is excellent It is selected from 0.1% by weight to 90% by weight, more preferably from 10% by weight to 85% by weight.

本發明的液晶配向劑中的溶劑成分可僅為由所述式(A)所表示的溶劑,但為了控制朝基板的塗布性、或確保樹脂成分的溶解性,理想的是除由所述式(A)所表示的第一溶劑以外,含有下述第2溶劑及/或第3溶劑。 The solvent component in the liquid crystal alignment agent of the present invention may be only the solvent represented by the above formula (A), but in order to control the coating property to the substrate or to ensure the solubility of the resin component, it is preferred to The second solvent and/or the third solvent described below are contained in addition to the first solvent represented by (A).

為了控制朝基板的塗布性,作為第2溶劑,可在所生成的聚醯胺酸聚合物或聚醯亞胺聚合物不析出的範圍內併用作為不良溶劑的醇類、酮類、酯類、醚類、鹵化烴類、烴類等。作為此種溶劑,例如可列舉:乙二醇碳酸酯、1,2-丙二醇碳酸酯、1,3-丙二醇碳酸酯、戊二醇碳酸酯、己二醇碳酸酯、2-甲基-1,3-丙二醇碳酸酯、2,2-二甲基-1,3-丙二醇碳酸酯、2-羥基-2-甲基-1,3-丙二醇碳酸酯、2-乙醯氧基-2-甲基-1,3-丙二醇碳酸酯、乙二醇甲醚、乙二醇二甲醚、乙二醇乙醚、乙二醇丙醚、乙二醇單丁醚(丁基溶纖劑)、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單苯醚、乙二醇苯醚乙酸酯、乙二醇甲基苯醚、乙二醇乙基苯醚、乙二醇二乙醚、二乙二醇單甲醚、二乙二醇二甲醚、二乙二醇甲基乙基醚、二乙二醇甲基苯醚、二乙二醇單乙醚、二乙二醇單乙醚乙酸酯、二乙二醇二乙醚、二乙二醇單丁醚、二乙二醇二丁醚、二乙二醇單丁醚乙酸酯、二乙二醇單丙醚、二乙二醇單-2-乙基己醚、三乙二醇單甲醚、三乙二醇單十二烷基醚、三乙二醇二甲醚、三乙二醇二乙醚、四乙二醇二甲醚、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二醇單甲醚、丙二醇單甲醚乙酸酯、丙二醇甲基苯醚、丙二醇單乙醚、丙二醇單乙醚乙酸酯、丙二醇單丁基乙醚乙酸酯、丙二醇單苯醚、丙二醇單丙醚、二丙二醇、 二丙二醇單甲醚、二丙二醇二甲醚、二丙二醇單乙醚、二丙二醇單丙醚、三丙二醇二甲醚、三丙二醇二乙醚、乙酸正丙酯、乙酸丁酯、乙酸戊酯、乙酸正己酯、乙酸環己酯、乙酸2-乙基丁酯、乙酸2-乙基己酯、乙酸3-甲氧基丁酯、乙酸2-甲基環己酯、丙酸正丁酯、2-羥基-異丁酸甲酯、丁酸丁酯、丁酸戊酯、丁酸異戊酯、2-甲基戊酮-2,4-二醇、第三丁醇、三乙基甲醇、第三戊醇、1-甲基環己醇、2,5-二甲基己烷-2,5-二醇、正丁醇、雙(3-甲基丁基)醚、二正戊醚(二戊醚)、2-戊酮、3-戊酮、2-己酮、2-庚酮、3-庚酮、4-庚酮、2-辛酮、2-壬酮、5-壬酮、2,6-二甲基-4-庚酮、乙酸4-甲基-2-戊酯、乳酸丁酯、乳酸異戊酯(isoamyl lactate)、乳酸異戊酯(lactic acid isoamyl ester)、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、二丙二醇甲醚、4-羥基-4-甲基-2-戊酮(二丙酮醇)、甲基-3-甲氧基丙酸酯、乙基-3-乙氧基丙酸酯、苄醇、1-苯氧基-2-丙醇、苯乙醇、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、2-(2-甲氧基丙氧基)丙醇、乙酸2-羥基乙酯、乙酸2-羥基丙酯、乙酸3-羥基丙酯、乙酸2-羥基丁酯、乙酸3-羥基丁酯、乙酸4-羥基丁酯、丙酸2-羥基乙酯、丙酸2-羥基丙酯、丙酸3-羥基丙酯、乳酸2-羥基乙酯、乳酸2-羥基丙酯、乳酸3-羥基丙酯、2,4-戊二酮、乙基-3-乙氧基丙酸酯、糠醇、四氫糠醇、3-甲基-3-甲氧基丁醇、1,3-二氧戊環、丙酸異戊酯、異丁酸異戊酯、二異戊醚、丁醯苯、甲基異丁基酮、環己酮、或二異丁基酮等。 In order to control the coating property to the substrate, as the second solvent, an alcohol, a ketone, an ester, or a solvent which is a poor solvent can be used in a range in which the produced polyaminic acid polymer or the polyimide polymer is not precipitated. Ethers, halogenated hydrocarbons, hydrocarbons, and the like. Examples of such a solvent include ethylene glycol carbonate, 1,2-propylene glycol carbonate, 1,3-propanediol carbonate, pentanediol carbonate, hexanediol carbonate, and 2-methyl-1. 3-propanediol carbonate, 2,2-dimethyl-1,3-propanediol carbonate, 2-hydroxy-2-methyl-1,3-propanediol carbonate, 2-ethoxycarbonyl-2-methyl -1,3-propanediol carbonate, ethylene glycol methyl ether, ethylene glycol dimethyl ether, ethylene glycol ether, ethylene glycol propyl ether, ethylene glycol monobutyl ether (butyl cellosolve), ethylene glycol monomethyl Ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monophenyl ether, ethylene glycol phenyl ether acetate, ethylene glycol methyl phenyl ether, ethylene Alcohol ethyl phenyl ether, ethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol methyl phenyl ether, diethylene Alcohol monoethyl ether, diethylene glycol monoethyl ether acetate, diethylene glycol diethyl ether, diethylene glycol monobutyl ether, diethylene glycol dibutyl ether, diethylene glycol monobutyl ether acetate, two Glycol monopropyl ether, diethylene glycol mono-2-ethylhexyl ether, triethylene glycol monomethyl ether, triethylene glycol single Dodecyl ether, triethylene glycol dimethyl ether, triethylene glycol diethyl ether, tetraethylene glycol dimethyl ether, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol monomethyl ether, propylene glycol monomethyl ether Acetate, propylene glycol methyl phenyl ether, propylene glycol monoethyl ether, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate, propylene glycol monophenyl ether, propylene glycol monopropyl ether, dipropylene glycol, Dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monopropyl ether, tripropylene glycol dimethyl ether, tripropylene glycol diethyl ether, n-propyl acetate, butyl acetate, amyl acetate, n-hexyl acetate , cyclohexyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, 3-methoxybutyl acetate, 2-methylcyclohexyl acetate, n-butyl propionate, 2-hydroxy- Methyl isobutyrate, butyl butyrate, amyl butyrate, isoamyl butyrate, 2-methylpentanone-2,4-diol, tert-butanol, triethylmethanol, third pentanol , 1-methylcyclohexanol, 2,5-dimethylhexane-2,5-diol, n-butanol, bis(3-methylbutyl)ether, di-n-pentyl ether (dipentyl ether) , 2-pentanone, 3-pentanone, 2-hexanone, 2-heptanone, 3-heptanone, 4-heptanone, 2-octanone, 2-nonanone, 5-nonanone, 2,6- Dimethyl-4-heptanone, 4-methyl-2-pentyl acetate, butyl lactate, isoamyl lactate, lactic acid isoamyl ester, methyl lactate, lactate B Ester, n-propyl lactate, n-butyl lactate, dipropylene glycol methyl ether, 4-hydroxy-4-methyl-2-pentanone (diacetone alcohol), methyl-3-methyl Propionate, ethyl-3-ethoxypropionate, benzyl alcohol, 1-phenoxy-2-propanol, phenylethyl alcohol, 1-methoxy-2-propanol, 1-ethoxyl 2-propanol, 1-butoxy-2-propanol, 2-(2-methoxypropoxy)propanol, 2-hydroxyethyl acetate, 2-hydroxypropyl acetate, 3-hydroxyacetic acid Propyl ester, 2-hydroxybutyl acetate, 3-hydroxybutyl acetate, 4-hydroxybutyl acetate, 2-hydroxyethyl propionate, 2-hydroxypropyl propionate, 3-hydroxypropyl propionate, lactic acid 2 -hydroxyethyl ester, 2-hydroxypropyl lactate, 3-hydroxypropyl lactate, 2,4-pentanedione, ethyl-3-ethoxypropionate, decyl alcohol, tetrahydrofurfuryl alcohol, 3-methyl- 3-methoxybutanol, 1,3-dioxolane, isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, butyl benzene, methyl isobutyl ketone, cyclohexanone, Or diisobutyl ketone and the like.

為了確保對於所述聚醯胺酸聚合物或聚醯亞胺聚合物的溶解性,可併用良溶劑作為第3溶劑(良溶劑)。作為此種溶劑,可列舉N-烷基-2-吡咯烷酮類、內酯類及1,3-二烷基-2-咪唑烷酮 類,例如可列舉:γ-丁內酯、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、N-環己基-2-吡咯烷酮、二甲基亞碸、二甲基碸、六甲基亞碸、N-甲基己內醯胺、2-吡咯烷酮、N-乙基吡咯烷酮、N-乙烯基吡咯烷酮、四甲基脲、1,3-二甲基-2-咪唑烷酮、六甲基磷醯三胺、N,N-二甲基甲醯胺、N,N-二乙基甲醯胺、N,N-二甲基乙醯胺、二乙基乙醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N-甲基丙醯胺、N,N-二甲基丙醯胺、3-己氧基-N,N-二甲基丙醯胺、間甲酚、二甲酚、苯酚、鹵化酚等。 In order to secure solubility in the polyamic acid polymer or the polyimine polymer, a good solvent may be used in combination as the third solvent (good solvent). Examples of such a solvent include N-alkyl-2-pyrrolidones, lactones, and 1,3-dialkyl-2-imidazolidinone. Examples thereof include γ-butyrolactone, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, dimethyl hydrazine, dimethyl hydrazine, and the like. Hexamethylarylene, N-methyl caprolactam, 2-pyrrolidone, N-ethylpyrrolidone, N-vinylpyrrolidone, tetramethylurea, 1,3-dimethyl-2-imidazolidinone, Hexamethylphosphonium triamine, N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylacetamide, diethylacetamide, 3- Methoxy-N,N-dimethylpropanamide, 3-butoxy-N-methylpropionamide, N,N-dimethylpropanamide, 3-hexyloxy-N,N- Dimethyl propyl amide, m-cresol, xylenol, phenol, halogenated phenol, and the like.

這些溶劑之中,第3溶劑特優選N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯及1,3-二甲基-2-咪唑烷酮。 Among these solvents, the third solvent is particularly preferably N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, and 1,3-dimethyl-2-imidazolidinone.

對本發明的液晶配向膜進行詳細說明。本發明的液晶配向膜是通過對所述本發明的液晶配向劑的塗膜進行加熱所形成的膜。本發明的液晶配向膜可通過從液晶配向劑製作液晶配向膜的通常的方法而獲得。例如,本發明的液晶配向膜可通過經過形成本發明的液晶配向劑的塗膜的步驟、進行加熱乾燥的步驟、及進行加熱煆燒的步驟而獲得。針對本發明的液晶配向膜,視需要,可如後述般對經過加熱乾燥步驟、加熱煆燒步驟所獲得的膜進行摩擦處理來賦予異向性。或者,視需要,可在塗膜步驟、加熱乾燥步驟後照射光,或在加熱煆燒步驟後照射光來賦予異向性。另外,也可以用作不進行摩擦處理的垂直配向(Vertical Alignment,VA)用液晶配向膜。 The liquid crystal alignment film of the present invention will be described in detail. The liquid crystal alignment film of the present invention is a film formed by heating the coating film of the liquid crystal alignment agent of the present invention. The liquid crystal alignment film of the present invention can be obtained by a usual method for producing a liquid crystal alignment film from a liquid crystal alignment agent. For example, the liquid crystal alignment film of the present invention can be obtained by a step of forming a coating film of the liquid crystal alignment agent of the present invention, a step of performing heat drying, and a step of heating and calcining. In the liquid crystal alignment film of the present invention, if necessary, the film obtained by the heating and drying step and the heating and calcining step may be subjected to a rubbing treatment to impart anisotropy. Alternatively, if necessary, the light may be irradiated after the coating step, the heat drying step, or the light may be irradiated after the heating calcination step to impart anisotropy. Further, it can also be used as a liquid crystal alignment film for vertical alignment (VA) which is not subjected to rubbing treatment.

塗膜可與通常的液晶配向膜的製作同樣地,通過將本發明的液晶配向劑塗布在液晶顯示元件中的基板上來形成。基板可列舉可設置有氧化銦錫(Indium Tin Oxide,ITO)、氧化銦鋅 (In2O3-ZnO,IZO)、氧化銦鎵鋅(In-Ga-ZnO4,IGZO)電極等電極或彩色濾光片等的玻璃制的基板。 The coating film can be formed by applying the liquid crystal alignment agent of the present invention to a substrate in a liquid crystal display element, similarly to the production of a normal liquid crystal alignment film. The substrate may be an electrode or color in which an indium tin oxide (ITO), an indium zinc oxide (In 2 O 3 -ZnO, IZO), an indium gallium zinc oxide (In-Ga-ZnO 4 , IGZO) electrode, or the like may be provided. A glass substrate such as a filter.

作為將液晶配向劑塗布在基板上的方法,通常己知有旋轉器法、印刷法、浸漬法、滴加法、噴墨法等。這些方法也可以同樣地應用於本發明中。 As a method of applying a liquid crystal alignment agent onto a substrate, a rotator method, a printing method, a dipping method, a dropping method, an inkjet method, and the like are generally known. These methods can also be equally applied to the present invention.

所述加熱乾燥步驟通常己知有在烘箱或紅外爐中進行加熱處理的方法、在加熱板上進行加熱處理的方法等。加熱乾燥步驟優選在溶劑可蒸發的範圍內的溫度下實施,更優選在相對於加熱煆燒步驟中的溫度為比較低的溫度下實施。具體而言,加熱乾燥溫度優選30℃~150℃的範圍,更優選50℃~120℃的範圍。 The heating and drying step is generally known as a method of performing heat treatment in an oven or an infrared furnace, a method of performing heat treatment on a hot plate, and the like. The heat drying step is preferably carried out at a temperature within a range in which the solvent can be evaporated, more preferably at a relatively low temperature with respect to the temperature in the heating calcination step. Specifically, the heating and drying temperature is preferably in the range of 30 ° C to 150 ° C, and more preferably in the range of 50 ° C to 120 ° C.

所述加熱煆燒步驟可在所述聚醯胺酸或其衍生物呈現脫水.閉環反應所需要的條件下進行。所述塗膜的煆燒通常已知有在烘箱或紅外爐中進行加熱處理的方法、在加熱板上進行加熱處理的方法等。這些方法也可以同樣地應用於本發明中。通常優選在100℃~300℃左右的溫度下進行1分鐘~3小時,更優選120℃~280℃,進而更優選150~250℃。 The heating calcination step may dehydrate the polylysine or its derivative. The conditions required for the ring closure reaction are carried out. The calcination of the coating film is generally known as a method of heat treatment in an oven or an infrared furnace, a method of performing heat treatment on a hot plate, and the like. These methods can also be equally applied to the present invention. It is usually preferably carried out at a temperature of from about 100 ° C to about 300 ° C for from 1 minute to 3 hours, more preferably from 120 ° C to 280 ° C, still more preferably from 150 to 250 ° C.

在本發明的液晶配向膜的形成方法中,為了使液晶相對於水平方向及/或垂直方向在一個方向上進行配向,可適宜地使用摩擦法或光配向法等公知的形成方法作為對配向膜賦予異向性的方法。可特別適宜地使用光配向法。 In the method for forming a liquid crystal alignment film of the present invention, in order to align the liquid crystal in one direction with respect to the horizontal direction and/or the vertical direction, a known formation method such as a rubbing method or a photo-alignment method can be suitably used as the alignment film. A method of imparting anisotropy. The photoalignment method can be used particularly suitably.

使用摩擦法的本發明的液晶配向膜可經過如下的步驟而形成:將本發明的液晶配向劑塗布在基板上的步驟、對塗布有配向劑的基板進行加熱乾燥的步驟、對該膜進行加熱煆燒的步驟、以及對膜進行摩擦處理的步驟。 The liquid crystal alignment film of the present invention using a rubbing method can be formed by the steps of applying the liquid crystal alignment agent of the present invention onto a substrate, heating and drying the substrate coated with the alignment agent, and heating the film. The step of simmering and the step of rubbing the film.

摩擦處理可與通常的用於液晶配向膜的配向處理的摩擦處理同樣地進行,只要是可在本發明的液晶配向膜中獲得充分的延遲的條件即可。優選的條件是毛壓入量為0.2mm~0.8mm,平臺移動速度為5mm/sec~250mm/sec,輥旋轉速度為500rpm~2,000rpm。 The rubbing treatment can be carried out in the same manner as the rubbing treatment for the alignment treatment of the liquid crystal alignment film, as long as it is a condition that a sufficient retardation can be obtained in the liquid crystal alignment film of the present invention. Preferred conditions are a hair injection amount of 0.2 mm to 0.8 mm, a platform moving speed of 5 mm/sec to 250 mm/sec, and a roll rotation speed of 500 rpm to 2,000 rpm.

對利用光配向法的本發明的液晶配向膜的形成方法進行詳細說明。利用光配向法的本發明的液晶配向膜可通過如下方式形成:對塗膜進行加熱乾燥後,照射放射線的直線偏光或無偏光,由此對塗膜賦予異向性,然後對該膜進行加熱煆燒。或者,可通過在對塗膜進行加熱乾燥,並進行加熱煆燒後,照射放射線的直線偏光或無偏光來形成。就配向性的觀點而言,放射線的照射步驟優選在加熱煆燒步驟前進行。 A method of forming the liquid crystal alignment film of the present invention by the photo-alignment method will be described in detail. The liquid crystal alignment film of the present invention by the photo-alignment method can be formed by heating and drying the coating film, irradiating the linearly polarized light or the non-polarized light of the radiation, thereby imparting anisotropy to the coating film, and then heating the film. Simmered. Alternatively, it may be formed by heating and drying the coating film, heating and simmering, and then irradiating the linearly polarized light or the non-polarized light of the radiation. From the viewpoint of the alignment, the irradiation step of the radiation is preferably performed before the heating calcination step.

進而,為了提高液晶配向膜的液晶配向性能,也可以一面對塗膜進行加熱一面照射放射線的直線偏光或無偏光。放射線的照射可在對塗膜進行加熱乾燥的步驟、或進行加熱煆燒的步驟中進行,也可以在加熱乾燥步驟與加熱煆燒步驟之間進行。該步驟中的加熱乾燥溫度優選30℃~150℃的範圍,更優選50℃~120℃的範圍。另外,該步驟中的加熱煆燒溫度優選30℃~300℃的範圍,更優選50℃~250℃的範圍。 Further, in order to improve the liquid crystal alignment performance of the liquid crystal alignment film, it is also possible to face the linearly polarized light or the non-polarized light which is irradiated with radiation while being heated by the coating film. The irradiation of the radiation may be carried out in the step of heating and drying the coating film or in the step of heating and calcining, or may be carried out between the heating and drying step and the heating and calcining step. The heating and drying temperature in this step is preferably in the range of 30 ° C to 150 ° C, and more preferably in the range of 50 ° C to 120 ° C. Further, the heating calcination temperature in this step is preferably in the range of 30 ° C to 300 ° C, and more preferably in the range of 50 ° C to 250 ° C.

作為放射線,例如可使用包含150nm~800nm的波長的光的紫外線或可見光,優選包含300nm~400nm的光的紫外線。另外,可使用直線偏光或無偏光。這些光只要是可對所述塗膜賦予液晶配向性能的光,則並無特別限定,但當欲對液晶顯現強的配向限制力時,優選直線偏光。 As the radiation, for example, ultraviolet light or visible light containing light having a wavelength of 150 nm to 800 nm can be used, and ultraviolet light containing light of 300 nm to 400 nm is preferable. In addition, linear or unpolarized light can be used. The light is not particularly limited as long as it imparts liquid crystal alignment performance to the coating film. However, when it is desired to exhibit a strong alignment regulating force to the liquid crystal, linear polarization is preferable.

即便是低能量的光照射,本發明的液晶配向膜也可以顯示出高液晶配向性能。所述放射線照射步驟中的直線偏光的照射量優選0.05J/cm2~20J/cm2,更優選0.5J/cm2~10J/cm2。另外,直線偏光的波長優選200nm~400nm,更優選300nm~400nm。直線偏光對於膜表面的照射角度並無特別限定,當欲顯現出對於液晶的強的配向限制力時,就縮短配向處理時間的觀點而言,優選相對於膜表面盡可能垂直。另外,通過照射直線偏光,本發明的液晶配向膜可使液晶在相對於直線偏光的偏光方向垂直的方向上進行配向。 The liquid crystal alignment film of the present invention can exhibit high liquid crystal alignment properties even with low-energy light irradiation. The irradiation step is preferably linearly polarized irradiation 0.05J / cm 2 ~ 20J / cm 2, more preferably 0.5J / cm 2 ~ 10J / cm 2. Further, the wavelength of the linearly polarized light is preferably 200 nm to 400 nm, and more preferably 300 nm to 400 nm. The angle of irradiation of the film surface by the linearly polarized light is not particularly limited. When a strong alignment regulating force for the liquid crystal is to be exhibited, it is preferable to be as perpendicular as possible to the film surface from the viewpoint of shortening the alignment treatment time. Further, by irradiating the linearly polarized light, the liquid crystal alignment film of the present invention can align the liquid crystal in a direction perpendicular to the polarization direction of the linearly polarized light.

當欲使預傾角顯現時,對所述膜照射的光可以是與所述相同的直線偏光,也可以是無偏光。當欲使預傾角顯現時,對所述膜照射的光的照射量優選0.05J/cm2~20J/cm2,特優選0.5J/cm2~10J/cm2,其波長優選250nm~400nm,特優選300nm~380nm。當欲使預傾角顯現時,對所述膜照射的光對於所述膜表面的照射角度並無特別限定,但就縮短配向處理時間的觀點而言,優選30度~60度。 When the pretilt angle is to be made to appear, the light irradiated to the film may be the same linearly polarized light as described, or may be unpolarized. When the pretilt angle purports to show, the film is irradiated with a light irradiation amount is preferably 0.05J / cm 2 ~ 20J / cm 2, particularly preferably 0.5J / cm 2 ~ 10J / cm 2, its wavelength is preferably 250nm ~ 400nm, It is particularly preferably 300 nm to 380 nm. When the pretilt angle is to be expressed, the irradiation angle of the light irradiated to the film on the surface of the film is not particularly limited, but from the viewpoint of shortening the alignment treatment time, it is preferably 30 to 60 degrees.

照射放射線的直線偏光或無偏光的步驟中所使用的光源可無限制地使用超高壓水銀燈、高壓水銀燈、低壓水銀燈、深紫外線(Deep Ultraviolet,Deep UV)燈、鹵素燈、金屬鹵化物燈、高功率金屬鹵化物燈、氙燈、水銀氙燈、準分子燈、KrF準分子雷射、螢光燈、發光二極管(Light Emitting Diode,LED)燈、鈉燈、微波激發無電極燈等。 The light source used in the step of illuminating the linearly polarized or non-polarized light of the radiation can use an ultrahigh pressure mercury lamp, a high pressure mercury lamp, a low pressure mercury lamp, a deep ultraviolet (Deep Ultraviolet, Deep UV) lamp, a halogen lamp, a metal halide lamp, and a high light source without limitation. Power metal halide lamps, xenon lamps, mercury xenon lamps, excimer lamps, KrF excimer lasers, fluorescent lamps, Light Emitting Diode (LED) lamps, sodium lamps, microwave-excited electrodeless lamps, and the like.

本發明的液晶配向膜可通過進而包含所述步驟以外的其他步驟的方法而適宜地獲得。例如,本發明的液晶配向膜雖然 不將利用清洗液對煆燒或放射線照射後的膜進行清洗的步驟作為必需步驟,但可根據其他步驟的情況而設置清洗步驟。 The liquid crystal alignment film of the present invention can be suitably obtained by a method including further steps other than the above steps. For example, the liquid crystal alignment film of the present invention is The step of washing the film after the simmering or radiation irradiation with the cleaning liquid is not an essential step, but the cleaning step may be provided according to the other steps.

作為利用清洗液的清洗方法,可列舉:刷洗、噴霧、蒸氣清洗或超聲波清洗等。這些方法可以單獨進行,也可以併用。作為清洗液,可使用:純水,或甲醇、乙醇、異丙醇等各種醇類,苯、甲苯、二甲苯等芳香族烴類,二氯甲烷等鹵素系溶劑,丙酮、甲基乙基酮等酮類,但並不限定於這些清洗液。當然,這些清洗液可使用經充分精製的雜質少的清洗液。此種清洗方法也可以應用於形成本發明的液晶配向膜時的所述清洗步驟中。 Examples of the cleaning method using the cleaning liquid include brushing, spraying, steam cleaning, or ultrasonic cleaning. These methods can be performed separately or in combination. As the cleaning liquid, pure alcohol or various alcohols such as methanol, ethanol, and isopropyl alcohol, aromatic hydrocarbons such as benzene, toluene, and xylene, halogen solvents such as dichloromethane, acetone, and methyl ethyl ketone can be used. Ketones are not limited to these cleaning solutions. Of course, these cleaning liquids can use a cleaning liquid which is sufficiently refined and has less impurities. Such a cleaning method can also be applied to the cleaning step in forming the liquid crystal alignment film of the present invention.

為了提高本發明的液晶配向膜的液晶配向性能,可在加熱煆燒步驟的前後、摩擦步驟的前後、或者偏光或無偏光的放射線照射的前後應用利用熱或光的退火處理。在該退火處理中,退火溫度為30℃~180℃,優選50℃~150℃,時間優選1分鐘~2小時。另外,用於退火處理的退火光可列舉UV燈、螢光燈、LED燈等。光的照射量優選0.3J/cm2~10J/cm2In order to improve the liquid crystal alignment performance of the liquid crystal alignment film of the present invention, annealing treatment by heat or light may be applied before and after the heating calcination step, before and after the rubbing step, or before or after the polarized or unpolarized radiation irradiation. In the annealing treatment, the annealing temperature is 30 ° C to 180 ° C, preferably 50 ° C to 150 ° C, and the time is preferably 1 minute to 2 hours. Further, examples of the annealing light used for the annealing treatment include a UV lamp, a fluorescent lamp, an LED lamp, and the like. Light exposure preferably 0.3J / cm 2 ~ 10J / cm 2 .

本發明的液晶配向膜的膜厚並無特別限定,但優選10nm~300nm,更優選30nm~150nm。本發明的液晶配向膜的膜厚可通過輪廓儀或橢偏儀(ellipsometer)等公知的膜厚測定裝置來測定。 The film thickness of the liquid crystal alignment film of the present invention is not particularly limited, but is preferably 10 nm to 300 nm, and more preferably 30 nm to 150 nm. The film thickness of the liquid crystal alignment film of the present invention can be measured by a known film thickness measuring device such as a profiler or an ellipsometer.

本發明的液晶配向膜的特徵在於配向的異向性特別大。此種異向性的大小可通過日本專利特開2005-275364等中所記載的使用偏光IR的方法來評價。另外,如以下的實施例所示般,也可以通過使用橢偏測量術(ellipsometry)的方法來評價。當將本發明的配向膜用作液晶組合物用配向膜時,可認為具有更大的 膜的異向性的材料對於液晶組合物具有大的配向限制力。 The liquid crystal alignment film of the present invention is characterized in that the anisotropy of the alignment is particularly large. The size of such anisotropy can be evaluated by a method using polarized light described in JP-A-2005-275364 or the like. Further, as shown in the following examples, it can also be evaluated by a method using ellipsometry. When the alignment film of the present invention is used as an alignment film for a liquid crystal composition, it can be considered to have a larger The anisotropic material of the film has a large alignment limiting force for the liquid crystal composition.

除液晶顯示器用的液晶組合物的配向用途以外,本發明的液晶配向膜可用於光學補償材料或其他所有液晶材料的配向控制。另外,本發明的配向膜由於具有大的異向性,因此可單獨用於光學補償材料用途。 In addition to the alignment use of the liquid crystal composition for liquid crystal displays, the liquid crystal alignment film of the present invention can be used for alignment control of optical compensation materials or all other liquid crystal materials. Further, the alignment film of the present invention can be used alone for optical compensation materials because of its large anisotropy.

本發明提供一種液晶顯示元件,其包括對向配置的一對基板、形成在所述一對基板各自的對向面的一者或兩者上的電極、形成在所述一對基板各自的對向面上的液晶配向膜、以及形成在所述一對基板間的液晶層,且所述液晶配向膜為本發明的配向膜。 The present invention provides a liquid crystal display element including a pair of substrates disposed oppositely, electrodes formed on one or both of opposite surfaces of the pair of substrates, and pairs formed on the pair of substrates a liquid crystal alignment film on the surface and a liquid crystal layer formed between the pair of substrates, and the liquid crystal alignment film is an alignment film of the present invention.

所述電極只要是形成在基板的一面上的電極,則並無特別限定。此種電極例如可列舉ITO或金屬的蒸鍍膜等。另外,電極可形成在基板的一個面的整個面上,也可以形成為例如經圖案化的所期望的形狀。電極的所述所期望的形狀例如可列舉梳型或鋸齒構造等。電極可形成在一對基板中的一個基板上,也可以形成在兩個基板上。電極的形成形態根據液晶顯示元件的種類而不同,例如在共面切換(In-Plane Switching,IPS)型液晶顯示元件或邊緣場切換(Fringe Field Switching,FFS)型液晶顯示元件的情況下,將電極配置在所述一對基板的一者上,在其他液晶顯示元件的情況下,將電極配置在所述一對基板兩者上。在所述基板或電極上形成所述液晶配向膜。 The electrode is not particularly limited as long as it is an electrode formed on one surface of the substrate. Examples of such an electrode include a vapor deposited film of ITO or metal. Further, the electrode may be formed on the entire surface of one face of the substrate, or may be formed, for example, in a patterned desired shape. The desired shape of the electrode may be, for example, a comb type or a sawtooth structure. The electrodes may be formed on one of the pair of substrates or may be formed on the two substrates. The form of formation of the electrode differs depending on the type of the liquid crystal display element. For example, in the case of an In-Plane Switching (IPS) type liquid crystal display element or a Fringe Field Switching (FFS) type liquid crystal display element, The electrode is disposed on one of the pair of substrates, and in the case of other liquid crystal display elements, the electrode is disposed on both of the pair of substrates. The liquid crystal alignment film is formed on the substrate or the electrode.

所述液晶層是以通過形成有液晶配向膜的面對向的所述一對基板來夾持液晶組合物的形式形成。在液晶層的形成過程中,視需要可使用微粒子或樹脂片等介於所述一對基板之間並形 成適當的間隔的間隔物。 The liquid crystal layer is formed in a form of sandwiching a liquid crystal composition by the pair of substrates facing each other in which the liquid crystal alignment film is formed. In the formation of the liquid crystal layer, a microparticle or a resin sheet or the like may be used between the pair of substrates as needed. Spacers in appropriate spacing.

液晶組合物並無特別限制,可使用介電常數異向性為正或負的各種液晶組合物。介電常數異向性為正的優選的液晶組合物可列舉:日本專利第3086228、日本專利第2635435、日本專利特表平5-501735、日本專利特開平8-157826、日本專利特開平8-231960、日本專利特開平9-241644(EP885272A1)、日本專利特開平9-302346(EP806466A1)、日本專利特開平8-199168(EP722998A1)、日本專利特開平9-235552、日本專利特開平9-255956、日本專利特開平9-241643(EP885271A1)、日本專利特開平10-204016(EP844229A1)、日本專利特開平10-204436、日本專利特開平10-231482、日本專利特開2000-087040、日本專利特開2001-48822、國際公開第2010/050324、日本專利特開2011-016986、日本專利特表2011-506707、國際公開第2010/0522891、日本專利特開2005-239763等中所揭示的液晶組合物。 The liquid crystal composition is not particularly limited, and various liquid crystal compositions having positive or negative dielectric anisotropy can be used. A preferred liquid crystal composition having positive dielectric anisotropy is exemplified by Japanese Patent No. 3086228, Japanese Patent No. 2635435, Japanese Patent Laid-Open No. Hei 5-501735, Japanese Patent Laid-Open No. Hei 8-157826, and Japanese Patent Laid-Open No. Hei 8- 231960, Japanese Patent Laid-Open No. Hei 9-241644 (EP 885272 A1), Japanese Patent Laid-Open No. Hei 9-302346 (EP 806 466 A1), Japanese Patent Laid-Open No. Hei 8-199168 (EP722998A1), Japanese Patent Laid-Open No. Hei 9-235552, Japanese Patent Laid-Open No. Hei 9-255956 Japanese Patent Laid-Open No. Hei 9-241643 (EP885271A1), Japanese Patent Laid-Open No. Hei 10-204016 (EP844229A1), Japanese Patent Laid-Open No. Hei 10-204436, Japanese Patent Laid-Open No. Hei 10-231482, Japanese Patent Laid-Open No. 2000-087040, Japanese Patent No. A liquid crystal composition disclosed in Unexamined-Japanese-Patent--------------------------------------------------------------------------------------------------------------------- .

作為具有所述負的介電常數異向性的液晶組合物的優選例,可列舉:日本專利特開昭57-114532、日本專利特開平2-4725、日本專利特開平4-224885、日本專利特開平8-40953、日本專利特開平8-104869、日本專利特開平10-168076、日本專利特開平10-168453、日本專利特開平10-236989、日本專利特開平10-236990、日本專利特開平10-236992、日本專利特開平10-236993、日本專利特開平10-236994、日本專利特開平10-237000、日本專利特開平10-237004、日本專利特開平10-237024、日本專利特開平10-237035、日本專利特開平 10-237075、日本專利特開平10-237076、日本專利特開平10-237448(EP967261A1)、日本專利特開平10-287874、日本專利特開平10-287875、日本專利特開平10-291945、日本專利特開平11-029581、日本專利特開平11-080049、日本專利特開2000-256307、日本專利特開2001-019965、日本專利特開2001-072626、日本專利特開2001-192657、日本專利特開2010-037428、國際公開第2011/024666、國際公開2010/072370、日本專利特表2010-537010、日本專利特開2012-077201、日本專利特開2009-084362等中所揭示的液晶組合物。 As a preferable example of the liquid crystal composition having the negative dielectric anisotropy, Japanese Patent Laid-Open No. Sho 57-114532, Japanese Patent Laid-Open No. Hei 2-4725, Japanese Patent Laid-Open No. Hei 4-224885, and Japanese Patent No. Japanese Patent Laid-Open No. Hei 8-104869, Japanese Patent Laid-Open No. Hei 10-168076, Japanese Patent Laid-Open No. Hei 10-168453, Japanese Patent Laid-Open No. Hei 10-236989, Japanese Patent Laid-Open No. Hei 10-236990, Japanese Patent Laid-Open 10-236992, Japanese Patent Laid-Open No. Hei 10-236993, Japanese Patent Laid-Open No. Hei 10-236994, Japanese Patent Laid-Open No. Hei 10--237000, Japanese Patent Laid-Open No. Hei 10-237004, Japanese Patent Laid-Open No. Hei 10-237024, Japanese Patent Laid-Open No. 10- 237035, Japanese patent special Kaiping 10-237075, Japanese Patent Laid-Open No. Hei 10-237076, Japanese Patent Laid-Open No. Hei 10-237448 (EP967261A1), Japanese Patent Laid-Open No. Hei 10-287874, Japanese Patent Laid-Open No. Hei 10-287875, Japanese Patent Laid-Open No. Hei 10-291945, Japanese Patent No. Kaiping 11-029581, Japanese Patent Laid-Open No. Hei 11-080049, Japanese Patent Laid-Open No. 2000-256307, Japanese Patent Laid-Open No. 2001-019965, Japanese Patent Laid-Open No. 2001-072626, Japanese Patent Laid-Open No. 2001-192657, Japanese Patent Laid-Open No. 2010 A liquid crystal composition disclosed in -037428, International Publication No. 2011/024666, International Publication No. 2010/072370, Japanese Patent Laid-Open No. 2010-537010, Japanese Patent Laid-Open No. Hei No. Hei.

另外,例如就提升配向性的觀點而言,本發明的元件中所使用的液晶組合物例如可進一步添加添加物。此種添加物為光聚合性單體、光學活性的化合物、抗氧化劑、紫外線吸收劑、色素、消泡劑、聚合起始劑、聚合抑制劑等。 Further, for example, from the viewpoint of improving the alignment property, the liquid crystal composition used in the element of the present invention may be further added with an additive, for example. Such additives are photopolymerizable monomers, optically active compounds, antioxidants, ultraviolet absorbers, dyes, antifoaming agents, polymerization initiators, polymerization inhibitors, and the like.

[實施例] [Examples]

以下,通過實施例來說明本發明,但本發明並不限定於這些實施例。實施例中的評價法如下所述。 Hereinafter, the present invention will be described by way of examples, but the invention is not limited to these examples. The evaluation method in the examples is as follows.

<重量平均分子量(Mw)> <weight average molecular weight (Mw)>

聚醯胺酸的重量平均分子量通過如下方式來求出:使用2695分離模塊.2414示差折射儀(沃特世(Waters)製造)並利用GPC法來測定,然後進行聚苯乙烯換算。利用磷酸-二甲基甲醯胺(Dimethylformamide,DMF)混合溶液(磷酸/DMF=0.6/100:重量比),以聚醯胺酸濃度變成約2wt%的方式對所獲得的聚醯胺酸進行稀釋。管柱使用HSPgel RT MB-M(沃特世製造),將所述混合溶液作為展開劑,在管柱溫度為50℃、流速為0.40mL/min的條 件下進行測定。標準聚苯乙烯使用東曹(Tosoh)(股份)製造的TSK標準聚苯乙烯。 The weight average molecular weight of polylysine is determined by using a 2695 separation module. A 2414 differential refractometer (manufactured by Waters) was measured by a GPC method and then converted to polystyrene. The obtained polylysine was subjected to a mixed solution of phosphoric acid-dimethylformamide (DMF) (phosphoric acid/DMF=0.6/100: weight ratio) in such a manner that the polyglycine concentration became about 2% by weight. dilution. The column was HSPgel RT MB-M (manufactured by Waters), and the mixed solution was used as a developing agent at a column temperature of 50 ° C and a flow rate of 0.40 mL / min. The measurement was carried out under the conditions. Standard polystyrene uses TSK standard polystyrene manufactured by Tosoh.

<黏度測定> <Viscometry>

聚醯胺酸的黏度是使用東機產業(股份)製造的TVE-25L形黏度計來測定。 The viscosity of polylysine was measured using a TVE-25L-shaped viscometer manufactured by Toki Sangyo Co., Ltd.

<印刷性(凹陷性)的評價> <Evaluation of printability (depression)>

在經徹底地清洗的玻璃基板上,滴加幾滴所合成的聚醯胺酸的試樣溶液,利用旋轉器以3000rpm的旋轉速度旋轉10秒後,在室溫下放置,並以目視評價配向劑的凹陷性。進行凹陷性的評價的室內的濕度約為50%。 On the thoroughly cleaned glass substrate, a few drops of the sample solution of the synthesized polylysine were added dropwise, rotated by a spinner at a rotation speed of 3000 rpm for 10 seconds, and then left at room temperature, and the alignment was visually evaluated. The depression of the agent. The humidity in the room where the evaluation of the depression was performed was about 50%.

<交流電(Alternating Current,AC)殘像(亮度變化率)> <Alternating Current (AC) afterimage (luminance change rate)>

測定後述的液晶顯示元件的亮度-電壓特性(B-V特性)。將其作為施加應力前的亮度-電壓特性:B(前)。繼而,對元件施加4.5V、60Hz的交流電20分鐘後,短路1秒,然後再次測定亮度-電壓特性(B-V特性)。將其作為施加應力後的亮度-電壓特性:B(後)。基於這些值,使用下式來估計亮度變化率△B(%)。 The luminance-voltage characteristics (B-V characteristics) of the liquid crystal display element described later were measured. This is taken as the luminance-voltage characteristic before stress is applied: B (front). Then, after applying an alternating current of 4.5 V and 60 Hz to the element for 20 minutes, the short circuit was performed for 1 second, and then the luminance-voltage characteristic (B-V characteristic) was measured again. This was taken as the luminance-voltage characteristic after stress application: B (post). Based on these values, the luminance change rate ΔB (%) was estimated using the following formula.

△B(%)=[B(後)-B(前)]/B(前) (式1)這些測定是參考國際公開2000/43833來進行。可以說電壓0.75V中的△B(%)的值越小,越可防止AC殘像的產生。 ΔB (%) = [B (post) - B (pre)] / B (pre) (Formula 1) These measurements were carried out in accordance with International Publication No. 2000/43833. It can be said that the smaller the value of ΔB (%) in the voltage of 0.75 V, the more the generation of the AC afterimage can be prevented.

<配向穩定性(液晶配向軸穩定性)> <Alignment stability (liquid crystal alignment axis stability)>

求出後述的液晶顯示元件的電極側的液晶配向軸的變化率。測定 施加應力前的電極側的液晶配向角度φ(前),其後,對元件施加4.5V、60Hz的矩形波20分鐘後,短路1秒,並在1秒後及5分鐘後再次測定電極側的液晶配向角度φ(後)。基於這些值,使用下式來估計1秒後及5分鐘後的液晶配向角度的變化△φ(deg.)。△φ(deg.)=φ(後)-φ(前) (式2)這些測定是參考J.Hilfiker,B.Johs,C.Herzinger,J.F.Elman,E.Montbach,D.Bryant,及P.J.Bos“固體薄膜(Thin Solid Films)”,455-456,(2004)596-600來進行。可以說△φ小會使液晶配向軸的變化率小,且使液晶配向軸的穩定性良好。 The rate of change of the liquid crystal alignment axis on the electrode side of the liquid crystal display element to be described later was obtained. Determination The liquid crystal alignment angle φ (front) on the electrode side before the stress was applied, and then a rectangular wave of 4.5 V and 60 Hz was applied to the device for 20 minutes, and then short-circuited for 1 second, and the electrode side was measured again after 1 second and 5 minutes. The liquid crystal alignment angle φ (back). Based on these values, the change of the liquid crystal alignment angle Δφ (deg.) after 1 second and 5 minutes was estimated using the following formula. △ φ (deg.) = φ (post) - φ (pre) (Formula 2) These measurements are referred to J. Hilfiker, B. Johs, C. Herzinger, JF Elman, E. Montbach, D. Bryant, and PJ Bos "Thin Solid Films", 455-456, (2004) 596-600. It can be said that Δφ is small, the rate of change of the liquid crystal alignment axis is small, and the stability of the liquid crystal alignment axis is good.

實施例中所使用的溶劑、添加劑、液晶組合物如下所述。 The solvent, the additive, and the liquid crystal composition used in the examples are as follows.

<溶劑> <solvent>

DMIB:N,N,2-三甲基丙醯胺 DMIB: N, N, 2-trimethylpropanamide

DEIB:N,N-二乙基-2-甲基丙醯胺 DEIB: N,N-diethyl-2-methylpropanamide

NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone

NEP:N-乙基-2-吡咯烷酮 NEP: N-ethyl-2-pyrrolidone

GBL:γ-丁內酯 GBL: γ-butyrolactone

BC:丁基溶纖劑(乙二醇單丁醚) BC: butyl cellosolve (ethylene glycol monobutyl ether)

BL:乳酸正丁酯 BL: n-butyl lactate

MMB:3-甲氧基-3-甲基丁醇 MMB: 3-methoxy-3-methylbutanol

DPM:二丙二醇甲醚 DPM: Dipropylene glycol methyl ether

PGB:丙二醇單丁醚 PGB: propylene glycol monobutyl ether

<添加劑> <additive>

Ad1:雙[4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基]甲烷 Ad1: bis[4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolide)phenyl]methane

Ad2:N,N,N',N'-四缩水甘油基-4,4'-二胺基二苯基甲烷 Ad2: N, N, N', N'-tetraglycidyl-4,4'-diaminodiphenylmethane

Ad3:3-胺基丙基三乙氧基硅烷 Ad3: 3-aminopropyltriethoxysilane

Ad4:1,3-雙(4,5-二氫-2-噁唑基)苯 Ad4: 1,3-bis(4,5-dihydro-2-oxazolyl)benzene

Ad5:2-(3,4-環氧基環己基)乙基三甲氧基矽烷 Ad5: 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane

<液晶組合物> <Liquid crystal composition>

正型液晶組合物: Positive liquid crystal composition:

物性值:NI 100.1℃;△ε 5.1;△n 0.093;η 25.6mPa.s. Physical property values: NI 100.1 ° C; △ ε 5.1; Δn 0.093; η 25.6 mPa. s.

負型液晶組合物: Negative liquid crystal composition:

物性值:NI 75.7℃;△ε -4.1;△n 0.101;η 14.5mPa.s. Physical property values: NI 75.7 ° C; Δ ε -4.1; Δn 0.101; η 14.5 mPa. s.

<1.聚醯胺酸的合成> <1. Synthesis of polyaminic acid>

[合成例1] [Synthesis Example 1]

向具備溫度計、攪拌機、原料投入添加口及氮氣導入口的50mL的褐色四口燒瓶中加入二胺(DI-5-1,m=2)1.4291g及脫水DMIB 18.5g,在乾燥氮氣氣流下進行攪拌溶解。繼而,加入酸二酐(AN-1-13)0.6899g、酸二酐(AN-3-2)0.8810g、及脫水DMIB 18.5g,並在室溫下持續攪拌24小時。向該反應溶液中添加BC 10.0g, 獲得聚合物固體成分濃度為6wt%的聚醯胺酸溶液。將該聚醯胺酸溶液設為PA1。PA1中所含有的聚醯胺酸的重量平均分子量為84,000。 Diamine (DI-5-1, m=2) 1.4291 g and dehydrated DMIB 18.5 g were placed in a 50 mL brown four-necked flask equipped with a thermometer, a stirrer, a raw material input port, and a nitrogen inlet, and dried under a nitrogen gas stream. Stir and dissolve. Then, 0.6899 g of acid dianhydride (AN-1-13), 0.8810 g of acid dianhydride (AN-3-2), and 18.5 g of dehydrated DMIB were added, and stirring was continued for 24 hours at room temperature. BC 10.0g was added to the reaction solution, A polyamic acid solution having a polymer solid content concentration of 6 wt% was obtained. The polyaminic acid solution was set to PA1. The polyamine acid contained in PA1 has a weight average molecular weight of 84,000.

[合成例2~合成例22] [Synthesis Example 2 to Synthesis Example 22]

除如表1所示般變更溶劑組成、四羧酸二酐及二胺以外,依據合成例1製備聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA2)~聚醯胺酸溶液(PA22)。包含合成例1的結果,將所獲得的聚醯胺酸的重量平均分子量的測定結果匯總於表1中。 A polyamic acid solution (PA2)-polyglycine solution having a polymer solid concentration of 6 wt% was prepared according to Synthesis Example 1, except that the solvent composition, the tetracarboxylic dianhydride, and the diamine were changed as shown in Table 1. PA22). The results of Synthesis Example 1 were included, and the results of measurement of the weight average molecular weight of the obtained polyamic acid were summarized in Table 1.

[比較合成例1~比較合成例5] [Comparative Synthesis Example 1 to Comparative Synthesis Example 5]

除如表2所示般變更溶劑組成、四羧酸二酐及二胺以外,依據合成例1製備聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA23)~聚醯胺酸溶液(PA27)。將所獲得的聚醯胺酸的重量平均分子量的測定結果匯總於表2中。 A polyamic acid solution (PA23)-polyglycine solution having a polymer solid concentration of 6 wt% was prepared according to Synthesis Example 1, except that the solvent composition, the tetracarboxylic dianhydride, and the diamine were changed as shown in Table 2. PA27). The measurement results of the weight average molecular weight of the obtained polyamic acid are summarized in Table 2.

<2.聚醯胺酸的保存穩定性與印刷性(凹陷性)> <2. Storage stability and printability (depression) of polyproline

[實施例1] [Example 1]

對合成例1中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA1)測定剛合成之後的黏度,結果為39.3Pa.s(初始黏度)。另外,測定將該清漆在室溫下保存30日後的黏度,結果為38.0Pa.s。通過所述方法,以目視確認印刷性(凹陷性),結果未看到配向劑的凹陷。 The polyamic acid solution (PA1) having a polymer solid content concentration of 6 wt% prepared in Synthesis Example 1 was measured for viscosity immediately after the synthesis, and the result was 39.3 Pa. s (initial viscosity). Further, the viscosity of the varnish after storage for 30 days at room temperature was measured, and it was 38.0 Pa. s. The printability (depression) was visually confirmed by the above method, and as a result, no depression of the alignment agent was observed.

[實施例2~實施例22] [Example 2 to Example 22]

針對合成例2~合成例22中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA2)~聚醯胺酸溶液(PA22),與實施例1同樣地也測定初始黏度與30日後的黏度。包含實施例1的結果,將所獲得的聚醯胺酸的黏度測定的結果與印刷性的結果匯總於表 3中。 The polyamic acid solution (PA2)-polyglycine solution (PA22) having a polymer solid content concentration of 6 wt% prepared in Synthesis Example 2 to Synthesis Example 22 was also measured for initial viscosity in the same manner as in Example 1. Viscosity after 30 days. The results of Example 1 were included, and the results of the viscosity measurement of the obtained polylysine and the results of the printability were summarized in the table. 3 in.

[比較例1~比較例5] [Comparative Example 1 to Comparative Example 5]

針對比較合成例1~比較合成例5中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA23)~聚醯胺酸溶液(PA27),與實施例1同樣地也測定初始黏度與30日後的黏度。將所獲得的聚醯胺酸的黏度測定的結果與印刷性的結果匯總於表4中。 The polyamic acid solution (PA23)-polyglycine solution (PA27) having a polymer solid content concentration of 6 wt% prepared in Comparative Synthesis Example 1 to Comparative Synthesis Example 5 was measured in the same manner as in Example 1. Viscosity and viscosity after 30 days. The results of the viscosity measurement of the obtained polylysine and the results of the printability are summarized in Table 4.

根據實施例1~實施例22與比較例1~比較例5的比較,可知本發明的液晶配向劑在室溫下的黏度的下降少,且液晶 配向劑的保存穩定性高。另外,可知本發明的液晶配向劑在塗布於基板上後無凹陷,印刷性高。 According to comparison between Example 1 to Example 22 and Comparative Example 1 to Comparative Example 5, it is understood that the liquid crystal alignment agent of the present invention has a small decrease in viscosity at room temperature, and liquid crystal The storage stability of the alignment agent is high. Further, it is understood that the liquid crystal alignment agent of the present invention has no depression after being applied onto a substrate, and has high printability.

<3.聚醯胺酸的摻合(blend)> <3. Blending of polylysine>

將作為聚合物[A]的合成例1中所合成的聚醯胺酸PA1、與作為聚合物[B]的合成例4中所合成的聚醯胺酸PA4以[A]/[B]=1.0/9.0的重量比混合,而製成PA28。 The poly-proline acid PA1 synthesized in Synthesis Example 1 as the polymer [A] and the poly-proline acid PA4 synthesized in Synthesis Example 4 as the polymer [B] were [A]/[B]= The weight ratio of 1.0/9.0 was mixed to make PA28.

除變更[A]成分聚醯胺酸與[B]成分聚醯胺酸的種類及[A]/[B]混合比以外,依據PA28來製備聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA29)~聚醯胺酸溶液(PA40)。包含PA28,將[A]成分聚醯胺酸與[B]成分聚醯胺酸的種類及[A]/[B]混合比匯總於表5中。 A polyglycine having a polymer solid content concentration of 6 wt% was prepared according to PA28, except that the kind of the poly (A) component polyamine and the [B] component polyamic acid and the [A]/[B] mixing ratio were changed. Solution (PA29) ~ polyaminic acid solution (PA40). In the case of PA28, the kind of the poly [A] component of the [A] component and the polyamine derivative of the [B] component and the [A]/[B] mixing ratio are summarized in Table 5.

在合成例5中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA5)中,以相對於聚合物重量為5wt%的比例添加添加劑(Ad1)。將所獲得的聚醯胺酸溶液設為PA41。 In the polyglycine solution (PA5) having a polymer solid content concentration of 6 wt% prepared in Synthesis Example 5, the additive (Ad1) was added in a ratio of 5 wt% based on the weight of the polymer. The obtained polyaminic acid solution was designated as PA41.

除變更聚醯胺酸的種類、添加劑的種類及量以外,依據PA41添加添加劑,而製備聚醯胺酸溶液(PA42)~聚醯胺酸溶液(PA45)。包含PA41,將聚醯胺酸的種類、添加劑的種類及量匯總於表6中。 In addition to changing the type of polylysine and the type and amount of the additive, a polyaminic acid solution (PA42) to a polyaminic acid solution (PA45) was prepared by adding an additive according to PA41. PA41 was contained, and the kind of the polyamic acid, the kind and amount of the additive were summarized in Table 6.

<4.液晶顯示元件的製作方法> <4. Method of Manufacturing Liquid Crystal Display Element>

<<4-1.IPS型液晶顯示元件>> <<4-1. IPS type liquid crystal display element>>

[實施例23] [Example 23]

向合成例1中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA1)中添加DMIB/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。利用旋轉器將液晶配向劑塗布在玻璃基板上。再者,也包括以後的實施例、比較例在內,對應於液晶配向劑的黏度調整旋轉器的旋轉速度,使配向膜變成下述的膜厚。塗膜後,在70℃下進行80秒加熱乾燥後,在230℃下進行15分鐘加熱處理,而形成膜厚為100±10nm的配向膜。以目視確認所形成的配向膜的白化,但未觀察到白化。 A mixed solvent of DMIB/BC=70/30 (weight ratio) was added to the polyamic acid solution (PA1) having a polymer solid content concentration of 6 wt% prepared in Synthesis Example 1, and diluted to a polymer solid content concentration. A liquid crystal alignment agent was prepared at 4 wt%. The liquid crystal alignment agent was coated on the glass substrate by a spinner. In addition, in the following examples and comparative examples, the rotational speed of the rotator was adjusted in accordance with the viscosity of the liquid crystal alignment agent, and the alignment film was changed to the following film thickness. After coating, the film was dried by heating at 70 ° C for 80 seconds, and then heat-treated at 230 ° C for 15 minutes to form an alignment film having a film thickness of 100 ± 10 nm. The whitening of the formed alignment film was visually confirmed, but no whitening was observed.

繼而,使用飯沼計量器(Iinuma Gauge)製作所股份有限公司製造的摩擦處理裝置,在摩擦布(毛長為1.8mm:人造絲)的毛壓入量為0.20mm、平臺移動速度為60mm/sec,輥旋轉速度為1,000rpm的條件下,對所獲得的液晶配向膜進行摩擦處理。 Then, using a friction processing device manufactured by Iinuma Gauge Co., Ltd., the amount of hair intrusion in the rubbing cloth (hair length: 1.8 mm: rayon) was 0.20 mm, and the moving speed of the platform was 60 mm/sec. The obtained liquid crystal alignment film was subjected to a rubbing treatment under the conditions of a roll rotation speed of 1,000 rpm.

使2片在基板上形成有配向膜的基板的形成有配向膜的面對向,以各自的配向膜的摩擦方向變成平行的方式,進而形成用以朝對向的配向膜間注入液晶組合物的空隙後貼合,從而組裝成單元厚度為4μm的空IPS單元。另外,用以向該空IPS單元中注入液晶的注入口設置在如注入時液晶的流動方向與配向膜的摩擦方向大致平行的位置上。向所製作的空IPS單元中真空注入所述正型液晶組合物,而製作液晶顯示元件。以目視確認所製作的液晶顯示元件的流動配向,但未觀察到流動配向。 Two sheets of the alignment film formed on the substrate are formed with the alignment film facing directions, and the rubbing directions of the respective alignment films are made parallel, thereby forming a liquid crystal composition for injecting the opposing alignment films. The voids are then laminated to assemble into an empty IPS unit having a cell thickness of 4 μm. Further, an injection port for injecting liquid crystal into the empty IPS unit is provided at a position where the flow direction of the liquid crystal is substantially parallel to the rubbing direction of the alignment film, for example, at the time of injection. The positive liquid crystal composition was vacuum-injected into the produced empty IPS unit to fabricate a liquid crystal display element. The flow alignment of the produced liquid crystal display element was visually confirmed, but no flow alignment was observed.

使用以所述方式製作的IPS液晶顯示元件,通過所述記載的方法來測定AC殘像(亮度變化率)△B(%),結果為4.9%。 The AC residual image (luminance change rate) ΔB (%) was measured by the method described above using the IPS liquid crystal display device produced as described above, and found to be 4.9%.

使用以所述方式製作的IPS液晶顯示元件,通過所述記載的方法來測定液晶配向軸穩定性△φ(deg),結果初始值為0.025deg,5分鐘後的值為0.015deg。 Using the IPS liquid crystal display device produced as described above, the liquid crystal alignment axis stability Δφ (deg) was measured by the above-described method, and the initial value was 0.025 deg, and the value after 5 minutes was 0.015 deg.

[實施例24~實施例34] [Examples 24 to 34]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA1及聚醯胺酸溶液PA2~聚醯胺酸溶液PA8、聚醯胺酸溶液PA28、聚醯胺酸溶液PA29、聚醯胺酸溶液PA41及聚醯胺酸溶液PA45中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例23的方法製作IPS液晶顯示元件,並注入正型液晶組合物。測定所獲得的IPS液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與實施例23的結果一同匯總於表7中。 Polymeric acid solution PA1 with polymer solid content concentration of 6wt%, polyglycine solution PA2~polyglycine solution PA8, polyaminic acid solution PA28, polyamidic acid solution PA29, polyaminic acid solution A solvent similar to the solvent composition of polylysine was added to PA41 and polyamine acid solution PA45, and diluted to a polymer solid content concentration of 4% by weight to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, an IPS liquid crystal display element was produced in accordance with the method of Example 23, and a positive type liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained IPS liquid crystal display device were measured. The results obtained are summarized in Table 7 together with the results of Example 23.

[比較例6] [Comparative Example 6]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA23中添加NMP/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例23的方法製作IPS液晶顯示元件,並注入正型液晶組合物。測定所獲得的IPS液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與所述實施例的結果一併記載於表7中。 Adding a mixed solvent of NMP/BC=70/30 (weight ratio) to a polyamic acid solution PA23 having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal alignment agent . Using the obtained liquid crystal alignment agent, an IPS liquid crystal display element was produced in accordance with the method of Example 23, and a positive type liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained IPS liquid crystal display device were measured. The results obtained are shown in Table 7 together with the results of the examples.

<<4-2.TN型液晶顯示元件>> <<4-2.TN type liquid crystal display element>>

[實施例35] [Example 35]

向合成例1中所製備的聚合物固體成分濃度為1wt%的聚醯胺酸溶液(PA9)中添加DMIB/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。利用旋轉器將液晶配向劑塗布在玻璃基板上。再者,也包括以後的實施例、比較例在內,對應於液晶配向劑的黏度調整旋轉器的旋轉速度, 使配向膜變成下述的膜厚。塗膜後,在70℃下進行80秒加熱乾燥後,在230℃下進行15分鐘加熱處理,而形成膜厚為100±10nm的配向膜。以目視確認所形成的配向膜的白化,但未觀察到白化。繼而,使用飯沼計量器製作所股份有限公司製造的摩擦處理裝置,在摩擦布(毛長為1.8mm:人造絲)的毛壓入量為0.30mm、平臺移動速度為60mm/sec,輥旋轉速度為1,000rpm的條件下,對所獲得的液晶配向膜進行摩擦處理。 A mixed solvent of DMIB/BC=70/30 (weight ratio) was added to a polyamic acid solution (PA9) having a polymer solid content concentration of 1 wt% prepared in Synthesis Example 1, and diluted to a polymer solid concentration. A liquid crystal alignment agent was prepared at 4 wt%. The liquid crystal alignment agent was coated on the glass substrate by a spinner. Further, in addition to the subsequent examples and comparative examples, the rotational speed of the rotator is adjusted corresponding to the viscosity of the liquid crystal alignment agent. The alignment film was changed to the following film thickness. After coating, the film was dried by heating at 70 ° C for 80 seconds, and then heat-treated at 230 ° C for 15 minutes to form an alignment film having a film thickness of 100 ± 10 nm. The whitening of the formed alignment film was visually confirmed, but no whitening was observed. Then, using the rubbing treatment device manufactured by Iidas Co., Ltd., the frictional cloth (hair length of 1.8 mm: rayon) was 0.30 mm, the platform moving speed was 60 mm/sec, and the roller rotation speed was The obtained liquid crystal alignment film was subjected to rubbing treatment at 1,000 rpm.

使2片在基板上形成有配向膜的基板的形成有配向膜的面對向,以各自的配向膜的摩擦方向變成垂直的方式,進而形成用以朝對向的配向膜間注入液晶組合物的空隙後貼合,從而組裝成單元厚度為4μm的空TN單元。另外,用以向該空TN單元中注入液晶的注入口設置在如注入時液晶的流動方向與配向膜的摩擦方向大致平行的位置上。向所製作的空TN單元中真空注入所述正型液晶組合物,而製作液晶顯示元件。以目視確認所製作的液晶顯示元件的流動配向,但未觀察到流動配向。 Two sheets of the substrate on which the alignment film is formed on the substrate are faced with the alignment film, and the rubbing direction of the respective alignment films is made vertical, thereby forming a liquid crystal composition for injecting the opposing alignment films. The voids are then laminated to assemble into an empty TN unit having a cell thickness of 4 μm. Further, an injection port for injecting liquid crystal into the empty TN unit is provided at a position where the flow direction of the liquid crystal is substantially parallel to the rubbing direction of the alignment film, for example, at the time of injection. The positive liquid crystal composition was vacuum-injected into the produced empty TN unit to fabricate a liquid crystal display element. The flow alignment of the produced liquid crystal display element was visually confirmed, but no flow alignment was observed.

使用以所述方式製作的TN液晶顯示元件,通過所述記載的方法來測定AC殘像(亮度變化率)△B(%),結果為5.8%。 The AC afterimage (luminance change rate) ΔB (%) was measured by the method described above using the TN liquid crystal display device produced as described above, and found to be 5.8%.

使用以所述方式製作的TN液晶顯示元件,通過所述記載的方法來測定液晶配向軸穩定性△φ(deg),結果初始值為0.036deg,5分鐘後的值為0.020deg。 Using the TN liquid crystal display element produced as described above, the liquid crystal alignment axis stability Δφ (deg) was measured by the above-described method, and the initial value was 0.036 deg, and the value after 5 minutes was 0.020 deg.

[實施例36~實施例41] [Example 36 to Example 41]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA10~聚醯胺酸溶液PA11、聚醯胺酸溶液PA30~聚醯胺酸溶液PA32及聚醯胺酸溶液PA42中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋 成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例35的方法製作TN液晶顯示元件,並注入正型液晶組合物。測定所獲得的TN液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與實施例35的結果一同匯總於表8中。 Adding polypyridic acid solution PA10~polyglycine solution PA11, polylysine solution PA30~polyglycine solution PA32 and polylysine solution PA42 to the polymer solid concentration of 6wt% The solvent of the amine acid consists of the same solvent and is diluted The polymer solid content concentration was 4% by weight to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a TN liquid crystal display element was produced in accordance with the method of Example 35, and a positive type liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained TN liquid crystal display element were measured. The results obtained are summarized in Table 8 together with the results of Example 35.

[比較例7] [Comparative Example 7]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA24中添加NMP/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例35的方法製作TN液晶顯示元件,並注入正型液晶組合物。測定所獲得的TN液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與所述實施例的結果一併記載於表8中。 Adding a mixed solvent of NMP/BC=70/30 (weight ratio) to a polyamic acid solution PA24 having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal alignment agent . Using the obtained liquid crystal alignment agent, a TN liquid crystal display element was produced in accordance with the method of Example 35, and a positive type liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained TN liquid crystal display element were measured. The results obtained are shown in Table 8 together with the results of the examples.

<<4-3.VA型液晶顯示元件>> <<4-3. VA type liquid crystal display element>>

[實施例42] [Example 42]

向合成例12中所製備的聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA12)中添加DMIB/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。利用旋轉器將液晶配向劑塗布在玻璃基板上。再者,也包括以後的實施例、比較例在內,對應於液晶配向劑的黏度調整旋轉器的旋轉速度,使配向膜變成下述的膜厚。塗膜後,在70℃下進行80秒加熱乾燥後,在230℃下進行15分鐘加熱處理,而形成膜厚為100±10nm的配向膜。以目視確認所形成的配向膜的白化,但未觀察到白化。 A mixed solvent of DMIB/BC=70/30 (weight ratio) was added to a polyglycine solution (PA12) having a polymer solid concentration of 6 wt% prepared in Synthesis Example 12, and diluted to a polymer solid concentration. A liquid crystal alignment agent was prepared at 4 wt%. The liquid crystal alignment agent was coated on the glass substrate by a spinner. In addition, in the following examples and comparative examples, the rotational speed of the rotator was adjusted in accordance with the viscosity of the liquid crystal alignment agent, and the alignment film was changed to the following film thickness. After coating, the film was dried by heating at 70 ° C for 80 seconds, and then heat-treated at 230 ° C for 15 minutes to form an alignment film having a film thickness of 100 ± 10 nm. The whitening of the formed alignment film was visually confirmed, but no whitening was observed.

使2片在基板上形成有配向膜的基板的形成有配向膜的面對向,進而形成用以朝對向的配向膜間注入液晶組合物的空隙後貼合,從而組裝成單元厚度為4μm的空VA單元。另外,用以向該空VA單元中注入液晶的注入口設置在如注入時液晶的流動方向與配向膜的摩擦方向大致平行的位置上。向所製作的空VA單元中真空注入所述負型液晶組合物,而製作液晶顯示元件。以目視確認所製作的液晶顯示元件的流動配向,但未觀察到流動配向。 Two sheets of the substrate on which the alignment film is formed on the substrate are faced with the alignment film, and a space for injecting the liquid crystal composition between the opposing alignment films is formed, and then bonded to each other to be assembled into a cell thickness of 4 μm. Empty VA unit. Further, an injection port for injecting liquid crystal into the empty VA unit is provided at a position where the flow direction of the liquid crystal at the time of injection is substantially parallel to the rubbing direction of the alignment film. The negative liquid crystal composition was vacuum-injected into the produced empty VA unit to fabricate a liquid crystal display element. The flow alignment of the produced liquid crystal display element was visually confirmed, but no flow alignment was observed.

使用以所述方式製作的VA液晶顯示元件,通過所述記載的方法來測定AC殘像(亮度變化率)△B(%),結果為6.3%。 The AC afterimage (luminance change rate) ΔB (%) was measured by the method described above using the VA liquid crystal display device produced as described above, and found to be 6.3%.

使用以所述方式製作的VA液晶顯示元件,通過所述記載的方法來測定液晶配向軸穩定性△φ(deg),結果初始值為0.047deg,5分鐘後的值為0.022deg。 Using the VA liquid crystal display device produced as described above, the liquid crystal alignment axis stability Δφ (deg) was measured by the above-described method, and the initial value was 0.047 deg, and the value after 5 minutes was 0.022 deg.

[實施例43~實施例47] [Examples 43 to 47]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA13~聚醯胺酸溶液PA14、聚醯胺酸溶液PA33、聚醯胺酸溶液PA34及聚醯胺酸溶液PA43中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋 成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例42的方法製作VA液晶顯示元件,並注入負型液晶組合物。測定所獲得的VA液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與實施例42的結果一同匯總於表9中。 Adding polypyridic acid solution PA13~polyglycine solution PA14, polylysine solution PA33, polylysine solution PA34 and polyglycine solution PA43 to the polymer solid concentration of 6wt% The solvent of the amine acid consists of the same solvent and is diluted The polymer solid content concentration was 4% by weight to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a VA liquid crystal display element was produced in accordance with the method of Example 42, and a negative liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained VA liquid crystal display device were measured. The results obtained are summarized in Table 9 together with the results of Example 42.

[比較例8] [Comparative Example 8]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA25中添加NMP/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例43的方法製作VA液晶顯示元件,並注入正型液晶組合物。測定所獲得的VA液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與所述實施例的結果一併記載於表9中。 Adding a mixed solvent of NMP/BC=70/30 (weight ratio) to a polyamic acid solution PA25 having a polymer solid content concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal alignment agent . Using the obtained liquid crystal alignment agent, a VA liquid crystal display element was produced in accordance with the method of Example 43, and a positive type liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the obtained VA liquid crystal display device were measured. The results obtained are shown in Table 9 together with the results of the examples.

<<4-4.橫向電場光異構化型液晶顯示元件>> <<4-4. Transverse electric field photoisomerization type liquid crystal display element>>

[實施例48] [Example 48]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA15)中添加 DMIB/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。利用旋轉器將液晶配向劑分別塗布在帶有柱狀間隔物的玻璃基板與帶有ITO電極的玻璃基板各1片上。再者,也包括以後的實施例、比較例在內,對應於液晶配向劑的黏度調整旋轉器的旋轉速度,使配向膜變成下述的膜厚。塗膜後,在70℃下進行80秒加熱乾燥。繼而,使用牛尾(Ushio)電機(股份)製造的Multi Light ML-501C/B,從鉛垂右向經由偏光板對基板照射紫外線的直線偏光。此時的曝光能量是使用牛尾電機(股份)製造的紫外線累計光量計UIT-150(光接收器UVD-S365)來測定光量,並以在波長365nm下變成2.0±0.1J/cm2的方式調整曝光時間。繼而,在230℃下進行15分鐘加熱煆燒,最後在加熱板上以100℃進行30分鐘熱退火。所形成的配向膜的膜厚為100±10nm。以目視確認所形成的配向膜的白化,但未觀察到白化。 Adding a mixed solvent of DMIB/BC=70/30 (weight ratio) to a polyglycine solution (PA15) having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal An aligning agent. The liquid crystal alignment agent was applied to each of the glass substrate with the column spacer and the glass substrate with the ITO electrode by a spinner. In addition, in the following examples and comparative examples, the rotational speed of the rotator was adjusted in accordance with the viscosity of the liquid crystal alignment agent, and the alignment film was changed to the following film thickness. After coating, the film was dried by heating at 70 ° C for 80 seconds. Then, Multi Light ML-501C/B manufactured by Ushio Electric Co., Ltd. was used to irradiate the substrate with ultraviolet light linearly polarized from the vertical right to the polarizing plate. The exposure energy at this time is measured by using an ultraviolet ray cumulative photometer UIT-150 (light receiver UVD-S365) manufactured by Oxtail Motor Co., Ltd., and is adjusted so as to become 2.0±0.1 J/cm 2 at a wavelength of 365 nm. Exposure time. Then, the crucible was heated at 230 ° C for 15 minutes, and finally thermally annealed at 100 ° C for 30 minutes on a hot plate. The film thickness of the formed alignment film was 100 ± 10 nm. The whitening of the formed alignment film was visually confirmed, but no whitening was observed.

使2片在基板上形成有配向膜的基板的形成有配向膜的面對向,以對各自的配向膜照射的紫外線的偏光方向變成平行的方式,進而形成用以朝對向的配向膜間注入液晶組合物的空隙後貼合,從而組裝成單元厚度為4μm的空FFS單元。另外,用以向該空FFS單元中注入液晶的注入口設置在如注入時液晶的流動方向與對配向膜照射的紫外線的偏光方向大致平行的位置上。向所製作的空FFS單元中真空注入所述正型液晶組合物,而製作橫向電場光異構化型液晶顯示元件。以目視確認所製作的液晶顯示元件的流動配向,但未觀察到流動配向。 Two sheets of the alignment film formed on the substrate are faced with the alignment film, and the polarization directions of the ultraviolet rays irradiated to the respective alignment films are parallel, thereby forming an alignment film for facing the opposite direction. The voids of the liquid crystal composition were injected and bonded, and assembled into an empty FFS unit having a cell thickness of 4 μm. Further, an injection port for injecting liquid crystal into the empty FFS unit is provided at a position where the flow direction of the liquid crystal at the time of injection is substantially parallel to the polarization direction of the ultraviolet ray irradiated to the alignment film. The positive liquid crystal composition was vacuum-injected into the produced empty FFS unit to produce a transverse electric field photoisomerization type liquid crystal display element. The flow alignment of the produced liquid crystal display element was visually confirmed, but no flow alignment was observed.

使用以所述方式製作的橫向電場光異構化型液晶顯示 元件,通過所述記載的方法來測定AC殘像(亮度變化率)△B(%),結果為2.8%。 Using a transverse electric field photoisomerization type liquid crystal display fabricated in the manner described The element was measured for the AC afterimage (luminance change rate) ΔB (%) by the method described above, and found to be 2.8%.

使用以所述方式製作的橫向電場光異構化型液晶顯示元件,通過所述記載的方法來測定液晶配向軸穩定性△φ(deg),結果初始值為0.021deg,5分鐘後的值為0.012deg。 Using the transverse electric field photoisomerization type liquid crystal display device produced as described above, the liquid crystal alignment axis stability Δφ (deg) was measured by the above-described method, and the initial value was 0.021 deg, and the value after 5 minutes was obtained. 0.012deg.

[實施例49~實施例53] [Example 49 to Example 53]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA16~聚醯胺酸溶液PA20中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例48的方法製作橫向電場光異構化型液晶顯示元件,並注入正型液晶組合物。測定所獲得的橫向電場光異構化型液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與實施例48的結果一同匯總於表10中。 A solvent having the same solvent composition as that of polylysine was added to the polypergic acid solution PA16-polyglycine solution PA20 having a polymer solid concentration of 6 wt%, and diluted to a polymer solid concentration of 4 wt%. A liquid crystal alignment agent is prepared. Using the obtained liquid crystal alignment agent, a transverse electric field photoisomerization type liquid crystal display element was produced in accordance with the method of Example 48, and a positive liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the transverse electric field photoisomerization type liquid crystal display device obtained were measured. The results obtained are summarized in Table 10 together with the results of Example 48.

[實施例54~實施例58] [Examples 54 to 58]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA35~聚醯胺酸溶液PA38及聚醯胺酸溶液PA44中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。除將光源的燈從牛尾電機(股份)製造的Multi Light ML-501C/B變更成牛尾電機(股份)製造的金屬鹵化物燈UVL-1500M2-N1以外,以依據實施例48的方法製作橫向電場光異構化型液晶顯示元件,並注入正型液晶組合物。測定所獲得的橫向電場光異構化型液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。 將所獲得的結果與實施例48~實施例53的結果一同匯總於表10中。 Adding a solvent having the same solvent composition as that of polylysine to polyphosphoric acid solution PA35~polyglycine solution PA38 and polylysine solution PA44 having a polymer solid concentration of 6 wt%, and diluting into a polymer The solid content concentration was 4% by weight to prepare a liquid crystal alignment agent. A transverse electric field was produced in accordance with the method of Example 48 except that the lamp of the light source was changed from Multi Light ML-501C/B manufactured by Oxtail Motor Co., Ltd. to a metal halide lamp UVL-1500M2-N1 manufactured by Oxtail Motor Co., Ltd. A photoisomerization type liquid crystal display element is injected into a positive type liquid crystal composition. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the transverse electric field photoisomerization type liquid crystal display device obtained were measured. The results obtained are summarized in Table 10 together with the results of Examples 48 to 53.

[比較例9] [Comparative Example 9]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA26中添加NMP/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例48的方法製作橫向電場光異構化型液晶顯示元件,並注入正型液晶組合物。測定所獲得的橫向電場光異構化型液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與所述實施例的結果一併記載於表10中。 Adding a mixed solvent of NMP/BC=70/30 (weight ratio) to a polyamic acid solution PA26 having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal alignment agent . Using the obtained liquid crystal alignment agent, a transverse electric field photoisomerization type liquid crystal display element was produced in accordance with the method of Example 48, and a positive liquid crystal composition was injected. The alignment film whitening, flow alignment, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg) of the transverse electric field photoisomerization type liquid crystal display device obtained were measured. The results obtained are shown in Table 10 together with the results of the examples.

<<4-5.橫向電場光分解型液晶顯示元件>> <<4-5. Transverse electric field photodecomposition type liquid crystal display element>>

[實施例59] [Example 59]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液(PA21)中添加DMIB/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。利用旋轉器將液晶配向劑分別塗布在帶有柱狀間隔物的玻璃基板與帶有ITO電極的玻璃基板各1片上。再者,也包括以後的實施例、比較例在內,對應於液晶配向劑的黏度調整旋轉器的旋轉速度,使配向膜變成下述的膜厚。塗膜後,在70℃下進行80秒加熱乾燥後,在230℃下進行30分鐘加熱煆燒,而形成膜厚為100±10nm的配向膜。繼而,使用牛尾電機(股份)製造的Multi Light ML-501C/B,從鉛垂右向經由偏光板對基板照射紫外線的直線偏光。此時的曝光能量是使用牛尾電機(股份)製造的紫外線累計光量計UIT-150(光接收器UVD-S365)來測定光量,並以在波長254nm下變成2.0±0.1J/cm2 的方式調整曝光時間。以目視確認所形成的配向膜的白化,但未觀察到白化。 Adding a mixed solvent of DMIB/BC=70/30 (weight ratio) to a polyglycine solution (PA21) having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal An aligning agent. The liquid crystal alignment agent was applied to each of the glass substrate with the column spacer and the glass substrate with the ITO electrode by a spinner. In addition, in the following examples and comparative examples, the rotational speed of the rotator was adjusted in accordance with the viscosity of the liquid crystal alignment agent, and the alignment film was changed to the following film thickness. After coating, the film was dried by heating at 70 ° C for 80 seconds, and then heated and calcined at 230 ° C for 30 minutes to form an alignment film having a film thickness of 100 ± 10 nm. Then, the Multi Light ML-501C/B manufactured by Oxtail Motor Co., Ltd. was used to irradiate the substrate with ultraviolet light linearly polarized from the vertical right to the polarizing plate. The exposure energy at this time is measured by using an ultraviolet ray cumulative photometer UIT-150 (photoreceiver UVD-S365) manufactured by Oxtail Motor Co., Ltd., and is adjusted so as to become 2.0±0.1 J/cm 2 at a wavelength of 254 nm. Exposure time. The whitening of the formed alignment film was visually confirmed, but no whitening was observed.

使2片在基板上形成有配向膜的基板的形成有配向膜的面對向,以對各自的配向膜照射的紫外線的偏光方向變成平行的方式,進而形成用以朝對向的配向膜間注入液晶組合物的空隙後貼合,從而組裝成單元厚度為4μm的空FFS單元。另外,用以向該空FFS單元中注入液晶的注入口設置在如注入時液晶的流動方向與對配向膜照射的紫外線的偏光方向大致平行的位置上。向所製作的空FFS單元中真空注入所述正型液晶組合物,而製作橫向電場光分解型液晶顯示元件。以目視確認所製作的液晶顯示元件的流動配向,但未觀察到流動配向。 Two sheets of the alignment film formed on the substrate are faced with the alignment film, and the polarization directions of the ultraviolet rays irradiated to the respective alignment films are parallel, thereby forming an alignment film for facing the opposite direction. The voids of the liquid crystal composition were injected and bonded, and assembled into an empty FFS unit having a cell thickness of 4 μm. Further, an injection port for injecting liquid crystal into the empty FFS unit is provided at a position where the flow direction of the liquid crystal at the time of injection is substantially parallel to the polarization direction of the ultraviolet ray irradiated to the alignment film. The positive liquid crystal composition was vacuum-injected into the produced empty FFS unit to produce a lateral electric field photodegradable liquid crystal display element. The flow alignment of the produced liquid crystal display element was visually confirmed, but no flow alignment was observed.

使用以所述方式製作的橫向電場光分解型液晶顯示元件,通過所述記載的方法來測定AC殘像(亮度變化率)△B(%),結果為7.8%。 The AC afterimage (luminance change rate) ΔB (%) was measured by the above-described method using the transverse electric field photodegradable liquid crystal display device produced as described above, and found to be 7.8%.

使用以所述方式製作的橫向電場光分解型液晶顯示元件,通過所述記載的方法來測定液晶配向軸穩定性△φ(deg),結果初始值為0.062deg,5分鐘後的值為0.032deg。 Using the transverse electric field photodegradable liquid crystal display device produced as described above, the liquid crystal alignment axis stability Δφ (deg) was measured by the above-described method, and the initial value was 0.062 deg, and the value after 5 minutes was 0.032 deg. .

[實施例60~實施例62] [Example 60 to Example 62]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA22、聚醯胺酸溶液PA39及聚醯胺酸溶液PA40中分別添加與聚醯胺酸的溶劑組成相同的溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例59的方法製作橫向電場光分解型液晶顯示元件,並注入正型液晶組合物。測定所獲得的橫向電場光分解型液晶顯示元件的配向膜白化、流動配 向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與實施例59的結果一同匯總於表11中。 Adding a solvent having the same solvent composition as the polylysine to the polyamic acid solution PA22, the polyaminic acid solution PA39, and the polyaminic acid solution PA40 having a polymer solid concentration of 6 wt%, respectively, and diluting into a polymer The solid content concentration was 4% by weight to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a transverse electric field photodegradable liquid crystal display element was produced in accordance with the method of Example 59, and a positive liquid crystal composition was injected. The alignment film whitening and flow distribution of the transverse electric field photodegradable liquid crystal display element obtained were measured Direction, AC afterimage (luminance change rate) ΔB (%), and liquid crystal alignment axis stability Δφ (deg). The results obtained are summarized in Table 11 together with the results of Example 59.

[比較例10] [Comparative Example 10]

向聚合物固體成分濃度為6wt%的聚醯胺酸溶液PA27中添加NMP/BC=70/30(重量比)的混合溶劑,並稀釋成聚合物固體成分濃度為4wt%而製成液晶配向劑。使用所獲得的液晶配向劑,以依據實施例59的方法製作橫向電場光分解型液晶顯示元件,並注入正型液晶組合物。測定所獲得的橫向電場光分解型液晶顯示元件的配向膜白化、流動配向、AC殘像(亮度變化率)△B(%)、以及液晶配向軸穩定性△φ(deg)。將所獲得的結果與所述實施例的結果一併記載於表11中。 Adding a mixed solvent of NMP/BC=70/30 (weight ratio) to a polyamic acid solution PA27 having a polymer solid concentration of 6 wt%, and diluting to a polymer solid content concentration of 4 wt% to prepare a liquid crystal alignment agent . Using the obtained liquid crystal alignment agent, a transverse electric field photodegradable liquid crystal display element was produced in accordance with the method of Example 59, and a positive liquid crystal composition was injected. The alignment film whitening, the flow alignment, the AC afterimage (luminance change rate) ΔB (%), and the liquid crystal alignment axis stability Δφ (deg) of the obtained transverse electric field photodegradable liquid crystal display device were measured. The results obtained are shown in Table 11 together with the results of the examples.

根據實施例23~實施例62與比較例6~比較例10的比較,可知使用本發明的液晶配向劑所製作的液晶顯示元件使AC殘像下降,且液晶配向性軸的穩定性高。 According to the comparison of Examples 23 to 62 and Comparative Example 6 to Comparative Example 10, it is understood that the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention lowers the AC afterimage and has high stability of the liquid crystal alignment axis.

[產業上的可利用性] [Industrial availability]

通過具備使用本發明的液晶配向劑所形成的液晶配向膜,而可製造殘像特性優異、且配向穩定性良好的液晶顯示元件。 By providing the liquid crystal alignment film formed using the liquid crystal alignment agent of the present invention, it is possible to produce a liquid crystal display element having excellent afterimage characteristics and excellent alignment stability.

Claims (16)

一種液晶配向劑,其是含有使四羧酸二酐與二胺進行反應而獲得的聚醯胺酸或其衍生物、及溶劑而成的溶液,所述溶劑含有由下述式(A)所表示的化合物的至少1個: 式中,R1及R2分別獨立地為碳數1~3的烷基。 A liquid crystal alignment agent containing a polyglycine or a derivative thereof obtained by reacting tetracarboxylic dianhydride with a diamine, and a solvent containing a solvent of the following formula (A) At least one of the indicated compounds: In the formula, R 1 and R 2 are each independently an alkyl group having 1 to 3 carbon atoms. 如申請專利範圍第1項所述的液晶配向劑,其中:所述由式(A)所表示的化合物為選自由下述式(A-1)~式(A-6)所表示的化合物的群組中的至少一個, The liquid crystal alignment agent according to claim 1, wherein the compound represented by the formula (A) is a compound selected from the group consisting of the compounds represented by the following formulas (A-1) to (A-6). At least one of the groups, 如申請專利範圍第2項所述的液晶配向劑,其中:所述由式(A)所表示的化合物為選自由式(A-1)、式(A-4)及式(A-6) 所表示的化合物的群組中的至少一個。 The liquid crystal alignment agent according to claim 2, wherein the compound represented by the formula (A) is selected from the group consisting of the formula (A-1), the formula (A-4) and the formula (A-6). At least one of the groups of compounds represented. 如申請專利範圍第1項至第3項中任一項所述的液晶配向劑,其中:所述溶劑含有選自不良溶劑的群組中的至少一個,所述不良溶劑包含:乙二醇碳酸酯、1,2-丙二醇碳酸酯、1,3-丙二醇碳酸酯、2-甲基-1,3-丙二醇碳酸酯、乙二醇單丁醚(丁基溶纖劑)、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單苯醚、乙二醇苯醚乙酸酯、乙二醇甲基苯醚、乙二醇乙基苯醚、乙二醇二乙醚、二乙二醇單甲醚、二乙二醇二甲醚、二乙二醇甲基乙基醚、二乙二醇甲基苯醚、二乙二醇單乙醚、二乙二醇單乙醚乙酸酯、二乙二醇二乙醚、二乙二醇單丁醚、二乙二醇二丁醚、二乙二醇單丁醚乙酸酯、二乙二醇單丙醚、二乙二醇單-2-乙基己醚、三乙二醇單甲醚、三乙二醇單十二烷基醚、三乙二醇二甲醚、三乙二醇二乙醚、四乙二醇二甲醚、丙二醇二乙酸酯、丙二醇單甲醚、丙二醇甲基苯醚、丙二醇單乙醚、丙二醇單乙醚乙酸酯、丙二醇單丁醚乙酸酯、丙二醇單苯醚、丙二醇單丙醚、二丙二醇二甲醚、二丙二醇單丙醚、三丙二醇二甲醚、三丙二醇二乙醚、乙酸正丙酯、乙酸丁酯、乙酸戊酯、乙酸正己酯、乙酸環己酯、乙酸2-甲基環己酯、丙酸正丁酯、2-羥基-異丁酸甲酯、2-甲基戊酮-2,4-二醇、第三丁醇、三乙基甲醇、第三戊醇、1-甲基環己醇、2,5-二甲基己烷-2,5-二醇、正丁醇、雙(3-甲基丁基)醚、二正戊醚(二戊醚)、4-庚酮、5-壬酮、2,6-二甲基-4-庚酮、乙酸4-甲基-2-戊酯、乳酸丁酯、乳酸異戊酯、乳酸正丁酯、二丙 二醇甲醚、4-羥基-4-甲基-2-戊酮(二丙酮醇)、甲基-3-甲氧基丙酸酯、乙基-3-乙氧基丙酸酯、苄醇、苯乙醇、1-丁氧基-2-丙醇、2-(2-甲氧基丙氧基)丙醇、乙酸2-羥基乙酯、2,4-戊二酮、乙基-3-乙氧基丙酸酯、糠醇、四氫糠醇、3-甲基-3-甲氧基丁醇、1,3-二氧戊環、丙酸異戊酯、異丁酸異戊酯、二異戊醚、丁醯苯、及二異丁基酮。 The liquid crystal alignment agent according to any one of claims 1 to 3, wherein the solvent contains at least one selected from the group consisting of a poor solvent, and the poor solvent comprises: ethylene glycol carbonate Ester, 1,2-propylene glycol carbonate, 1,3-propanediol carbonate, 2-methyl-1,3-propanediol carbonate, ethylene glycol monobutyl ether (butyl cellosolve), ethylene glycol monomethyl ether Acid ester, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monophenyl ether, ethylene glycol phenyl ether acetate, ethylene glycol methyl phenyl ether, ethylene glycol Phenyl phenyl ether, ethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol methyl phenyl ether, diethylene glycol single Ether, diethylene glycol monoethyl ether acetate, diethylene glycol diethyl ether, diethylene glycol monobutyl ether, diethylene glycol dibutyl ether, diethylene glycol monobutyl ether acetate, diethylene glycol Monopropyl ether, diethylene glycol mono-2-ethylhexyl ether, triethylene glycol monomethyl ether, triethylene glycol monododecyl ether, triethylene glycol dimethyl ether, triethylene glycol diethyl ether Tetraethylene glycol dimethyl ether, propylene glycol diacetic acid Ester, propylene glycol monomethyl ether, propylene glycol methyl phenyl ether, propylene glycol monoethyl ether, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate, propylene glycol monophenyl ether, propylene glycol monopropyl ether, dipropylene glycol dimethyl ether, dipropylene glycol Monopropyl ether, tripropylene glycol dimethyl ether, tripropylene glycol diethyl ether, n-propyl acetate, butyl acetate, amyl acetate, n-hexyl acetate, cyclohexyl acetate, 2-methylcyclohexyl acetate, n-butyl propionate Ester, methyl 2-hydroxy-isobutyrate, 2-methylpentanone-2,4-diol, tert-butanol, triethylmethanol, third pentanol, 1-methylcyclohexanol, 2 , 5-dimethylhexane-2,5-diol, n-butanol, bis(3-methylbutyl)ether, di-n-pentyl ether (dipentyl ether), 4-heptanone, 5-fluorenone , 2,6-dimethyl-4-heptanone, 4-methyl-2-pentyl acetate, butyl lactate, isoamyl lactate, n-butyl lactate, dipropylene Glycol methyl ether, 4-hydroxy-4-methyl-2-pentanone (diacetone alcohol), methyl-3-methoxypropionate, ethyl-3-ethoxypropionate, benzyl alcohol , phenylethyl alcohol, 1-butoxy-2-propanol, 2-(2-methoxypropoxy)propanol, 2-hydroxyethyl acetate, 2,4-pentanedione, ethyl-3- Ethoxypropionate, decyl alcohol, tetrahydrofurfuryl alcohol, 3-methyl-3-methoxybutanol, 1,3-dioxolane, isoamyl propionate, isoamyl isobutyrate, diiso) Pentyl ether, butyl benzene, and diisobutyl ketone. 如申請專利範圍第1項至第3項中任一項所述的液晶配向劑,其中:所述溶劑含有選自包含N-烷基-2-吡咯烷酮類、N-環己基-2-吡咯烷酮、內酯類及1,3-二烷基-2-咪唑烷酮類的良溶劑的群組中的至少一個。 The liquid crystal alignment agent according to any one of claims 1 to 3, wherein the solvent contains a group selected from the group consisting of N-alkyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, At least one of the group of good solvents of lactones and 1,3-dialkyl-2-imidazolidinones. 如申請專利範圍第5項所述的液晶配向劑,其中:所述良溶劑為選自N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、N-環己基-2-吡咯烷酮、γ-丁內酯、及1,3-二甲基-2-咪唑烷酮中的至少一個。 The liquid crystal alignment agent according to claim 5, wherein the good solvent is selected from the group consisting of N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, and N-cyclohexyl-2-pyrrolidone. At least one of γ -butyrolactone and 1,3-dimethyl-2-imidazolidinone. 如申請專利範圍第1項至第3項中任一項所述的液晶配向劑,其中:所述與二胺進行反應的四羧酸二酐為選自由下述式(AN-I)~式(AN-VII)及式(PAN-1)~式(PAN-8)所表示的四羧酸二酐的群組中的至少一個: 式(AN-I)、式(AN-IV)及式(AN-V)中,X獨立為單鍵或-CH2-;式(AN-II)中,G為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(AN-II)~式(AN-IV)中,Y獨立為選自下述的三價的基的群組中的1個,結合鍵與任意的碳連結,所述基的至少1個氫可由甲基、乙基或苯基取代; 式(AN-III)~式(AN-V)中,環A為碳數3~10的單環式烴的基或碳數6~30的縮合多環式烴的基,所述基的至少1個氫可由甲基、乙基或苯基取代,連接在環上的結合鍵與構成環的任意的碳連結,2根結合鍵可與同一個碳連結;式(AN-VI)中,X10為碳數2~6的伸烷基,Me表示甲基,Ph表示苯基;式(AN-VII)中,G10獨立為-O-、-COO-或-OCO-,而且,r獨立為0或1; The liquid crystal alignment agent according to any one of claims 1 to 3, wherein the tetracarboxylic dianhydride which is reacted with the diamine is selected from the group consisting of the following formula (AN-I) (AN-VII) and at least one of the group of tetracarboxylic dianhydride represented by the formula (PAN-1) to (PAN-8): In the formula (AN-I), the formula (AN-IV) and the formula (AN-V), X is independently a single bond or -CH 2 -; in the formula (AN-II), G is a single bond, and the carbon number is 1~ 20 alkyl, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; (AN-II)~ In AN-IV), Y is independently one selected from the group consisting of trivalent groups, and a bond is bonded to any carbon, and at least one hydrogen of the group may be methyl, ethyl or benzene. Base substitution In the formula (AN-III) to the formula (AN-V), the ring A is a monocyclic hydrocarbon group having 3 to 10 carbon atoms or a condensed polycyclic hydrocarbon group having 6 to 30 carbon atoms, and at least the group One hydrogen may be substituted by a methyl group, an ethyl group or a phenyl group, and the bond bond attached to the ring may be bonded to any carbon constituting the ring, and two bond bonds may be bonded to the same carbon; in the formula (AN-VI), X 10 is an alkylene group having 2 to 6 carbon atoms, Me represents a methyl group, and Ph represents a phenyl group; in the formula (AN-VII), G 10 is independently -O-, -COO- or -OCO-, and r is independent. Is 0 or 1; 如申請專利範圍第7項所述的液晶配向劑,其中:所述與二胺進行反應的四羧酸二酐為選自由下述式(AN-1-1)、式(AN-1-13)、式(AN-2-1)、式(AN-2-2)、式(AN-3-1)、式(AN-3-2)、式(AN-4-1)、式(AN-4-5)、式(AN-4-6)、式(AN-4-17)、式(AN-4-21)、式(AN-4-26)、式(AN-4-30)、式(AN-9-1)、式(AN-13-1)、式(AN-16-1)及式(PAN-1)所組 成的群組中的至少一個: 式(AN-4-17)中,m為1~12的整數;式(AN-13-1)中,Ph表示苯基。 The liquid crystal alignment agent according to claim 7, wherein the tetracarboxylic dianhydride which is reacted with the diamine is selected from the group consisting of the following formula (AN-1-1) and the formula (AN-1-13). ), Formula (AN-2-1), Formula (AN-2-2), Formula (AN-3-1), Formula (AN-3-2), Formula (AN-4-1), Formula (AN) -4-5), formula (AN-4-6), formula (AN-4-17), formula (AN-4-21), formula (AN-4-26), formula (AN-4-30) At least one of the group consisting of: (AN-9-1), (AN-13-1), (AN-16-1), and (PAN-1): In the formula (AN-4-17), m is an integer of 1 to 12; in the formula (AN-13-1), Ph represents a phenyl group. 如申請專利範圍第1項至第3項中任一項所述的液晶配向劑,其中:所述與四羧酸二酐進行反應的二胺為選自由下述式(DI-1)~式(DI-16)、式(DIH-1)~式(DIH-3)、式(DI-31) ~式(DI-35)及式(PDI-1)~式(PDI-12)所組成的群組中的至少一個: 式(DI-1)中,G20為-CH2-,至少1個-CH2-可被-NH-、-O-取代,m為1~12的整數,伸烷基的至少1個氫可被-OH取代;式(DI-3)及式(DI-5)~式(DI-7)中,G21獨立為單鍵、-NH-、-NCH3-、-O-、-S-、-S-S-、-SO2-、-CO-、-COO-、-CONH-、-CONCH3-、-C(CH3)2-、-C(CF3)2-、-(CH2)m'-、-O-(CH2)m'-O-、-N(CH3)-(CH2)k-N(CH3)-、-(O-C2H4)m'-O-、-O-CH2-C(CF3)2-CH2-O-、-O-CO-(CH2)m'-CO-O-、-CO-O-(CH2)m'-O-CO-、-(CH2)m'-NH-(CH2)m'-、-CO-(CH2)k-NH-(CH2)k-、-(NH-(CH2)m')k-NH-、 -CO-C3H6-(NH-C3H6)n-CO-或-S-(CH2)m'-S-,m'獨立為1~12的整數,k為1~5的整數,n為1或2;式(DI-4)中,s獨立為0~2的整數;式(DI-6)及式(DI-7)中,G22獨立為單鍵、-O-、-S-、-CO-、-C(CH3)2-、-C(CF3)2-、或碳數1~10的伸烷基;式(DI-2)~式(DI-7)中的環己烷環及苯環的至少1個氫可由-F、-Cl、碳數1~3的伸烷基、-OCH3、-OH、-CF3、-CO2H、-CONH2、-NHC6H5、苯基或苄基取代,而且,在式(DI-4)中,環己烷環及苯環的至少1個氫可由下述式(DI-4-a)~式(DI-4-e)取代;鍵結位置未固定在構成環的碳原子上的基表示在所述環上的鍵結位置任意,-NH2在環己烷環或苯環上的鍵結位置為除G21或G22的鍵結位置以外的任意的位置; 式(DI-4-a)及(DI-4-b)中,R20獨立為氫或-CH3 式(DI-11)中,r為0或1;式(DI-8)~式(DI-11)中,鍵結在環上的-NH2的鍵結位置為任意的位置; 式(DI-12)中,R21及R22獨立為碳數1~3的烷基或苯基,G23獨立為碳數1~6的伸烷基、伸苯基或經烷基取代的伸苯基,w為1~10的整數;式(DI-13)中,R23獨立為碳數1~5的烷基、碳數1~5的烷氧基或-Cl,p獨立為0~3的整數,q為0~4的整數;式(DI-14)中,環B為單環的雜環式芳香族基,R24為氫、-F、-Cl、-B、碳數1~6的烷基、烷氧基、乙烯基、炔基,q獨立為0~4的整數;式(DI-15)中,環C為雜環式芳香族基或雜環式脂肪族基;式(DI-16)中,G24為單鍵、碳數2~6的伸烷基或1,4-伸苯基,r為0或1;鍵結位置未固定在構成環的碳原子上的基表示在所述環上的鍵結位置任意;式(DI-13)~式(DI-16)中,鍵結在環上的-NH2的鍵結位置為任意的位置; 式(DIH-1)中,G25為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(DIH-2)中,環D為環己烷環、苯環或萘環,此基的至少1個氫可由甲基、乙基或苯基取代;式(DIH-3)中,環E分別獨立地為環己烷環或苯環,此基的至少1個氫可由甲基、乙基或苯基取代,Y為單鍵、碳數1~20的伸烷基、-CO-、-O-、-S-、-SO2-、-C(CH3)2-或-C(CF3)2-;式(DIH-2)及式(DIH-3)中,鍵結在環上的-CONHNH2的鍵結位置為任意的位置; 式(DI-31)中,G26為單鍵、-O-、-COO-、-OCO-、-CO-、-CONH-、-CH2O-、-OCH2-、-CF2O-、-OCF2-或-(CH2)m'-,m'為1~12的整數,R25為碳數3~30的烷基、苯基、具有類固醇骨架的基、或由下述的式(DI-31-a)所表示的基,所述烷基中,至少1個氫可由-F取代,而且至少1個-CH2-可由-O-、-CH=CH-或-C≡C-取代,所述苯基的氫可由-F、-CH3、-OCH3、-OCH2F、-OCHF2、-OCF3、碳數3~30的烷基、或碳數3~30的烷氧基取代,鍵結在苯環上 的-NH2的鍵結位置表示在所述環中為任意的位置, 式(DI-31-a)中,G27、G28及G29為鍵結基,它們獨立為單鍵、或碳數1~12的伸烷基,所述伸烷基的1個以上的-CH2-可由-O-、-COO-、-OCO-、-CONH-、-CH=CH-取代,環B21、環B22、環B23及環B24獨立為1,4-伸苯基、1,4-伸環己基、1,3-二噁烷-2,5-二基、嘧啶-2,5-二基、吡啶-2,5-二基、萘-1,5-二基、萘-2,7-二基或蒽-9,10-二基,環B21、環B22、環B23及環B24中,至少1個氫可由-F或-CH3取代,s、t及u獨立為0~2的整數,它們的合計為1~5,當s、t或u為2時,各個括號內的2個鍵結基可以相同,也可以不同,而且,2個環可以相同,也可以不同,R26為-F、-OH、碳數1~30的烷基、碳數1~30的氟取代烷基、碳數1~30的烷氧基、-CN、-OCH2F、-OCHF2或-OCF3,所述碳數1~30的烷基的至少1個-CH2-可由以下述式(DI-31-b)所表示的二價的基取代, 式(DI-31-b)中,R27及R28獨立為碳數1~3的烷基,v為1~6的整數; 式(DI-32)及式(DI-33)中,G30獨立為單鍵、-CO-或-CH2-,R29獨立為氫或-CH3,R30為氫、碳數1~20的烷基、或碳數2~20的烯基;式(DI-33)中的苯環的1個氫可由碳數1~20的烷基或苯基取代,鍵結位置未固定在構成環的任一個碳原子上的基表示在所述環上的鍵結位置任意;式(DI-32)及式(DI-33)中,鍵結在苯環上的-NH2表示在所述環上的鍵結位置任意; 式(DI-34)及式(DI-35)中,G31獨立為-O-或碳數1~6的伸烷基,G32為單鍵或碳數1~3的伸烷基,R31為氫或碳數1~20的烷基,所述烷基的至少1個-CH2-可由-O-、-CH=CH-或-C≡C-取代,R32為碳數6~22的烷基,R33為氫或碳數1~22的烷基,環B25為1,4-伸苯基或1,4-伸環己基,r為0或1;而且,鍵結在苯環上的-NH2表示在所述環上的鍵結位置任意; 式(PDI-7)中,R51獨立為-CH3、-OCH3、-CF3或-COOCH3,b獨立為0~2的整數。 The liquid crystal alignment agent according to any one of claims 1 to 3, wherein the diamine reacted with the tetracarboxylic dianhydride is selected from the group consisting of the following formula (DI-1) (DI-16), formula (DIH-1) ~ formula (DIH-3), formula (DI-31) ~ formula (DI-35) and formula (PDI-1) ~ formula (PDI-12) At least one of the groups: In the formula (DI-1), G 20 is -CH 2 -, at least one -CH 2 - may be substituted by -NH- or -O-, m is an integer of from 1 to 12, and at least one hydrogen of the alkyl group is extended. Can be substituted by -OH; in formula (DI-3) and formula (DI-5)~ (DI-7), G 21 is independently a single bond, -NH-, -NCH 3 -, -O-, -S -, -SS-, -SO 2 -, -CO-, -COO-, -CONH-, -CONCH 3 -, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 m' -, -O-(CH 2 ) m' -O-, -N(CH 3 )-(CH 2 ) k -N(CH 3 )-, -(OC 2 H 4 ) m' -O- , -O-CH 2 -C(CF 3 ) 2 -CH 2 -O-, -O-CO-(CH 2 ) m' -CO-O-, -CO-O-(CH 2 ) m' -O -CO-, -(CH 2 ) m' -NH-(CH 2 ) m' -, -CO-(CH 2 ) k -NH-(CH 2 ) k -, -(NH-(CH 2 ) m' k -NH-, -CO-C 3 H 6 -(NH-C 3 H 6 ) n -CO- or -S-(CH 2 ) m' -S-, m' is independently an integer from 1 to 12, k is an integer from 1 to 5, n is 1 or 2; in the formula (DI-4), s is independently an integer of 0 to 2; in the formula (DI-6) and (DI-7), G 22 is independently a single bond, -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, or an alkylene group having a carbon number of 1 to 10; formula (DI-2) At least one hydrogen of the cyclohexane ring and the benzene ring in the formula (DI-7) may be -F, -Cl, an alkyl group having 1 to 3 carbon atoms, -OCH 3 , -OH, -CF 3 , - CO 2 H, -C ONH 2 , -NHC 6 H 5 , phenyl or benzyl group, and, in the formula (DI-4), at least one hydrogen of the cyclohexane ring and the benzene ring may be represented by the following formula (DI-4-a) a substituent of the formula (DI-4-e); a group in which the bonding position is not fixed to a carbon atom constituting the ring means that the bonding position on the ring is arbitrary, and -NH 2 is on the cyclohexane ring or the benzene ring. The bonding position is any position other than the bonding position of G 21 or G 22 ; In the formulae (DI-4-a) and (DI-4-b), R 20 is independently hydrogen or -CH 3 ; In the formula (DI-11), r is 0 or 1; in the formula (DI-8) to the formula (DI-11), the bonding position of -NH 2 bonded to the ring is an arbitrary position; In the formula (DI-12), R 21 and R 22 are independently an alkyl group having 1 to 3 carbon atoms or a phenyl group, and G 23 is independently an alkylene group having a carbon number of 1 to 6, a phenyl group or an alkyl group. Phenyl is extended, w is an integer of 1 to 10; in the formula (DI-13), R 23 is independently an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or -Cl, and p is independently 0. An integer of ~3, q is an integer from 0 to 4; in the formula (DI-14), ring B is a monocyclic heterocyclic aromatic group, and R 24 is hydrogen, -F, -Cl, -B, carbon number 1 to 6 alkyl, alkoxy, vinyl, alkynyl, q is independently an integer of 0 to 4; in the formula (DI-15), ring C is a heterocyclic aromatic group or a heterocyclic aliphatic group In the formula (DI-16), G 24 is a single bond, an alkylene group having 2 to 6 carbon atoms or a 1,4-phenylene group, and r is 0 or 1; the bonding position is not fixed to the carbon atom constituting the ring; The upper base indicates that the bonding position on the ring is arbitrary; in the formula (DI-13) to the formula (DI-16), the bonding position of the -NH 2 bonded to the ring is an arbitrary position; In the formula (DIH-1), G 25 is a single bond, an alkylene group having 1 to 20 carbon atoms, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; in the formula (DIH-2), the ring D is a cyclohexane ring, a benzene ring or a naphthalene ring, and at least one hydrogen of the group may be substituted by a methyl group, an ethyl group or a phenyl group; In (DIH-3), ring E is independently a cyclohexane ring or a benzene ring, and at least one hydrogen of the group may be substituted by a methyl group, an ethyl group or a phenyl group, and Y is a single bond and has a carbon number of 1 to 20 carbon atoms. Alkyl, -CO-, -O-, -S-, -SO 2 -, -C(CH 3 ) 2 - or -C(CF 3 ) 2 -; formula (DIH-2) and formula (DIH- In 3), the bonding position of -CONHNH 2 bonded to the ring is an arbitrary position; In the formula (DI-31), G 26 is a single bond, -O-, -COO-, -OCO-, -CO-, -CONH-, -CH 2 O-, -OCH 2 -, -CF 2 O- , -OCF 2 - or -(CH 2 ) m' -, m' is an integer of 1 to 12, and R 25 is an alkyl group having 3 to 30 carbon atoms, a phenyl group, a group having a steroid skeleton, or the following a group represented by the formula (DI-31-a) wherein at least one hydrogen of the alkyl group may be substituted by -F, and at least one -CH 2 - may be -O-, -CH=CH- or -C≡ C-substituted, the hydrogen of the phenyl group may be -F, -CH 3 , -OCH 3 , -OCH 2 F, -OCHF 2, -OCF 3, an alkyl group having 3 to 30 carbon atoms, or a carbon number of 3 to 30 The alkoxy group is substituted, and the bonding position of -NH 2 bonded to the benzene ring means an arbitrary position in the ring. In the formula (DI-31-a), G 27 , G 28 and G 29 are a bonding group, which are independently a single bond or an alkylene group having 1 to 12 carbon atoms, and one or more alkylene groups. -CH 2 - may be substituted by -O-, -COO-, -OCO-, -CONH-, -CH=CH-, and ring B 21 , ring B 22 , ring B 23 and ring B 24 are independently 1,4-stretched Phenyl, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, naphthalene-1,5- In the diyl, naphthalene-2,7-diyl or inden-9,10-diyl, ring B 21 , ring B 22 , ring B 23 and ring B 24 , at least one hydrogen may be substituted by -F or -CH 3 , s, t, and u are independent integers of 0 to 2, and their total is 1 to 5. When s, t, or u is 2, the two bonding groups in each parenthesis may be the same or different, and The two rings may be the same or different, and R 26 is -F, -OH, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, or CN, -OCH 2 F, -OCHF 2 or -OCF 3 , at least one -CH 2 - of the alkyl group having 1 to 30 carbon atoms may be divalent represented by the following formula (DI-31-b) Substitution, In the formula (DI-31-b), R 27 and R 28 are independently an alkyl group having 1 to 3 carbon atoms, and v is an integer of 1 to 6; In formula (DI-32) and formula (DI-33), G 30 is independently a single bond, -CO- or -CH 2 -, R 29 is independently hydrogen or -CH 3 , R 30 is hydrogen, and carbon number is 1~ An alkyl group of 20 or an alkenyl group having 2 to 20 carbon atoms; one hydrogen of the benzene ring in the formula (DI-33) may be substituted by an alkyl group having 1 to 20 carbon atoms or a phenyl group, and the bonding position is not fixed. The group on any one of the carbon atoms represents any bonding position on the ring; in the formula (DI-32) and the formula (DI-33), -NH 2 bonded to the benzene ring is represented in The bonding position on the ring is arbitrary; In the formula (DI-34) and the formula (DI-35), G 31 is independently -O- or an alkylene group having 1 to 6 carbon atoms, and G 32 is a single bond or an alkylene group having 1 to 3 carbon atoms, R 31 is hydrogen or an alkyl group having 1 to 20 carbon atoms, and at least one -CH 2 - of the alkyl group may be substituted by -O-, -CH=CH- or -C≡C-, and R 32 is a carbon number of 6~ An alkyl group of 22, R 33 is hydrogen or an alkyl group having 1 to 22 carbon atoms, and ring B 25 is a 1,4-phenylene group or a 1,4-cyclohexylene group, and r is 0 or 1; -NH 2 on the benzene ring means that the bonding position on the ring is arbitrary; In the formula (PDI-7), R 51 is independently -CH 3 , -OCH 3 , -CF 3 or -COOCH 3 , and b is independently an integer of 0 to 2. 如申請專利範圍第9項所述的液晶配向劑,其中:所述與四羧酸二酐進行反應的二胺為選自由下述式(DI-1-3)、式(DI-2-1)、式(DI-4-1)、式(DI-4-5)、式(DI-5-1)、式(DI-5-5)、式(DI-5-9)、式(DI-5-30)、式(DI-5-37)、式(DI-7-3)、式(DI-8-2)、式(DI-12-1)、式(DI-13-1)、式(DI-14-8)、式(DIH-2-1)、式(DI-31-2)、式(DI-31-5)、式(DI-31-47)、式(DI-34-2)、式(DI-34-4)、式(DI-34-7)、式(PDI-6-1)、及式(PDI-7-1)所組成的群組中的至少一個: 式(DI-5-1)、式(DI-5-37)及式(DI-7-3)中,m為1~12的整數;式(DI-5-30)中,k為1~5的整數;式(DI-7-3)中,n為1或2;式(DI-31-2)中,R34為碳數1~30的烷基或碳數1~30的烷氧基;式(DI-31-5)中,R35為碳數1~30的烷基或碳數1~30的烷氧基; 式(DI-34-2)中,R40為氫或碳數1~20的烷基;式(DI-34-4)及式(DI-34-7)中,R41為氫或碳數1~12的烷基。 The liquid crystal alignment agent according to claim 9, wherein the diamine reacted with the tetracarboxylic dianhydride is selected from the following formula (DI-1-3), formula (DI-2-1) ), formula (DI-4-1), formula (DI-4-5), formula (DI-5-1), formula (DI-5-5), formula (DI-5-9), formula (DI -5-30), formula (DI-5-37), formula (DI-7-3), formula (DI-8-2), formula (DI-12-1), formula (DI-13-1) , formula (DI-14-8), formula (DIH-2-1), formula (DI-31-2), formula (DI-31-5), formula (DI-31-47), formula (DI- At least one of a group consisting of 34-2), a formula (DI-34-4), a formula (DI-34-7), a formula (PDI-6-1), and a formula (PDI-7-1) : In the formula (DI-5-1), the formula (DI-5-37), and the formula (DI-7-3), m is an integer from 1 to 12; in the formula (DI-5-30), k is 1~ An integer of 5; in the formula (DI-7-3), n is 1 or 2; in the formula (DI-31-2), R 34 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms. In the formula (DI-31-5), R 35 is an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms; in the formula (DI-34-2), R 40 is hydrogen or carbon. In the formula (DI-34-4) and the formula (DI-34-7), R 41 is hydrogen or an alkyl group having 1 to 12 carbon atoms. 如申請專利範圍第1項至第3項中任一項所述的液晶配向劑,其中:更包括選自包含烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、噁嗪化合物、噁唑啉化合物、及環氧化合物的化合物的群組中的至少一個。 The liquid crystal alignment agent according to any one of claims 1 to 3, further comprising a compound selected from the group consisting of an alkenyl-substituted nadic ylidene compound having a radical polymerizable unsaturated double bond. At least one of the group of the compound of the oxazine compound, the oxazoline compound, and the epoxy compound. 如申請專利範圍第11項所述的液晶配向劑,其中:所述烯基取代納迪克醯亞胺化合物為選自包含雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)苯基}甲烷、N,N'-間苯二甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、及N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)的化合物的群組中的至少一個。 The liquid crystal alignment agent according to claim 11, wherein the alkenyl-substituted nadicilimine compound is selected from the group consisting of bis{4-(allylbicyclo[2.2.1]hept-5-ene -2,3-dicarboxy quinhomine)phenyl}methane, N,N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyl In the group of compounds of quinone imine) and N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmineimine) at least one. 如申請專利範圍第11項所述的液晶配向劑,其中:所述具有自由基聚合性不飽和雙鍵的化合物為選自包含N,N'-伸乙基雙丙烯醯胺、N,N'-(1,2-二羥基伸乙基)雙丙烯醯胺、伸乙基雙丙烯酸酯、及4,4'-亞甲基雙(N,N-二羥基伸乙基丙烯酸酯苯胺)的化合物的群組中的至少一個。 The liquid crystal alignment agent according to claim 11, wherein the compound having a radical polymerizable unsaturated double bond is selected from the group consisting of N, N'-extended ethyl bis acrylamide, N, N' a compound of -(1,2-dihydroxyethylidene)bisacrylamide, ethylidene diacrylate, and 4,4'-methylenebis(N,N-dihydroxyethylidene anilide) At least one of the groups. 如申請專利範圍第11項所述的液晶配向劑,其中:所述環氧化合物為選自包含N,N,N',N'-四縮水甘油基-間二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N',N'-四縮水甘油基-4,4'-二胺基二苯基甲烷、2-[4-(2,3-環氧基丙氧基)苯 基]-2-[4-[1,1-雙[4-([2,3-環氧基丙氧基]苯基)]乙基]苯基]丙烷、3,4-環氧基環己烯基甲基-3',4'-環氧基環己烯羧酸酯、N-苯基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、及2-(3,4-環氧基環己基)乙基三甲氧基矽烷的化合物的群組中的至少一個。 The liquid crystal alignment agent according to claim 11, wherein the epoxy compound is selected from the group consisting of N, N, N', N'-tetraglycidyl-m-xylylenediamine, 1,3- Bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane, 2-[ 4-(2,3-epoxypropoxy)benzene 2-[4-[1,1-bis[4-([2,3-epoxypropoxy]phenyl)]ethyl]phenyl]propane, 3,4-epoxy ring Hexenylmethyl-3',4'-epoxycyclohexenecarboxylate, N-phenylmaleimide-glycidyl methacrylate copolymer, and 2-(3,4-ring At least one of the group of compounds of oxycyclohexyl)ethyltrimethoxydecane. 一種液晶配向膜,其由如申請專利範圍第1項至第14項中任一項所述的液晶配向劑形成。 A liquid crystal alignment film formed of the liquid crystal alignment agent according to any one of claims 1 to 14. 一種液晶顯示元件,包括如申請專利範圍第15項所述的液晶配向膜。 A liquid crystal display element comprising the liquid crystal alignment film according to claim 15 of the patent application.
TW103109220A 2013-03-14 2014-03-14 Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device TWI638856B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013052001 2013-03-14
JP2013-052001 2013-03-14

Publications (2)

Publication Number Publication Date
TW201434974A true TW201434974A (en) 2014-09-16
TWI638856B TWI638856B (en) 2018-10-21

Family

ID=51499773

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103109220A TWI638856B (en) 2013-03-14 2014-03-14 Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device

Country Status (4)

Country Link
JP (1) JP6398236B2 (en)
KR (1) KR102159410B1 (en)
CN (1) CN104046369B (en)
TW (1) TWI638856B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI631184B (en) * 2013-05-09 2018-08-01 Jsr股份有限公司 Liquid crystal aligning agent and method for producing liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, method for producing liquid crystal aligning film, retardation film and method for producing retardation f
TWI726845B (en) * 2014-06-04 2021-05-11 日商宇部興產股份有限公司 Method of producing polyimide film
CN112852446A (en) * 2019-11-27 2021-05-28 奇美实业股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI747894B (en) * 2016-03-31 2021-12-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI773714B (en) * 2016-12-28 2022-08-11 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102280839B1 (en) * 2013-10-10 2021-07-22 닛산 가가쿠 가부시키가이샤 Composition, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2015053394A1 (en) * 2013-10-10 2015-04-16 日産化学工業株式会社 Composition, treatment agent for liquid crystal alignment, liquid crystal alignment film, and liquid crystal display element
JP6422657B2 (en) 2014-02-18 2018-11-14 東京応化工業株式会社 Manufacturing method of polyimide resin, manufacturing method of polyimide film, manufacturing method of polyamic acid solution, polyimide film, and polyamic acid solution
JP6557963B2 (en) * 2014-02-25 2019-08-14 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6701635B2 (en) * 2014-10-08 2020-05-27 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
JP6421545B2 (en) * 2014-10-21 2018-11-14 Jnc株式会社 Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element containing polyamic acid or derivative thereof
JP2016138236A (en) * 2014-12-26 2016-08-04 Jsr株式会社 Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP6716966B2 (en) * 2015-03-11 2020-07-01 Jnc株式会社 Liquid crystal aligning agent for forming liquid crystal aligning film, liquid crystal aligning film, and liquid crystal display device using the same
CN118344769A (en) * 2015-03-30 2024-07-16 日产化学工业株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP6821594B2 (en) * 2015-03-31 2021-01-27 ロリク アーゲーRolic Ag Optical alignment composition
JP6672815B2 (en) * 2015-04-14 2020-03-25 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal element
CN106479518B (en) * 2015-08-24 2018-09-28 阜阳欣奕华材料科技有限公司 Diamine compound and polyamic acid and preparation method thereof, polyimides, aligning agent for liquid crystal and liquid crystal cell
KR101879834B1 (en) 2015-11-11 2018-07-18 주식회사 엘지화학 Prapapation method of liquid crystal alignment film, liquid crystal alignment film using the same and liquid crystal display device
JP6589657B2 (en) * 2016-01-21 2019-10-16 Jnc株式会社 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element using the same
CN106188579B (en) * 2016-07-13 2018-11-20 深圳市华星光电技术有限公司 The manufacturing method of the solvent of alignment film material, orientation coating solution, alignment film
WO2018066494A1 (en) * 2016-10-07 2018-04-12 シャープ株式会社 Liquid crystal aligning agent for tft substrates and method for producing liquid crystal display panel
JP7167715B2 (en) * 2016-12-28 2022-11-09 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2018159284A1 (en) * 2017-02-28 2018-09-07 Jsr株式会社 Liquid crystal aligning agent, liquid crystal alignment film, method for producing same, liquid crystal element and polymer
WO2018216664A1 (en) * 2017-05-22 2018-11-29 日産化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
KR102117151B1 (en) 2017-09-29 2020-05-29 주식회사 엘지화학 Polyimide precursor solution and polyimide film prepared by using same
TWI651313B (en) * 2018-03-07 2019-02-21 台虹科技股份有限公司 Alkenylbenzene derivative
JP7167781B2 (en) * 2018-03-27 2022-11-09 Jnc株式会社 Liquid crystal alignment agent for forming liquid crystal alignment film, liquid crystal alignment film and liquid crystal display element using the same
TWI767019B (en) * 2018-06-28 2022-06-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP7151214B2 (en) * 2018-06-29 2022-10-12 東レ株式会社 resin composition
JP2020050864A (en) * 2018-09-20 2020-04-02 住友化学株式会社 Composition
KR102391473B1 (en) 2019-01-17 2022-04-26 주식회사 엘지화학 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same
JP7494537B2 (en) * 2019-04-26 2024-06-04 Jnc株式会社 Liquid crystal alignment agent for photoalignment, liquid crystal alignment film, and liquid crystal display element
JP2020008867A (en) * 2019-09-03 2020-01-16 Jnc株式会社 Tetracarboxylic acid dianhydride
JP7484622B2 (en) * 2019-10-30 2024-05-16 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element using the same, and diamine and polymer
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032297T3 (en) * 1987-11-16 1993-02-01 Kolon Industries Inc. PREPARATION PROCEDURE OF AROMATIC POLYAMIDE FIBERS AND FILM.
JPH10274772A (en) 1997-03-31 1998-10-13 Hitachi Chem Co Ltd Composition for liquid crystal orienting film, production of liquid crystal orienting film, liquid crystal orienting film, liquid crystal holding substrate and liquid crystal display device
JP4788899B2 (en) * 2006-03-24 2011-10-05 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP4844721B2 (en) * 2006-03-22 2011-12-28 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101319206B1 (en) * 2006-03-22 2013-10-16 제이에스알 가부시끼가이샤 Liquid crystal aligning agent and liquid crystal display device
KR20080025316A (en) * 2006-09-15 2008-03-20 칫소가부시키가이샤 Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
JP5201330B2 (en) * 2007-02-23 2013-06-05 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element for forming horizontal alignment film
JP5273357B2 (en) * 2007-07-06 2013-08-28 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP5578075B2 (en) 2008-06-04 2014-08-27 日産化学工業株式会社 Liquid crystal alignment treatment agent and liquid crystal display element using the same
KR101818787B1 (en) * 2010-03-15 2018-01-15 닛산 가가쿠 고교 가부시키 가이샤 Polyamic acid ester liquid crystal alignment agent, and liquid crystal alignment film using same
TWI465483B (en) * 2010-12-28 2014-12-21 Chi Mei Corp Liquid crystal alignment agent, liquid crystal alignment film and a liquid crystal display comprising said liquid crystal alignment film

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI631184B (en) * 2013-05-09 2018-08-01 Jsr股份有限公司 Liquid crystal aligning agent and method for producing liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, method for producing liquid crystal aligning film, retardation film and method for producing retardation f
TWI726845B (en) * 2014-06-04 2021-05-11 日商宇部興產股份有限公司 Method of producing polyimide film
TWI747894B (en) * 2016-03-31 2021-12-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI773714B (en) * 2016-12-28 2022-08-11 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN112852446A (en) * 2019-11-27 2021-05-28 奇美实业股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN112852446B (en) * 2019-11-27 2023-11-17 奇美实业股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
JP6398236B2 (en) 2018-10-03
CN104046369B (en) 2018-04-20
TWI638856B (en) 2018-10-21
KR20140113421A (en) 2014-09-24
JP2014199446A (en) 2014-10-23
KR102159410B1 (en) 2020-09-23
CN104046369A (en) 2014-09-17

Similar Documents

Publication Publication Date Title
TWI638856B (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
TWI692506B (en) Liquid crystal aligning agent for forming liquid crystal aligning layer, liquid crystal aligning layer and liquid crystal display device using the same
TWI586709B (en) Polyamic acid and derivatives thereof, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device using the same
TWI596138B (en) Method to form liquid crystal photo-alignment film, and liquid crystal display
TWI621643B (en) Polyamic acid and derivatives thereof and usages thereof, liquid crystal aligning films for photo alignment, liquid crystal display devices and tetracarboxylic dianhydrides
TWI609853B (en) Photosensitive diamine, polyamic acid or derivatives thereof, liquid crystal aligning agents, liquid crystal aligning film and liquid crystal display devices
TWI592437B (en) Liquid crystal alignment agent for forming liquid crystal alignment film for photoalignment, liquid crystal alignment film and liquid crystal display device using the same
TWI612098B (en) Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same
TWI700312B (en) Liquid crystal aligning agent for forming liquid crystal alignment film for photoalignment, liquid crystal alignment film, and liquid crystal display device using the same
TWI573814B (en) Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same
JP6421545B2 (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element containing polyamic acid or derivative thereof
JP6252009B2 (en) Novel diamine, polymer using the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI705091B (en) Liquid crystal aligning agents for photoalignment, liquid crystal alignment layers, and liquid crystal display devices and lateral electric field display devices using the same
TWI663163B (en) Triazole-containing tetracaboxylic acid dianhydrides, polymer, liquid crystal aligning agents, liquid crystal alignment layers, and liquid crystal display devices using the same
TW201741395A (en) Liquid crystal aligning agents for forming liquid crystal alignment films, liquid crystal alignment films and liquid crystal display devices using the same
TW201809078A (en) Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layer, liquid crystal alignment layers and liquid crystal display devices using the same capable of forming a liquid crystal alignment layer having high adhesiveness with sealant, and providing a liquid crystal display element with a high degree of adhesiveness between narrow frame substrates
JP6904216B2 (en) A liquid crystal alignment agent for forming a liquid crystal alignment film, a liquid crystal alignment film, and a liquid crystal display element using the same.
JP2019007988A (en) Liquid crystal aligning agent for forming liquid crystal alignment film, liquid crystal alignment film, and liquid crystal display element using the same